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SUMMARY
1. The E.coli aroB gene,' encoding 3-dehydroquinate 
synthase has been sub-cloned from pLC29-47, a member of 
the Clarke-Carbon E.coli gene bank. Cells harbouring an 
aroB recombinant plasmid pKDlOl, overexpress the enzyme 
20-23 fold. Further sub-cloning of a 3*5 kh EcoRI-Bglll 
fragment, and comparison with an independently isolated 
aroB clone, pJBl4, has located the coding sequence of 
the gene.
2. The E.coli structural gene encoding 3-dehydroquinase
(aroD) has been subcloned on a 1.8 kb Clal fragment from
the plasmid pJKK12. The resulting recombinant, pKD201,
overexpresses the enzyme approximately 100-fold. The
entire DNA sequence of the Clal fragment has been determined
and the coding sequence of the aroD gene identified. The
aroD gene encodes a 240 amino acid polypeptide of calculated
M 28117. r
3* The aroA gene of E. coli, encoding 3-enolpyruvylshikimate 
phosphate synthase was sub-cloned from the tranducing 
bacteriophage ApserC. Further sub-cloning located the gene 
on a 1.9 kb Clal-PvuII fragment. Cells harbouring a number 
of aroA recombinant plasmids overexpress EPSP synthase 
approximately 100-fold, including pKD301 which is now used 
as a source of the purified enzyme; these cells are also 
tolerant to high levels of the herbicide glyphosate, the
target of which is EPSP synthase. It was found, however, 
that cloning from a Clal site in the phage reduced the 
level of expression to that found in wild type cells. 
Polyacrylamide gel electrophoresis in the presence of SDS 
of crude extracts of plasmid carrying cells showed that 
in those clones which overexpress EPSP synthase at a 
high level, a heavily stained 40 000 band is present.
4. The DNA sequence of the aroA gene has been determined. 
The gene encodes a 427 amino acid polypeptide with a 
calculated of 46112. The location of the coding sequence 
of aroA in the DNA sequence revealed that it is positioned 
700 bp away from the Clal site and examination of the 
sequence revealed that there was no obvious promoter for 
the gene. Further cloning experiments showed that the aroA 
promoter was located at least 1 200 bp upstream of the 
initiation codon.
5* DNA sequencing and analysis of the sequences upstream 
of aroA revealed the presence of another gene. This gene 
encodes a polypeptide of 3^2 amino acids and calculated 
39834, corresponding to the 40 000 band seen on SDS—PAGE 
of the crude extracts of cells carrying EPSP synthase 
overexpressing plasmids. The gene was identified as serC, 
which encodes the enzyme phosphoserine aminotransferase, 
the second enzyme on the three-step serine biosynthetic 
pathway.
6. Northern blot analysis and SI nuclease mapping have 
been used to show that the two genes are linked to form 
the serC-aroA operon. The operon is expressed from a 
single promoter, located 55 "bp upstream of the initiation 
codon for serC. Two messages are produced: the first is 
monocistronic, encoding only the serC gene; the second is 
polycistronic, and encodes both genes.
CHAPTER 1 INTRODUCTION
1.1 Overview of the shikimate pathway, and its organisation
1.1.1 The shikimate pathway
The shikimate, or common aromatic amino acid>pathway 
is responsible for the biosynthesis of chorismic acid from 
the carbohydrate precursors erythrose-4-phosphate (E-4-P) 
and.phosphoenol pyruvate (PEP). It takes its name from the 
central intermediate, shikimic acid. The conversion of 
E-4-P and PEP to chorismate is a seven step process 
(Figure l.l). Bacteria, fungi and plants are capable of 
synthesising chorismate using the same chemical steps; the 
pathway is not found in other eukaryotic organisms.
Chorismate is the branch point intermediate for 
pathways leading to synthesis of the aromatic amino acids 
phenylalanine, tryptophan and tyrosine, and for a number 
of aromatic ring containing compounds (Figure 1.2).
The steps in the pathway were elucidated by Davis and 
his co-workers in the 1950’s. Auxotrophic mutants of 
Escherichia coli were isolated which identified blocks in 
the pathway (Davis, 1951)> and it was shown that shikimate 
was the common precursor of several aromatic metabolites.
The field has been extensively reviewed (Haslam, 1974;
Weiss & Edwards, 1980; Herrmann, 1983) and is discussed 
briefly in the sections which follow.
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1.1.2 Organisation of the enzymes and genes in the pathway
In E.coli and in most bacteria which have been studied, 
each pathway enzyme occurs on a separate polypeptide 
chain, which can be purified free of the activity of any 
other pathway enzyme (Coggins _et al• , 1985)* The structural 
genes for these enzymes are widely scattered about the 
genome (Bachmann, 1983; Sanderson & Roth, 1983; Henner 
& Hoch, 1980).
In contrast, most fungi contain a pentafunctional 
enzyme, the arom complex in which the five central pathway 
activities (steps 2-6, Figure l*l) occur on a single 
polypeptide chain, the product of a single gene (Lumsden & 
Coggins, 1977; Gaertner & Cole, 1977; Larimer _et al•, 1983)* 
In plants, two of the enzyme activities, 3 - d o h y d r o -  
quinase and shikimate dehydrogenase are always found 
associated even after various procedures are employed to 
separate them (Boudet & Lecusson, 1974; M.S. Campbell &
D.M. Mousdale, unpublished results). Each of the other 
pathway enzymes is clearly separable (Mousdale & Coggins, 
1984b).
1.1.3 The shikimate pathway as a model system
The shikimate pathway is therefore a good model system 
for studying the organisation of a biosynthetic pathway. 
Several questions can be asked of the system. For example: 
Why is there a multifunctional polypeptide in some organisms 
but not in others?
Why are there multifunctional enzymes catalysing the
reactions of* some biosynthetic pathways and not all 
biosynthetic pathways within the same organism?
How might the gene encoding a multifunctional enzyme have 
evolved?
The answers to these and a number of related questions 
may be obtained by detailed studies of the enzymology of 
•the pathway and by cloning and DNA sequence analysis of 
the genes encoding the enzymes of the pathway, from a 
spectrum of'organisms.
1.1.4 Definition of a multifunctional enzyme
The arom complex represents an example of a special 
class of enzymes, the multifunctional enzymes (Kirschner & 
Bisswanger, 1976; Bisswanger & Schimcke-Ott, 1980). 
Multifunctional proteins/enzymes may be defined by two 
characteristic properties. Firstly, they have multiple 
catalytic or binding functions and secondly, these functions 
are located on the same polypeptide chain. The active 
centres and/or binding sites may be generated by the 
folding of contiguous stretches of the polypeptide chain 
to yield autonomous globular domains. The active sites 
may lie within a domain, between domains, or at intersubunit 
interfaces (Kirschner & Bisswanger, 1976).
Examples of multifunctional enzymes will be discussed 
later in this chapter, along with .the catalytic properties 
of these enzymes and their possible modes of evolution.
1.2 Genetic studies on the shikimate pathway
1.2.1 Bacteria
The structural genes for the shikimate pathways enzymes 
have been most intensively Studied in E.coli. Mutants 
completely lacking each of the enzymatic activities of the 
pathway, except shikimate kinase, have been identified.
The distribution of five of the genes (aroA - aroE) was 
deduced by Pittard & Wallace (1966), and the auxotrophic 
mutations were correlated with enzymatic deficiencies 
(Figure 1.3)* There are three isoenzymes for DAHP synthase; 
mutations in each gene (aroF, aroG, aroH) were isolated and 
mapped by Wallace & Pittard (1967)* The regions of the 
chromosome flanking the three genes described in detail in 
this work (aroA, aroB and aroD) are shown in Figure 1.4.
The aro genes of Salmonella typhimurium have been 
studied (Gollub <ej; al., 1967; Sanderson & Roth, 1983); 
their distribution is scattered and very similar to that 
of E.coli. In Bacillus subtills. there is some clustering 
of the aro genes (Henner & Hoch, 1980), but it is not known 
if the gene clustering represents a functional unit of 
transcription.
1.2.2 Control of aro gene expression in E.coli
It has been shown (Tribe ejt al. , 1976) that the 
shikimate pathway genes are expressed constitutively, with 
the exceptions of the DAHP synthases and shikimate kinase. 
Synthesis of the enzymes is unaffected by mutations in 
tyrR and trpR, the regulatory genes for tyrosine and
kroF 
  aroC
Figure 1»3: Location of the aro genes on the 100 minute E« coli 
genetic map (Bachmann, 1983)*
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7 aroC chorismate synthase
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tryptophan synthesis, respectively. With the exception of* 
the three DAHP synthases, there is no specific regulation 
by either the aromatic amino acids' or by DAHP or chorismate. 
There is, however, an unexplained change in the rate of 
enzyme synthesis co-ordinated with the growth rate.
There are two shikimate kinase isoenzymes in E.coli. 
Shikimate kinase I is expressed constitutively, but shikimate 
kinase II is under the control of the tyrR regulatory 
protein (Ely & Pittard, 1979)*
The aroH (tryptophan sensitive DAHP synthase) gene is 
regulated by trpR (trp repressor). Zurawski e_t al. (l98l) 
showed that the operator sequence of aroH has a l4/l8 bp 
similarity in the DNA sequence to the trp operator, suggesting 
that this gene is regulated by repression.
Expression of aroG (phenylalanine sensitive DAHP 
synthase) is controlled by phenylalanine and tryptophan 
through the action of the tyrR repressor (Brown & Somerville,
1971).
The aroF gene (tyrosine repressible DAHP synthase) 
is a member of the tyr operon, along with tyrA, the 
structural gene for chorismate mutase/prephenate dehydrogen­
ase. Control of the tyr operon depends on the concentration 
of tyrosine within the cell and is mediated by tyrR 
(Brown & Somerville, 1971)•
The DAHP synthase genes are also derepressed by growth 
in medium deficient in iron (McCray & Herrmann, 1976).
This is presumably to allow the replenishment of the 
intracellular pool of chorismate, which is the precursor 
of the iron chelator enterochelin.
1.2.3 Fungi
There are marked differences in the organisation of 
the enzymes and genes of the shikimate pathway in fungi.
In stark contrast to the separable enzymes/scattered genes 
found in E.coli for the five central enzymes of the pathway, 
the enzymes in most fungi that have been studied are encoded 
by the arom gene cluster. The arom gene cluster was first 
identified in Neurospora crassa (Giles e_fc al., 1976a), and 
has subsequently been found in a number of organisms, 
including other fungi (Ahmed & Giles, 1969)* Euglena 
(Berlyn e_fc al., 1970), Saccharomyces cerevisiae (de Leeuw, 
1967) and Schizosaccharomyces pombe (Strauss, 1979)*
Figure 1.5 shows the structure of the arom gene cluster 
from N. Crassa. Giles <et al. (1967a) obtained evidence for 
a gene cluster from the study of a number of polyaromatic 
mutants. These mutants displayed biochemical pleiotropic 
effects, polarity effects and the genetic localisation of 
completely non-complementing mutants was asymmetric, 
suggesting that the cluster was normally transcribed in 
a polarised fashion as a polycistronic mRNA. All' five 
enzyme activities were identified after sucrose density 
gradient centrifugation of Neurospora crude extracts as 
part of an aggregate of M^200 000.
The * arom aggregate* was first purified by Burgoyne 
et al. (1969), who showed that the five activities were 
inseparable during purification and provided preliminary 
evidence for smaller components - the five polypeptide 
chains from which, it was supposed, the aggregate was
E1 E4 E3
DNA
mRNA
intact arom polypeptide
N r --------------  ------------- ---------------------------
E2/E3 fragment
E5 fragment
Figure 1.5: Structure of the arom gene of N. crassa (Rines
et al.t 1969)* Mutations in the five enzyme 
activities of the arom complex, E1-E5 (corresponding 
to steps 2-6 in the pathway, respectively) were 
mapped in the DNA as shown above. Limited 
proteolysis has been used to isolate fragments 
of arom, carrying the activities shown (Smith & 
Coggins, 1983; M.R. Boocock, Ph.D. Thesis,
University of Glasgow, 1983)*
composed. However, when the arom complex was purified 
rapidly in the presence of proteinase inhibitors, it was 
found to be composed of two subunits of 165 000 (Lumsden 
& Coggins, 1977; Gaertner & Cole, 1977)> which are identical 
(Lumsden & Coggins, 1978).
1.2.4 Cloning of fungal arom genes
The arom gene cluster has recently been cloned from 
three organisms. Recombinants carrying the arom gene were 
identified by complementation of various E.coli auxotrophic 
mutants:
Organism: Complements E.coli:
Aspergillus aroD (Kinghorn & Hawkins,
nidulans 1982)
S. cerevisiae aro A , aroB, aroD, (Larimer e_t al. ,
aroE 1983)
S.pombe aroD, aroE (Nakanishi & Yamamoto,
1984)
The observation that the S.cerevisiae gene complements 
a number of E.coli mutants suggests that the protein coding 
region is not interrupted by introns, as these would not be 
processed in the E. coli host.
1.3 The shikimate pathway in plants
The organisation of the shikimate pathway enzymes was 
investigated in a number of photosynthetic organisms for 
evidence of enzyme aggregation (Berlyn ejfc al., 1970).
Sucrose density gradient centrifugation showed that in 
Anabaena, Chlamydamonas, Nicotiana and Physcomitrella, all 
the pathway enzymes were separable, with the exception of
3-deh.ydroquinase and shikimate dehydrogenase. It was 
also shown that Buglena has an arom-like enzyme complex. 
Boudet & Lecusson (1974) used several techniques to 
separate 3-dbhydroquinase and shikimate dehydrogenase from 
higher plants but found that they were always associated, 
suggesting the occurrence of either a multienzyme complex 
or a bifunctional enzyme. It has recently been shown 
that the shikimate pathway enzyme activities are located 
in the chloroplast (Mousdale & Coggins, 1984b), and that 
in pea seedlings 3-dehydroquinase and shikimate dehydrogen­
ase occur on a bifunctional polypeptide of 60 000 
(M.S. Campbell & D.M. Mousdale, . unpublished results).
1.4 The shikimate pathway: enzymology
1.4.1 Step 1: 3-deoxy-D-arabino-heptulosonate 7-phosphate 
synthase (E.C. 4.2.1.15)
The condensation of E-4-P and PEP to form the seven 
carbon compound DAHP and inorganic phosphate is the first 
committed step in the shikimate pathway. The enzyme which 
catalyses this step, DAHP synthase, is very important in 
that it is at the gateway to the synthesis of a number of 
compounds and it therefore regulates the amount of carbon 
flowing through the pathway. Genetic and biochemical 
analysis has shown that there are three DAHP isoenzymes 
in E.coli, each of which is repressible by a different 
aromatic amino acid (Doy & Brown, 1965; Wallace & Pittard,
All thfee DAHP synthases have been purified to 
homogeneity and shown to have a similar structure. DAHP 
synthase (phe) is a tetrameric enzyme with a subunit 
of 35 000 (McCandliss ejb al. , 1978). Both DAHP synthase 
(tyr) and DAHP synthase (trp) are dimeric enzymes with a 
subunit of 39 000 (Schoner & Herrmann, 1976; Poling 
et al. . 1981). The DNA sequences of aroF (Shultz _et al. . 
1984), aroG (Davis & Davidson, 1982) and aroH (Zurawski 
et al., 1981) show that there are regions of strong 
homology in the genes, suggesting a common ancestry.
Each DAHP synthase isoenzyme is inhibited specifically 
by a single aromatic end product. Phenylalanine and tyrosine 
inhibit DAHP synthase (phe) and DAHP synthase (tyr), 
respectively, by more than 95$>« Tryptophan does not inhibit 
DAHP synthase (trp) by more than 40$>, ensuring a continuous 
supply of chorismate for the biosynthesis of aromatic 
compounds, even when the aromatic amino acids are in excess 
(Herrman, 1983)* Feedback regulation of DAHP synthase is 
the major regulator of carbon flow through the shikimate 
pathway.
In common with E.coli, N .crassa contains three DAHP 
synthases, each of which is inhibited ‘by a different 
aromatic amino acid end product. The tryptophan sensitive 
isoenzyme has been purified to homogeneity; it is a 
tetramer with a subunit of 52 000 (Nimmo & Coggins, 198l).
1.4.2 Step 2: 3-dehydroquinate synthase (E.C. 4.6.1.3)
The second enzyme of the shikimate. pathway, 3” 
dehydroquinate synthase, is responsible for the cyclisation 
of DAHP to form 3-dehydroquinate (DHQ). During the course 
of this reaction, the enzyme catalyses an oxidation, a 
^-elimination, an intramolecular aldol condensation and 
a reduction. The E.coli enzyme has been purified to 
homogeneity from wild type E.coli (Maitra & Sprinson, 1978) 
and from both wild type and an overproducing strain of 
E.coli (Frost ejfc al•, 1984). The subunit of this monomeric 
enzyme has been reported as 56 000 (Sucrose density gradient 
centrifugation; Berlyn & Giles, 1969); 57 000 (gel filtration
and SDS-PAGE; Maitra & Sprinson, 1978); and 40 000 (SDS-PAGE; 
Frost et al., 1984). The sub-cloning of the aroB gene of 
E.coli, encoding 3-dehydroquinate synthase from pLC29-47, 
has been reported (Duncan & Coggins, 1983; K. Duncan, this 
work; Frost ejfc al •, 1984).
+The E.coli enzyme requires catalytic amounts of NAD 
2+and Co (Maitra & Sprinson, 1978). The 3-dehydroquinate ay*.t£v
activity of the arom complex also requires NAD+, but requires
2+ 2+Zn rather than Co (Lambert, Boocock & Coggins, 1984).
The purified B.subtilis enzyme has an M^ of 17 000
and is found associated with chorismate synthase and an
NADPH-dependent flavin reductase activity (Hasan & Wester,
1978a).
1.4.3 Step 3: 3-dehydroquinase (E.C. 4.2.1.10)
The first double bond of the aromatic ring system 
is introduced by the third enzyme in the pathway, 
3-dehydroquinase, which converts dehydroquinate to 
dehydroshikimate (DHS). The enzyme has been purified to 
homogeneity from E.coli K12 (Chaudhuri & Coggins, 1984b), 
and from an overproducing strain of E.coli (Dr S. Chaudhuri, 
unpublished results); it is a monomeric enzyme with a 
subunit M^, estimated by SDS-PAGE, of 29 000.
Boudet & Lecusson (1974) showed that in a number of 
plant species, 3-dehydroquinase activity is inseparable 
from shikimate dehydrogenase activity. Bifunctional 3-de.- 
hydroquinase/shikimate dehydrogenase has been purified 
to homogeneity from the moss Physcomitrella patens (Polley, 
1978), from Phaseolus mungo (Koshiba, 1979) > sxid from 
Pisum sativum.(M.S..Campbell & Dr D.M. Mousdale, unpublished 
results). The P.patens enzyme has an M^ of 49 000 while 
the Pisum sativum enzyme has an M^ of 60 000; both of 
these enzymes are monomeric.
The amino acid sequence around the active site lysine 
of the 3-dehydroquinase _ of the arom multifunctional
protein has recently been determined (Dr S. Chaudhuri, 
unpublished results).
1.4.4 Step 4: shikimate dehydrogenase (B.C. 1.1.1.25)
The dehydrogenation of dehydroshikimate to form
shikimate is catalysed by shikimate dehydrogenase. The 
NADP+ specific enzyme has been isolated from E.coli K12;
it has a subunit of 31 000 (by SDS-PAGE) and is unusual 
in that it is a monomeric dehydrogenase (Chaudhuri & 
Coggins, 1984a). The E.coli structural gene for shikimate 
dehydrogenase, aroE, has been cloned and the DNA sequence 
determined (Anton & Coggins, 1983; I* Anton, Ph.D. Thesis, 
University of Glasgow, 1984).
1.4.5 Step 5: shikimate kinase (E.C. 2.7«l»7l)
Shikimate is phosphorylated to shikimate 3 - p t Lo s p h a t e  
by shikimate kinase. Mutants which totally lack shikimate 
kinase have never been isolated from E.coli (Pittard & 
Wallace, 1966) and at least two peaks of shikimate kinase 
activity were observed on sucrose density gradient centri­
fugation of an E.coli crude extract (Berlyn & Giles, 1969) 
indicating that there are two isoenzymatic forms, shikimat 
kinase I and shikimate kinase II. Shikimate kinase I is 
synthesised constitutively, but the shikimate kinase II 
gene (aroL) is under the control of the tyrR repressor 
(Ely & Pittard, 1979)* The M^ of the enzyme has been 
estimated to be approximately 20 000 by gel filtration 
(Ely & Pittard, 1979)*
There is a single shikimate kinase in B.subtilis.
It has been purified to homogeneity and is a polypeptide 
of M^ 10 000 which is complexed with a bifunctional DAHP 
synthase-chorismate mutase (Huang et; al• , 1975)* Shikimat 
kinase may represent the key allosteric control point of 
the pathway in this organism.
1.4.6 Step 6: 5-enolpyruvylshikimate 3-phosphate synthase 
(E.C.2.5»1»19)
The reaction catalysed by EPSP synthase (alternative
name: 3-phosphoshikimate 1-carboxyvinyltransferase) is
the transfer of the enolpyruvyl moiety of PEP to shikimate
3-phosphate, yielding 5-enolpyruvylshikimate 3-phosphate
and inorganic phosphate (Levin & Sprinson, 1964). EPSP
synthase has been purified to homogeneity from E.coli K12
(Lewendon & Coggins, 1983) and from pea seedlings (Mousdale
& Coggins, 1984a). Both enzymes are monomeric, with a
subunit M of 49 000. r
A great deal, of interest has been focussed on this 
enzyme recently, following the discovery that glyphosate 
(N-phosphonomethylglycine, ’Roundup’), a successful broad 
spectrum, post emergence herbicide acts by blocking aromatic 
amino acid biosynthesis at the level of EPSP synthase 
(Steinrucken & Amrhein, 1980). Until recently, detailed 
mechanistic studies of herbicidal action on EPSP synthase 
have been hindered by the lack of sufficient quantities 
of the purified enzyme. At first the only pure preparations 
of EPSP synthase available were those of the arom enzyme 
complex of N.crassa and a detailed kinetic study of the 
effect of glyphosate on this enzyme has appeared (Boocock & 
Coggins, 1983)* The E.coli enzyme is now available in 
milligram quantities (Duncan, Lewendon & Coggins, 1984a) 
and is being studied as a model for the action of the 
herbicide on the plant enzyme.
1.4.7 Step 7: Chorismate synthase (E.C. 4.6*1.4)
Chorismate synthase introduces the second double bond 
in the aromatic ring system by trans-1,4-elimination of 
orthophosphate from EPSP to yield chorismate. The enzyme 
has been partially purified from E. coli (Morell e_t al. ,
1967) and purified to homogeneity from B.subtilis (Hasan 
& Nester, 1978b). The B.subtilis enzyme is part of a 
trimeric complex with 3-dellydroquinate synthase and NADH- 
dependent flavin reductase. In Neurospora, the chorismate 
synthase and flavin reductase reside on the same polypeptide 
chain (Welch e_t al• , 1974). Recently, a much improved 
purification of the N.crassa enzyme has been reported 
(M.R. Boocock, Ph.D. Thesis, University of Glasgow, 1983) 
but there is very little mechanistic information about 
the enzyme.
1.5 The qa gene cluster of N.crassa
In N. crassa. there is a second 3-dehydroquinase 
activity, which has a function in the catabolism of quinic 
acid (Giles _et al., 1967b). The catabolic dehydroquinase 
gene, qa-2, is a member of the cja. cluster which consists of 
five structural genes and two regulatory genes, all of 
which are tightly linked (Giles, 1978; Patel ejb al. , 1981; 
Huiet, 1984). Transcription of the structural genes is 
induced 300-1 000 fold by quinic acid, which is plentiful 
in the rotting vegetation upon which Neurospora thrives 
(Patel _et al. , 1981). Transcription is controlled by the
two regulatory genes, qa-lF and qa-lS (Huiet, 1984). The
gene products of qa-2 (catabolic 3-dehydroquinase), qa-3
(quinate/shikimate dehydrogenase) and qa-4 (dehydroshikimate
dehydratase) are responsible Tor the first three steps of
quinate and shikimate catabolism (Figure 1.6).
qa-2 was the first Neurospora structural gene to be
cloned, by complementation of an E.coli aroD mutant
(Yapnek e_t al. , 1977) * Subsequently, the entire c|a region
was cloned (Schweizer _et al• , 1981) and its genetic
organisation and transcriptional regulation investigated
(Patel ejb al. , 1981; Alton ejb al. , 1982; Huiet, 1984;
Tyler et al•, 1984).
Catabolic dehydroquinase has been purified to homogeneity
(Hautala _et al. , 1975; Chaudhuri & Coggins, 1984c). It
exists as a dodecamer with a subunit M of 20 000 (Chaudhurir v
& Coggins, 1984c). The DNA sequence of the qa-2 gene has 
been determined (Alton ^t al•, 1982; Dr M.E. Case, 
unpublished results).
The availability of the DNA sequence of the E.coli 
aroD gene and the Neurospora arom gene will allow the 
evolutionary relationships of the three dehydroquinases 
to be deduced.
1.6 The aromatic pathways beyond chorismate
Chorismate is an important substrate for a range of 
biosynthetic pathways, too numerous and too complex to 
describe in detail here. The end products of these pathways 
are shown in Figure 1.2. It is interesting, however, to
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note the diversity in the organisation of the enzymes 
and genes of the aromatic amino acid biosynthetic pathways 
of different organisms.
1.6.1 Phenylalanine
The phenylalanine biosynthetic pathway has been recently 
reviewed and a full account is given in Garner & Hermann 
(1983)* Chorismate is converted to phenylalanine in three 
steps by one of two routes (Figure 1.7)» The phenylpyruvate 
route is found in E.coli, Salmonella. Bacillus, Neurospora 
and Saccharomyces. The arogenate pathway occurs in blue- 
green bacteria and Pseudomonas aeruginasa.
In E.coli, Salmonella and K1ebsiella there is a bi­
functional chorismate mutase/prephenate dehydratase, but 
in Bacillus. Brevibacterium, Neurospora and Saccharomyces, 
the two activities reside on different polypeptides.
1.6.2 Tyrosine
An account of tyrosine biosynthesis is given in 
Camakaris & Pittard (1983)* The conversion of chorismate 
to tyrosine is a three step process (Figure 1.7)> via 
k-hydroxypyruvate (E.coli, Salmonella. Klebsiella. Bacillus. 
Pseudomonas, and Neurospora) or arogenate (blue green algae, 
Pseudomonas and Neurospora).
In E.coli. S.typhimurium and K.aerogenes a bifunctional 
chorismate mutase/prephenate dehydrogenase is found. In 
B.subtilis the single chorismate mutase provides prephenate 
for the monofunctional prephenate dehydrogenase and prephenate 
dehydratase enzymes.
Figure 1. The biosynthesis of tyrosine, phenyl­
alanine and tryptophan from chorismate.
Enzymes:
ASI (8) anthranilate synthase catalytic 
subuni t '
A S H  (g ) anthranilate synthase glutaminase 
subunit
9 anthranilate phosphoribosyl 
transferase
10 phosphoribosyl anthranilate 
isomerase
11 indoleglycerol phosphate synthase
12 tryptophan synthase step A
13 tryptophan synthase step B
CM chorismate mutase
PDH prephenate dehydrogenase
PDase prephenate dehydratase
D diaphorase (NADP-dependent
flavin reductase)
Intermediates:
PRA phosphoribosyl anthranilate
CDRP (O-carboxyphenylamino)-l-
deoxyribulose 5-phosphate
PRPP phosphoribosyl .pyrophosphate
G3P glyceraldehyde 3-phosphate
ant in 
anilate
tyrosine
1. 6. 3 Tryptophan
The tryptophan biosynthetic pathway provides the most 
striking diversity of organisation to be found. The 
enzymes which catalyse the reactions in this five step 
pathway (Figure 1*7) are organised very differently in 
different organisms. For example, some organisms have 
multifunctional enzymes for certain steps in the pathway, 
whereas others have monofunctional polypeptides. The 
combinations of enzymatic steps found associated with one 
another is also different in different organisms.
The organisation of the shikimate and tryptophan 
biosynthetic pathway enzymes is shown in Figure 1.8. The 
tryptophan pathway enzymes are organised in the following 
way.
The first reaction in tryptophan synthesis, the 
conversion of chorismate and ammonia to anthranilate and 
pyruvate, is catalysed by anthranilate synthase, which is 
subject to feedback regulation by tryptophan. E.coli 
anthranilate synthase is made up of two components: ASI,
which catalyses the NH^-dependent synthesis of anthranilate 
from chorismate and is encoded by the trpE gene, and ASH, 
which forms a covalent glutaminyl intermediate to deliver 
the amide of glutamine to ASI for anthranilate synthesis. 
The A S H  component is fused to the second enzyme in the 
pathway, anthranilate phosphoribosyltransferase; this 
bifunctional protein chain is the product of the trpD gene. 
In Neurospora, the A S H  component is fused, not to the 
second enzyme of the pathway, but to the third and fourth
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Figure 1.8: Structural organisation of enzymes of the shikimate 
and tryptophan pathways of a range of organisms.
The enzymes are numbered as in Figures 1.1 and 1*7• 
Key: Rectangles - multifunctional polypeptides
Circles - monofunctional polypeptides
Joined
circles - multienzyme complexes
enzymes of the pathway, phosphoribosyl anthranilate isomerase 
and indoleglycerol phosphate synthase, respectively. The 
yeast A S H  component is fused only to indoleglycerol phosphate 
synthase (Zalkin, 1980). Phosphoribosyl anthranilate 
isomerase and indoleglycerol phosphate synthase form a 
bifunctional enzyme in E.coli, encoded by the trpC gene.
Tryptophan synthase catalyses the conversion of indole- 
glycerol phosphate to tryptophan via the- enzyme bound 
intermediate indole. In prok aryotes, tryptophan synthase 
is a tetramer of the a2^2 eukaryotes such as
Neurospora or Sac charomyc e s. the enzyme occurs as a dimer 
of identical subunits, although it catalyses the same 
overall and partial reactions (Crawford, 1980).
In E.coli, the structural genes for the enzymes of this 
pathway are organised into the trp operon. A 7 kb region 
of DNA Encodes five trp genes, which are transcribed as a 
polycistronic message, trp EDCBA. The primary promoter for 
this operon is located 200 bp upstream of trpE. Transcription 
of the operon is regulated by repressor-operator interactions. 
Trp repressor binding to the trp operator is controlled by 
tryptophan (Platt, 1978).
A second control process, attenuation, was first 
described for the trp operon by Yanofsky (1981). During 
transcription, RNA polymerase must traverse a 162 bp leader 
region before encountering the trpE gene. The leader 
contains a transcription terminator, and whether or not 
termination occurs depends on the availability of amino- 
acylated tRNA^1'*5. If tRNA^r^ is uncharged, the full length
transcripts are produced, and tryptophan synthesis can 
go ahead.
1.7 Non-aromatic amino acid biosynthetic pathways
The structural genes for the enzymes which catalyse 
the reactions involved in the biosynthesis of the non- 
aromatic amino acids show a wide diversity in organisation 
and regulation. Like the aromatic amino acid biosynthetic 
pathways, differences are found both between the organisation 
of the same pathway in different species and between the 
types of organisation of different pathways in the same 
organism. Examples can be found in E.coli of such diverse 
modes of organisation as scattered, constitutively expressed 
genes; scattered, regulated genes; operons; and many 
multifunctional proteins. A few examples of different 
modes of gene organisation are given below.
1.7*1 Serine biosynthesis in E.coli
The three step conversion of 3-pkosphoglycerate to 
serine is described in detail in Chapter 6. McKitrick &
Pizer (1980) have shown that the serA. serB and serC 
structural genes are constitutively expressed. The genes 
are scattered about the genome (Bachmann, 1983) and so 
this organisation is similar to that found for the shikimate 
pathway structural genes (other than DAHP synthase and 
shikimate kinase genes).
1*7*2 Arginine biosynthesis in E.coli
Arginine is synthesised in eight steps from glutamine. 
Four of the genes of arginine biosynthesis are clustered 
(arg ECBH) and the others are scattered about the genome 
(Bachmann, 1983)* The synthesis of the arg biosynthetic 
enzymes is under arginine control; the genes are repressed 
by the arg repressor, the product of the argR gene (Gorini 
et al•, I96I; Mass, 1961). The genes are thus organised 
as a 1regulon1 where the product of one regulatory gene 
governs the expression of unlinked but functionally related 
structural genes.
1.7*3 Histidine biosynthesis in E.coli
The most extreme case of coordinate regulation of 
expression of the structural genes for a biosynthetic pathway 
is in the his operon. The his operon contains the structural 
genes encoding the nine enzymes which catalyse the synthesis 
of histidine from phosphoribosyl pyrophosphate and ATP. 
Histidine biosynthesis requires the expenditure of a large 
amount of metabolic resources and is unnecessary under 
conditions where histidine is available in the growth medium. 
Biosynthesis is regulated by a number of effectors, 
including operon repression mediated by attenuation; a 
transcriptional control responsive to the general availability 
of amino acids; and feedback inhibition of the first enzyme 
of the pathway (Artz. & Holzschu, 1983)*
1.7*^- Coordinate regulation of gene expression in-
bio synthetic pathways
The modes of regulation of the structural genes on the 
pathways described above suggest that coordinate synthesis 
of the enzymes is important to the economy of the cell.
Under conditions where the end product of a pathway is freely 
available in the growth medium there is no need to synthesise 
that compound and thus no requirement for the catalytic 
enzymes of the pathway. The substrate for the enzyme may 
be an intermediate which is not normally present in the 
cell and so synthesis of that enzyme on its own would be 
extremely wasteful as there would be no substrate, and/or 
no use for the product of the reaction. For this reason, 
the structural genes for most biosynthetic enzymes are 
regulated at the transcription level. It is likely that 
only the genes of those pathways, the products of which 
are required in large amounts, or are constantly depleted 
by the cell, will be constitutively expressed. But what 
of multifunctional enzymes? It is possible that they have 
evolved as a solution to this same problem. Having two or 
more activities on a single polypeptide chain ensures that 
the activities are co-ordinately expressed. It is also 
possible that bacterial operons represent the half-way 
stage between scattered genes and a multifunctional enzyme.
It is unlikely, however, that co-ordinate expression 
represents the only reason for the existence of multifunctional 
enzymes. The evolution of multifunctional enzymes is 
discussed in the sections which follow.
1.8 Evolution of multifunctional enzymes
A large number of multifunctional enzymes have been 
described (Kirschner & Bisswanger, 1976); they are found 
throughout nature, in prokaryotes, lower eukaryotes and in 
higher eukaryotes. How might such enzymes have evolved and 
is there any evidence to support the hypothesis that they 
confer some advantage to an organism?
Three reasons for the existence of multifunctional 
enzyme s are:
(i) Co-ordinate expression of enzyme activities: having 
more than one enzyme activity on a polypeptide chain ensures 
that the enzyme activities are synthesised in equimolar 
amounts.
(ii) Co-ordinate regulation of enzyme activity, the presence 
of a number of enzyme activities on a single polypeptide 
chain, possibly along with a regulatory domain, may allow 
the co-ordinate allosteric control of a number of enzyme 
activities by a single effector molecule.
(iii) Metabolic channeling: the segregation, within the cell, 
of intermediates may be important in preventing an intermediate 
being used as a substrate on a competing biosynthetic pathway. 
Multifunctional enzymes might be able to achieve this by
the slow dissociation of a product from the complex, providing 
a high steady state concentration for the next enzyme.
It has been suggested (Bonner e_t al. , 1965) that multi­
functional enzymes arose by the fusion of ancestral mono­
functional polypeptide chains, perhaps via a stage where 
the independent components were associated. This would
depend on the genes specifying the individual components 
being located adjacent to one another on the genome and 
fusion taking place at the DNA level. There are known to 
be two mechanisms by which the individual genes might be 
brought together in the genome. The first is transposition. 
Transposable elements are very common and have been shown 
to be responsible for a number of rearrangement events. 
Scattered ancestral genes might have been.transposed into 
close proximity leading either to operons (common in 
bacteria) or, after fusion, to multifunctional enzymes 
(common in eukaryotes). The second mechanism is gene 
duplication, followed by divergence and fusion. A mutation 
in a duplicate copy of a gene will not have a detrimental 
effect on the cell, and if the mutation provides a new 
function then it might confer a selective advantage.
Giles (1978) has suggested that there are two'routes 
by which multifunctional enzymes may have arisen. The 
first is, as suggested above, the transposition of scattered 
ancestral genes to a single site. A second possibility is 
that the ancestral organism possessed a true gene cluster - 
a cluster of non-contiguous, independent genes which have 
either been scattered as in the case of the E.coli aro 
genes or have been fused to form a multifunctional enzyme 
(as in arom), or an operon (E.coli trp genes).
A number of examples are given below of detailed 
investigations of the evolution of multifunctional enzymes 
which provide evidence in support of the above hypotheses.
1.8.1 Tryptophan Synthase
In E.coli and other prokaryotes, tryptophan synthase 
is a tetramer of the form a2^2* Each subunit catalyses a 
partial reaction. The sequence of the trpA and trpB genes, 
encoding the a and |3 subunits respectively, have been 
determined both from E.coli and S.typhimurium (Nichols & 
Yanofsky, 1979; Crawford £t al•, 1980). The Neurospora 
and Yeast enzymes are homodimers which catalyse the same 
overall and partial reactions, but are slightly larger 
than E.coli a +- P. The DNA sequence of the S.cerevisiae 
tryptophan synthase gene (TRP5) has recently been determined 
(Zalkin & Yanofsky, 1982).
The E.coli and yeast native enzymes are therefore similar 
in size and catalytic properties implying that the bifunctional 
enzyme has arisen by fusion of E.coli-like a and P subunits.
The homology between the E. coli a and |3 sequences and the a 
and P domains of the yeast enzyme is striking. TRP5 amino 
acids I-269 are equivalent to the E.coli a subunit (trpA) 
and amino acids 298-708 are equivalent to the E. coli f* 
subunit (trpB). This implies a fusion in the order a followed 
by (3, but in all prokaryotes which have been studied, the 
order of the structural genes in the trp operon is £ followed 
by a. In the yeast gene there is a 28 amino acid connecting 
region which may reflect the DNA sequence associated with 
the genetic events leading to the fusion event i.e. preceding 
trpB or following trpA in the ancestral organism. The 
sequence was found to be homologous to the 3 1 end of E.coli 
trpC and the trpC-trpB intercistronic region.
In E.coli, the trpB-trpA intercistronic region has the 
sequence:
trpB stop 
UGAUG
start trpA 
dUctioK. (or de («Kok)
A single base c- ^ could therefore fuse the genes 
and yet a bifunctional enzyme with a P-a fusion has not 
been found. This suggests two things. Firstly, the yeast 
enzyme has an advantage over a £-a fusion enzyme; the 
connecting region may be necessary. For example, to permit 
correct folding and interaction of the domains. Secondly, 
the fusion in yeast ensures coordinate expression of the 
subunits. In E.coli, it is possible that the close association 
of the stop and start codons allows the cell to bypass some 
of the normal steps in termination and initiation in order 
to translate the polycistronic trpB-trpA message more 
efficiently (Platt, 1978).
The sequence of the yeast TRP3 gene (ASIl/indoleglycerol 
phosphate synthase) has been compared to the corresponding 
Neurospora gene (trp-1; ASIl/phosphoribosyl anthranilate 
isomerase/indoleglycerol phosphate synthase). It has been 
shown that in each case there is a connecting region between 
the ancestral E.coli-like trpG-trpC sequences, but the 
sequence of the connector is not conserved. The connector 
is therefore probably essential for the structural integrity 
of the multifunctional enzyme, but its sequence is not 
important (Zalkin crt al. , 1984).
It is also interesting to note that in the trifunctional 
yeast HIS4 enzyme, the component activities are fused in the 
order:
HIS4A (Step 3) - HIS4B (Step Z) - HIS4C (Step 10)
In the S.typhimurium his operon the genes are linked in 
the order:
hisD (Step 10) .•..(3 genes) ....hisi (step 3 ) “ hisE
(Step 2)
During evolution of HIS4, a rearrangement of the ancestral 
components must have taken place before fusion, possibly 
allowing the most favourable interactions between domains 
(Donahue e_fc al. , 1982).
1.8.2 Aspartokinase/Homoserine dehydrogenase from E.coli
In E.coli, the first and third reactions of the common 
pathway leading to threonine and methionine are catalysed 
by two bifunctional enzymes, Aspartokinase/Homoserine 
dehydrogenase, or AKl/HDHI and AKIl/HDHII, encoded by the 
thrA and metL genes respectively. The native enzyme is a 
tetramer with each chain carrying on discrete domains the 
AK.and HDH activities. The sequence of the genes has been 
determined (Katinka ejb al• , 1980; Zakin ad., 1983) and 
comparison of the two amino acid sequences established that 
they are derived from a common ancestor.
Analysis of the thrA gene (Katinka ejt al • , 1980) has 
revealed how the bifunctional enzyme has arisen. Met-24-9 
in the sequence is the start of the dehydrogenase part of
the chain and is preceded by the sequence GAGGU which is 
homologous to the consensus E.coli ribosome binding site 
(Shine & Dalgarno, 1975)* Also i n .the preceding sequence, 
two separate base changes could have abolished two stop 
codons, yielding a fused polypeptide. The formation of the 
fused polypeptide may have given bacteria an advantage in 
co-ordinately controlling both activities at the transcription 
and translation levels, in addition to aliosteric control 
of both activities by threonine.
A computer study has shown that there are internal
homologies within the gene (Ferrara et al., 1984). It has
been postulated that there were two ancestral genes AKq
and HDH which duplicated and fused to give AK 1 AK and o ^ o o
HDH *HDH . These then fused to give AK * AK HDH fHDH, which 
o o o . o o 7
is the common ancestor of thrA and metL. This is an example 
of both a gene duplication and fusion event followed by 
divergence of the ancestral function and a fusion of two 
different enzyme activities.
The thrA gene is a member of the thr operon, along with 
thrB and thrC. The thrA-thrB and thrB-thrC junctions have 
been studied and it has been shown that only one nucleotide 
separates thrA and thrB, and that the thrB and thrC genes 
are adjacent (Cossart et^  al• , 1981). Only two nucleotide 
changes would be necessary to make the thr operon genes 
into a single tetrafunctional gene/enzyme. That this has 
not happened may reflect the necessity for connecting 
regions between protein domains, or it may suggest that the 
proximity of the genes to one another allows for enhanced
translational efficiency, as is the case with the trpB-trpA 
junction, and that this is the primary function of the 
operon, i.e. co-ordinate regulation of transcription and 
translation.
1.8.3 Fatty acid synthase
The fatty acid synthase (FAS) of mammals represents the 
most extreme case known of a multifunctional enzyme - seven 
enzyme activities on a single polypeptide chain. The 
mechanism of FAS is essentially the same in all organisms 
which have been studied and yet there is a complex variety 
of structural forms. FAS is ubiquitous; it is essential 
for the growth of membranes and the conversion of excess 
carbohydrate into fat. In bacteria and plants the FAS 
enzyme activities occur as discrete polypeptide chains but 
in most other species there are various combinations of 
multifunctional enzymes. Fungal FAS has two subunits, a 
and (3, whereas most other organisms have a single subunit 
FAS (McCarthy & Hardie, 1984).
The simplest hypothesis to explain the evolution of 
FAS is a gene fusion model. The independent polypeptides 
fused to form the vertebrate seven-function polypeptide 
seen today, and the fungal two subunits represents a more 
primitive between-stage. This, however is not the case. 
There are a number of differences between the vertebrate 
and fungal FAS enzymes; in particular the active sites 
of both enzymes have been mapped, and their order along the 
polypeptide chain is different (McCarthy & Hardie, 1984).
The gene fusion events leading to the vertebrate and fungal 
FAS must therefore have occurred independently. This is 
an example of convergent evolution; the different FAS 
enzymes must confer some advantage to the organisms which 
possess them over the monofunctional enzymes.
1.8.4 Arom
Evidence has been obtained from limited proteolysis 
and chemical modification studies that the active sites of 
the arom complex are spatially distinct and that at least 
four of the activities can be isolated on stable proteolyti 
fragments of the pentafunctional polypeptide (Coggins e^fc al 
1981; Coggins, 1982; Smith & Coggins, 1983; M.R. Boocock, 
Ph.D. Thesis, University of Glasgow, 1983)* This suggests 
that the complex may have evolved by fusion of E. coli-like 
gene sequences. "What are the advantages to fungi of the 
arom polypeptide?
The first, most obvious advantage is in co-ordinate 
expression of the activities of a number of enzymes on the 
same biosynthetic pathway. The second advantage might be 
in co-ordinate regulation of the enzyme activities. It 
has been suggested that the catalytic constants of the arom 
enzymes are altered by DAHP, the first substrate of the 
complex. An activation is seen in the presence of DAHP 
(Welch & Gaertner, 1976). The final advantage might be 
in the channeling of intermediates through the pathway. 
Giles ejfc al. (1967a, 1967b) suggested that the function of 
the arom complex was to prevent the build up of DHQ in
the cell by channeling the intermediates from DAHP to 
EPSP down the shikimate pathway, preventing the induction 
of the catabolic dehydroquinase. Kinetic evidence for 
compartmentation of the intermediates has been obtained 
(Welsh & Gaertner, 1975)> although independent experiments 
on more highly purified and more active arom complex do 
not support these results (Dr J.M. Lambert and Dr M.R. 
Boocock, unpublished results).
1.9 Aims of this project
Structural and mechanistic studies in our laboratory 
on the shikimate pathway enzymes from both Neurospora and 
E.coli have been hindered by a lack of adequate quantities 
of the enzymes in purified form. This is especially true 
for EPSP synthase, where interest in the mechanism of action 
of the herbicide glyphosate has stimulated the need for 
a three-dimensional model of the enzyme.
The contrast between the separable E.coli enzymes and 
the pentafunctional arom complex of Neurospora provides a 
model system for the structural and functional organisation 
of a biosynthetic pathway. A detailed knowledge of gene 
sequences might allow us to delineate possible modes of 
evolution leading to these very different levels of-gene/ 
enzyme organisation.
Both of these problems can be approached by cloning 
and DNA sequence analysis of the genes from both E.coli 
and Neurospora. The aim of this project was to isolate and
study a number of the E.coli genes for the shikimate pathway 
enzymes. This thesis describes the sub-cloning of the 
aroB gene (Chapter 3)» Ike sub-cloning and DNA sequence 
analysis of the aroD gene (Chapter 4); the sub-cloning and 
DNA sequence analysis of the aroA gene (Chapter 5); and 
the investigation of the expression of the aroA gene (Chapter 
6). Cloning of the E.coli aro genes has assisted the 
purification of the corresponding enzymes from overproducing 
strains; the study of EPSP synthase (Ann Lewendon, Ph.D. 
Thesis, University of Glasgow, 1984) has progressed in 
parallel with this work. No DNA sequence for an arom gene 
is yet available, and so an investigation of the evolution 
of this multifunctional enzyme has hot been carried out. 
However, a limited and preliminary comparative study of the 
genes sequenced in this work is presented in Chapter 7»
1.10 Strategy employed in cloning the aro genes
The successful completion of the work described in this 
thesis has been due mainly to three factors, namely, the 
identification of the aro genes by relief of auxotrophy of 
suitable E.coli mutants; the Close association of gene 
and enzyme studies; and the choice of the M13/dideoxy 
method of DNA sequencing. These techniques are outlined 
below.
1.10.1 Identification of cloned genes by relief of auxotrophy 
At the outset, the strategy envisaged for obtaining 
clones of these genes was to produce a plasmid gene bank of
E. coli DNA, by random * shotgun’ cloning of genomic DNA into one 
of the unique restriction enzyme cleavage sites of the 
plasmid vector pAT133 (Twigg & Sherratt, 1980). Recombinants 
carrying the gene(s) of interest were to be identified by 
transforming suitable E.coli aro strains, and selecting for 
relief of auxotrophy by the ability to grow on unsupplemented 
medium.
It was realised, however, that for an E.coli gene, it 
is not always necessary to look in a genomic library of DNA 
fragments. A large proportion of the genome has now been 
characterised on either:
(a) the Clarke & Carbon (1976) ColEl gene bank and a gene/ 
protein index is also available for these plasmids 
(Neidhart eJi al. , 1983)
(b) a number of A.-transducing phages.
If the location of a gene of interest is known, a 
plasmid or phage carrying the region of the chromosome near 
to the gene can often be found after careful searching of 
the literature. The aroB and aroA genes were sub-cloned 
from a plasmid and a phage, respectively, which were used 
initially in studies of neighbouring genes.
1.10.2 Correlation with enzymatic studies
As stated earlier, work on the E.coli genes has proceeded 
in parallel with and complementary to studies on the 
corresponding enzymes. For example, the ease with which 
the enzymes can be assayed spectrophotometrically in our 
laboratory has helped to answer a number of questions about
the expression of the genes. The amino terminal sequences 
of the enzymes and amino acid compositions have proved 
beyond doubt the location of the gene coding sequences 
on sequenced DNA fragments.
1.10.3, DNA sequencing studies
The DNA sequencing technique employed in this work 
was the M13/dideoxy method. The Sanger method of chain 
termination sequencing (Sanger, 1981) is based upon the use 
of deoxynucleotide analogues which are randomly incorporated 
into a growing DNA strand to give specific chain termination. 
The 'Klenow* fragment of E.coli DNA polymerase I is used 
to synthesise a complementary strand from a single-stranded 
template. During sequence analysis, four different reactions 
are carried out; each contains all four deoxynucleotides 
(one of which is radioactively labelled), but a different 
dideoxynucleotide, at a low concentration. Since dideoxy- 
nucleotides lack a 3*-hydroxyl group, the chain can no 
longer be extended beyond the point of incorporation and 
the end result of each reaction is a family of DNA molecules, 
each starting at the same point (the primer) and ending at 
a different dideoxynucleotide. The fragments can then be 
separated by electrophoresis on polyacrylamide gels and 
detected by autoradiography. This is summarised in Figure 
l«9a which is taken from the Amersham "M13 cloning and 
sequencing handbook”.
Figure 1.9? The M13/dideoxy method of DNA 
sequencing.
(a) The dideoxy sequencing reaction, 
beginning with single-stranded 
template DNA
(b) The life cycle of phage M13
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This sequencing method depends on a supply of pure 
single-stranded template DNA. The life cycle of the 
single-stranded filamentous phage M13 can be exploited to 
prepare template DNA (Figure 1.9h). DNA for sequencing 
can be cloned into the double stranded replicative form 
of the phage in a series of vectors developed by Messing 
(1983), prior to preparation of template for the sequencing 
reaction.
CHAPTER 2 MATERIALS AND METHODS
2.1 Materials
All reagents, with the exception of the speciality 
reagents mentioned in.the text, were purchased from BDH 
Chemicals, Poole, Dorset.
Suppliers of speciality reagents:
Amersham - Amersham International, Amersham, Buckinghamshire
Boehringer - BCL, Lewes, East Sussex
BRL - Bethesda Research Laboratories, Paisley, .
Scotland
Difco - Difco Laboratories, Detroit, USA
Sigma - Sigma Chemical Company, Poole,. Dorset
2.2 Bacterial strains
The bacterial strains used in this work are all 
derivatives of E.coli K12. They are listed in Table 2.1, 
along with the markers carried on the strains, and the 
source of the strain.
Stocks of each strain, and of plasmid carrying strains 
were maintained as follows: A 10 ml LB culture was inoculated 
with a single colony isolate of the strain and grown over­
night at 37° with shaking. A 1 ml sample was taken and 
tested for either markers carried by the strain or for a 
plasmid present within the strain. 9 ml of sterile 80$ 
glycerol was added to the remainder of the culture and f? 
after thorough mixing was placed at -20° for long term 
storage.
Strain Genotype Origin/Reference
E.coli K12 wild type ATCC 14948
A cixiwetwe.
UeJLe^ -ber^ strftX^ . ^ >3ioo.
American Type Culture 
Collection
(Rockville, Maryland 
USA)
E.coli AB2826 aroB, supE42, A.” CGSC
(E.coli Genetic Stock 
Centre
Dept, of Human Genetics 
Yale University 
New Haven, USA)
E.coli AB2848 aroD352, tsx356, 
supE42, A"
CGSC
E.coli AB2829 aroA354, supE42,A.” CGSC
E.coli KL282 serC13, (serSl4, serSl6), 
phoA4, relAl, tonA22,
T? , supD32
CGSC
E.coli 3M101 'Aflac pro\ thi, supE, 
F'traD36, proAB, lacl^, 
lacZA |»I15
Messing _et al. (1981)
E.coli HB101 F~, pro, leu, thi, lacY, . 
hsdR, endA, recA, rpsL20, 
aral4, qalK2, xyl5, mtll, 
supE44
Bolivar & Backman (1979)
Table 2.1: E.coli strains described in this study.
2.3 Plasmids and phage described in this study
The plasmids and phage described in this stndy are 
shown in Tables 2.2 and 2*3» Table 2.2 lists those plasmids 
and phage which have been used as vectors, or source 
material; Table 2*3 describes the plasmids constructed 
during the course of* this work.
2.4 Growth media
The growth media used in the course of* this work are 
listed in Table 2.4. All media were sterilised by auto- 
claving; (+ 1 x *) indicates that this item was added 
after autoclaving.
In making MM plates, the M9Salts and agar were auto- 
claved separately, as 2 x M9 salts and 30$> agar. Then 
equal volumes were mixed before plating.
Any supplements to plates were added as concentrated 
stock solutions after the medium had cooled to 35°, and 
immediately before pouring.
Throughout the text, the notation LB/amp is used to 
indicate L broth supplemented with ampicillin at 30 p-g/ml.
2.3 Supplements to growth media
Supplements to growth media are listed in Table 2.3 
or in the text of the results chapters. They were sterilised 
by autoclaving, where possible, or by passage through a 
0.22 p.M filter (Millipore).
Plasmid Markers Origin/Reference
pAT153 R 4- 4.R amp , tet Tuigg & Sherratt (1980)
pBR322
R . . R amp , tet Sutcliffe (1977)
PKK223-3
Ramp 0. Brosius, unpublished 
(Dr 3. Knoules)
pLC29-47 aroB+ , ponA+ Takeda et al. (1981) 
(Dr S.R. Kushner)
Phaqe
ApserC serC+ , aroA+ , rpsA+ Kitakaua et al. (1980) 
(Dr K. Isono)
Table 2.2; Plasmid vectors; plasmid and phage source material.
Plasmid Markers DNA inserted at Vector
pKDlOl aroB+ 4. 4-Rtet Pst I PAT153
pKD102 aroB+
. .R tet Pst I pAT153
pKD103 aroB+ 4- 4.Rtet Pst I PAT153
pKD104 aroB+ 4- 4-Rtet Pst I pAT153
pKD105
R
amp BamHI pAT153
pKD106 aroB+
R
amp EcoRI - BamHI PAT153
pKD201 aroD+
R
am£ Cla I PAT153
pKD202
R
amp Cla I pAT153
pKD501 aroA+ serC+ tet^ Pst I pAT153
pKD502 aroA+ serC+ tet^ Pst I pAT153
pKD503 aroA+
n+ R 
serC amp BamHI - Hind III pAT153
pKD504
+
aroA
n+ R serC amp BamHI - Aval pAT153
pKD505 aroA+
R
amp Clal - Aval pAT153
pKD506 aroA+
R
am£i Clal - PvuII pBR322
pKD508 aroA+ serC+ tet^ PstI PAT153
Table 2.3: Plasmids constructed during the course of this work.
Medium Composition, per litre (final concentration)
L-Broth (LB) 10 g bactotryptone (Difco) 
5 g yeast extract (Difco) 
10 g NaCl
(+ 5 ml 20$ glucose) (0.1$)
L-Agar (LA) as LB, + 15 g agar (Difco)
Minimal medium 1 g NH4C1 (0.02 M)
(M9 Salts, MM) 0.13 g MgS04 7 H20 (0.5 mM)
3 g k h 2p o 4 (0.02 M)
6 g Na2HP04 (0.04 M)
(+ 1 ml 100 mM CaCl ) (100 *M)
(+ 2 ml thiamine (l mg/ml)(Sigma) (2 p-g/ml)
(+ 10 ml 20$ glucose) (0.2$)
MM plates as MM, + 1 5  g agar
2TY 16 g bactotryptone 
10 g yeast extract 
5 g NaCl
H plates 10 g bactotryptone 
8 g NaCl 
12 g agar
H top agar 10 g bactotryptone 
8 g NaCl 
8 g agar
Table 2.4: Growth media.
Supplement Concentration
(vo/ml)
Stock solution
Ampicillin 50 -pg/ml 25 mg/ml
Tetracycline 20 p-g/ml 10 mg/ml in ethanol
Chloramphenicol 170 v-g/ml 34 mg/ml in ethanol
Aromatics:
(i) phenylalanine 300 p>g/fnl
(ii) tryptophan 150 p-g/ml
(iii) tyrosine 300 p-g/ml
(iv) p-aminobenzoate 1.2 -jig/ml 300 p-g/ml
(v) p-hydroxybenzoate 1.2 p,g/ml 300 p,g/ml
Serine 20 p-g/ml
Pyridoxine 0.075 75 p,g/ml
Table 2.5: Supplements to growth media.
2.6 Preparation of plasmids (small scale)
For small scale (’mini-prep1) plasmid preparations, 
the method of Holmes & Quigley (1981) was followed. Lysis 
buffer is: lOmM-tris (pH 8.0), 50mM -EDTA, 8°/o sucrose,
0.5$> Triton X-100. . Lysozyme was prepared as a stock solution 
(10 mg/ml in TE) and stored in small aliquots at -20°.
TE buffer is lOmM-tris (pH 8.0), 2mM-EDTA.
2.6.1(a) 1 ml Preparations
1 ml of plasmid carrying cells in medium was placed in 
a 1.5 ml microfuge tube and the cells harvested by centri­
fugation (l min.). The pellet was resuspended in 350 pi 
lysis solution and 25 p-l lysozyme (10 mg/ml) was added.
The tube was placed in a boiling water bath for 4-5 s and 
then spun for 5 min. The supernatant was removed to a 
fresh tube and the plasmid DNA recovered by the addition of 
an equal volume of isopropanol, followed by chilling at 
-70° (dry ice/methanol) for 10 min and centrifugation 
(10 min). The plasmid DNA pellet was resuspended in 30 pi 
TE. 5 V-l was sufficient for a single restriction enzyme 
digest (approximately 1 pg of DNA).
2.6.2(b) 10 ml Preparations
As above, except that: cells harvested by centrifugation
in an MSE18 centrifuge (9 000 x g, 2 min); resuspension 
volume was 700 p.1 lysis solution + 50 pi 10 mg/ml lysozyme; 
plasmid DNA was resuspended in 50 pi TE.
A large amount of RNA is present in these preparations 
which obscures the lower part of an agarose gel. If bands 
with lengths 500 bp were to be visualised, the preparation 
was treated with RNAse A (2.5 pi of 1 mg/ml stock; 37°,
15 min) before analysis or storage.
2.7 Preparation of plasmids (large scale)
The method used is described in Maniatis ejb al. (1982) 
and is a modification of the alkali lysis technique of 
Birnboim & Doly (l979)»
2.7»l(a) Growth of plasmid carrying cells
A single plasmid carrying colony was inoculated into 
10 ml LB/antibiotic and shaken overnight. 0.1 ml of this 
culture was used to inoculate 25 ml LB/antibiotic and the 
flask shaken till late log phase was reached (A^^^= 0.8) •
The whole 25 ml culture was then poured into 500 ml LB/ 
antibiotic (prewarmed to 37°) and shaken exactly 2-§- h.
Then 2*5 ml of chloramphenicol (3 -^ mg/ml in ethanol) was 
added (170 pg/ml final concentration) and incubation 
continued a further 16-20 hours.
The cells were then harvested and washed in 100 ml 
ice-cold STE (0.1M - NaCl, lOmM-tris (pH 7*8), ImM-EDTA).
2.7»2(b) Alkali lysis
The bacterial pellet was resuspended in 10 ml 50mM- 
glucose, 25mM-tris (pH 8.0), lOmM-EDTA and 1 ml lysozyme 
(50 mg/ml) added. The solution was transferred to a 100 ml
polycarbonate tube and 20 ml 0.2N - NaOH, 1 $ SDS was 
added and mixed. After standing the tube on ice for 
10 min, 15 ml of 5M-potassium acetate (pH 4.8) was added, 
mixed, and the tube placed on ice a further 10 min. The 
cell DNA and debris was pelleted by centrifugation 
(MSE Prepspin 50, 30 000 x g, 30 min). The supernatant 
was divided between two 50 ml polycarbonate tubes and 
15 ml isopropanol added to each. After standing at room 
temperature for 15 min, the DNA was recovered by centri­
fugation (MSE 18, 12 000 x g, 30 min). The pellet was 
washed with 70$ ethanol then dried briefly under vacuum.
The DNA was resuspended in 8 ml TE (lOmM-tris pH 8.0,
2mM-EDTA), before treatment with RNAse. RNAse A (pre­
treated at 100° for 10 min) and RNAse T^ (pre-treated at 
80° for 10 min) were added to a final concentration of 
100 pg/ml and 100 U/ml respectively and incubated for 
1 h at 37°.
2.7«3(c) Equilibrium centrifugation in CsCl - ethidium bromide 
gradients
The volume of the DNA solution was carefully measured.
1 g of solid CsCl was added for every ml of solution and 
the contents mixed to dissolve the salt. The volume was 
again measured exactly. Ethidium bromide (lO mg/ml) was 
added (0.8 ml per 10 ml CsCl solution). The final density 
was 1.55 g/ml and the ethidium bromide concentration 
600 pg/ml.
The solution was transferred into a 10 ml polycarbonate 
tube, suitable for a Beckman Ti50 rotor and centrifuged in
a Beckman L8-M, 4-5 000 rpm, 20°, for 48 h.
The band containing the plasmid DNA was viewed under 
long-wave TJV light and removed by pumping through a needle 
inserted through the top of the tube to just below the 
band. Ethidium bromide was removed by extraction with 
1-butanol saturated in TE buffer, till all the pink colour 
had been extracted. The aqueous DNA solution was dialysed 
against three changes, each of 1 000 x sample volume, of 
TE buffer. The DNA concentration was determined by reading 
the A-26O ^260 = 1,0 = 50 pg/ml DNA) and the concentration 
of the solution adjusted to 1 mg/ml by the addition of 
TE buffer.
2.8 Preparation of E.coli K12 genomic DNA
DNA was prepared from E.coli K12 as follows:
A single colony of E.coli K12 was inoculated into 100 ml 
LB and shaken at 37° till the reached 0.7» The cells
were harvested, washed with 50 ml TE, then resuspended in 
2 ml 0.15M-NaCl, 0.1M-EDTA. 0.2 ml lysozyme (10 mg/ml) 
was added and the tube incubated at room temperature for 
15 min. It was then frozen to -70° (dry ice/methanol).
12.5 ml of 0.1M NaCl, O.IM-tris (pH 8.0), 1$ SDS was added 
and the tube placed in 65° water bath till the frozen 
material thawed. The tube was again frozen to -70° and 
thawed to 65°. The sample was kept at 65° for several 
days to dissolve the DNA; very gentle inversion of the 
tube at intervals assisted this process.
The volume was estimated and 1.282 g CsCl/ml DNA 
solution added. Using a rofractometer, the concentration
of the solution was adjusted till the refractive index 
was 1*39970 (l.70 g/ml). The solution was centrifuged 
to equilibrium (Prepspin 30, 10 x 10 ml Rotor, 190 000 x g, 
Gh h) and the gradient fractionated by taking samples down 
the tube with a wide-bore pipette. DNA containing fractions 
were pooled and dialysed against TE buffer.
2.9 Preparation of ApserC
The method used was modified from that described in 
detail in Maniatis e_t al. (1982).
2.9.1(a) Preparation of phage
A single colony of E.coli KL282, lysogenic for ApserC 
was inoculated into 100 ml LB and shaken overnight at 30°. 
Two 500 ml batches of LB, prewarmed to 30°, were then 
inoculated with sufficient of the overnight culture to give 
a starting of 0.05* The flasks were shaken at 30°
till the reached 0.3* The culture was induced by
incubation at ^3° in a shaking water bath. The induced 
culture was shaken a further k h at 37°• 10 ml of
chloroform was added to each flask and shaking continued 
a further 30 min.
The lysed cultures were cooled to room temperature 
and pancreatic DNAse and RNAse (Sigma) were added, both 
to a final concentration of 1 ]ig/ml. After a 30 min 
incubation, solid NaCl was added to 1 M final concentration 
and the flasks allowed to stand for 1 h. Debris was removed 
by centrifugation (ll 000 x g, 10 min). Solid polyethylene
glycol (PEG 6 000) was added to 10% w/v and dissolved by 
slowly stirring on a magnetic stirrer. Phage particles
were precipitated by standing the flask on ice for 1 h.
The precipitate was recovered by centrifugation (ll 000 x g, 
10 min)• The phage pellet was then resuspended in 16 ml 
SM(50mM-tris (pH 7 •5) O.lM-NaCl, 7.5mM-MgS0^, 0.01% 
gelatin); to this was added 16 ml chloroform and the two 
solutions vortex mixed. The phases were separated by 
centrifugation (l 600 x g, 15 min) and the aqueous phase 
retained. 0.5 g/ml of solid CsCl was added and the phage 
suspension layered on top of a CsCl step gradient, prepared 
with CsCl solutions of 1.^5> 1»50 and 1.70 g/ml densities. 
Gradients were centrifuged in a Prepspin 50 6 x 14 ml 
swing-out rotor at 33 000 rpm for 2 h.
The phage particles were seen as a band at the inter­
phase of the 1.^ -5 and 1*50 g/ml layers; the band was 
removed with a pasteur pipette. CsCl solution (l»5 g/ml) 
was added to the phage suspension to make up to the volume 
necessary for a polycarbonate tube for a Prepspin 50 
10 x 10 ml rotor. The suspension was then centrifuged at 
40 000 rpm for 36 h and the phage band recovered. Phage 
were then stored at 4° in the CsCl solution.
2.9.2(b) Extraction of phage DNA
1 ml of purified phage suspension was dialysed against 
two changes of 1 1 of lOmM-NaCl, 50mM-tris (pH 8.0), 
lOmM-MgCl^. The following were added (final concentration 
in brackets):
EDTA ‘ (20 mM)
proteinase K
(Boehringer) (50 p,g/ml)
SDS (0.5%)
Incubation was lor 1 h at 65° •
The DNA was extracted by phenol and chloroform, 
transferring the aqueous phase with a wide-bore pipette.
It was then dialysed against three 1 000-fold volumes of 
TE.
2.10 Restriction enzyme digestions
Restriction enzymes will tolerate a wide variation in
the conditions under which they will cleave DNA, although
with a possible reduction in activity under non-ideal
conditions. For this reason, five buffers were used,
according to the conditions recommended by the manufacturer.
The composition of four of the buffers is shown below:
high salt medium salt low salt Smal
NaCl (mM) 100 60 0
tris (pH 7 .5) (mM) 50 10 10 10
(pH 8.
MgCl2 (mM) 10 10 10 10
DTT (mM) 1 1 1 1
KC1 (mM) - - . - 20
Smal buffer was used for Smal only. The fifth buffer 
was 'Core Buffer' (BRL); a number of enzymes use this 
standard buffer.
Restriction enzyme digests were routinely carried 
out in a final volume of 20 pi, but larger volumes were 
also used, where appropriate. A typical digest contained: 
DNA (0.5 - 1.0 pg) l - 5 ) i l
10 x restriction enzyme buffer 2 pi 
10 x BSA 2 pi
water to 20 p,l
The BSA stock concentration (10 x) was 1 mg/ml 
(BRL, nuclease-free).
In multiple digests where a different buffer was 
required, the lowest salt buffer digestion was carried out, 
then the higher salt buffer + second enzyme was added, and 
digestion carried out for a further period.
Digests were routinely incubated with the manufacturer' 
recommended quantity of restriction enzyme at 37° for 1 h, 
except for Smal (30°) and TaqI (55° oven).
2.11 Phenol/Chloroform extraction of DNA and ethanol 
precipitation
DNA was routinely purified free of enzymes by phenol/ 
chloroform extraction and ethanol precipitation. Phenol 
was redistilled before use, saturated with TE buffer and 
stored at -20°.
Phenol/chloroform extractions were performed as follows 
volume of sample to be extracted was adjusted to 50 pi 
with TE, if necessary; 50 pi phenol was added and vortex 
mixed; centrifuged 1 min; upper aqueous layer transferred 
to fresh microfuge tube and phenol extraction repeated;
500 pi chloroform added and vortex mixed; centrifuged 
5 s; aqueous layer transferred to fresh tube and chloroform 
extraction repeated.
Ethanol precipitation: l/lO volume of 2»5M-Na
acetate pH 5*2 and 2\ volumes of ethanol added and vortex 
mixed; placed -20° overnight, or -70° (dry ice/methanol) 
for 15 min; centrifuged 10 min.
2.12 Gel electrophoresis of DNA
DNA and DNA fragments were separated by gel electrophoresis
on agarose or polyacrylamide, as follows:
size range: gel concentration:
10 - 100 kb 0.59^ agarose
0.5 - 10 kb 1.0^ agarose
0.5 - 5 kb 1.2°/o agarose
0 . 1 -  2 kb (2.0io agarose or
(5$> polyacryl amide
2.12.1(a) Agarose gel electrophoresis
Agarose (BRL) gels were prepared by heating to boiling 
point in a reflux apparatus the desired quantity of tris- 
borate buffer (89mM-tris, pH 8.0, 89mM-borate, 2mM-EDTA) 
containing the appropriate concentration of agarose. The 
molten agarose was allowed to cool to 55°> ethidium 
bromide (10 mg/ml) was added to give a final concentration 
of 0.5 pg/ml, and the gel poured. Gels were run immersed 
in the same buffer containing ethidium bromide (0.5 Pg/ml) 
at 100 - 150 mA.
DNA samples were prepared for electrophoresis by 
the addition of l/lO volume of ’dye loading buffer1 (30Jo 
sucrose, 0.1$> bromophenol blue, in 1 x tris borate).
2.12.2(b) LMT gels (low melting temperature)
LMT gels were prepared exactly as described above, 
except that they were poured and run in the cold room. 
LMT agarose was purchased from BRL.
2.12.3(c) Polyacrylamide gel electrophoresis
Polyacrylamide gel electrophoresis was carried out 
as described in Maniatis at al. (1982).
2.13 Photography of gels
DNA was visualised by ethidium bromide fluorescence 
on a transilluminator (UV Products, Inc.). Gels were 
photographed with a Polaroid CU-5 camera and type 665 
positive/negative film.
2.14 Recovery of DNA fragments from LMT gels
DNA fragments were recovered from LMT gels for sub­
cloning free of other fragments in a restriction digest, 
or for further sub-digestion of a specific region of a 
plasmid. These two procedures differ in the degree of 
purity of DNA required.
2.14(a) Recovery of fragments for sub-cloning
Efficient sub-cloning requires purified DNA fragment 
for ligation to vector DNA« The fragment of interest was 
excised from a gel and placed in a 1*5 ml microfuge tube.
5 volumes of LMT extraction buffer (20mM-tris (pH 8.0), 
ImM-EDTA) were added (100-200 p-l) the tube heated at
65° for. 15 min. An equal volume of phenol was added, 
vortex mixed, and the phases separated by centrifugation 
(2 min). The aqueous layer was removed to a fresh tube 
and the phenol layer was back-extracted with 50 • ‘P-l TE.
The aqueous phases were combined and the phenol extraction 
repeated two times. This was followed by three 1 ml 
chloroform extractions and the DNA was recovered by 
ethanol precipitation.
2.14.2(b) Preparation of gel slices for further digestion 
In this case, the DNA was prepared for digestion, 
without further purification. Gel slices, containing the 
DNA fragment of interest were placed in a 1.5 ml microfuge 
tube and 1 ml ice-cold water added. The tube was kept on 
ice for 1 h, with one change of water, then changed to 
1 x restriction enzyme buffer for a further 1 h. The 
buffer was removed and the tube heated at 65° for 10 min, 
before being quickly transferred to a 37° bath. 10 x 
restriction enzyme buffer, 10 x BSA and water were added 
to adjust the components to the correct concentrations. 
Restriction enzyme (approximately three times more than 
usual) was added and digestion carried out for 1-2 h.
2.15 Phosphatase treatment of DNA
Phosphatase treatment of DNA removes the 5 1-phosphate 
groups, preventing self-religation, and thereby increasing 
the yield of recombinants.
Plasmids were treated with phosphatase as follows.
The plasmid DNA was cleaved with restriction enzyme and 
purified by phenol/chloroform extraction and ethanol 
precipitation. DNA was resuspended in:
10 x CIP buffer 5 pi
water to 50 pi
(CIP buffer is 0.5mM-tris (pH 9*0), lOmM-MgCl^, lmM-ZnCl^)
To this was added calf-intestinal-phosphatase (Boehringer) 
and samples were incubated as follows:
5' - protruding ends - 0.05 37° > 30 min then a further
0.05 TJ, 37°, 30 min.
blunt ends  ^ 0.05 U, 37°> 15 min then 5^°, 15 min
) followed by a further 
3* - protruding ends ) 0.05 U, 37°> 15 min then 56°, 15 min
40 pi of water, 10 pi of 10 x STE and 5 pi of4 10$ SDS were
added, and the tube was then heated to 65° for 10 min to
inactivate the phosphatase and the DNA recovered by phenol/
chloroform extraction and ethanol precipitation.
2.16 Ligation of DNA fragments
Ligation reactions were carried out in mixes containing
the following:
insert D N A  2  - 5 pi ( ^ O n j )
vector DNA 2 - 5  pi (foO
10 x ligase reaction
buffer 2 pi’
ATP (5mM) 2 ]il
dithiothreitol (lOOmM) 2 pi 
water to 20 pi
The DNA ligase (BRL) was added, and incubated for: 
sticky ends 0.1 U, 1^°, k - 6 h
blunt ends 0.5 U, 0°, 16 - 2k h
The amount of DNA in the ligation reaction was adjusted 
to meet a target molar ratio of 5 si insert ends:vector ends.
2.17 Transformation of E.coli
2.17.1(a) Preparation of competent cells
The transformation protocol was modified from the
method of Dagert & Ehrlich (l979)« This method involves
the treatment of logarithmically growing cells with CaCl^
and' storage of the transformation competent cells on ice
for 2k h before use. The authors claimed that this treatment
increases the proportion of competent cells approximately
20-30 fold, despite a reduction in cell viability.
Experiments with the strains most frequently used in this
work (E.coli AB2826, AB2829> and AB2848) showed that the
increased proportion of competent cells gained on overnight
storage was matched by the decrease in viability of the
cells. For this reason, competent cells were routinely made
on the day they were needed. The transformation efficiency
5 6of the strains was optimised, yielding 5 x 10 - 1 x 10
transformation/pg covalently closed circular pAT153 DNA.
Competent cells were prepared from a fresh, overnight 
culture of E.coli grown in 10 ml LB. 0.3 ml of this culture 
was inoculated into 30 ml LB and shaken vigorously at 37° •
"When the A ^ ^  reached 0.3 - 0.3» the cells were placed on 
ice (10 min) then harvested (MSE18, 7 000 x g, 3 min).
All subsequent steps were performed on ice and the cells 
handled carefully (i.e. no vortexing) to avoid damage of 
the fragile CaCl^-treated cells. The cells were resuspended 
in 20 ml ice-cold 30mM-CaCl2 and kept on ice 20 min. They 
were then harvested and resuspended in 0.3 ml 30mM-CaCl2*
2.17*2(b) Transformation
100 11I of competent cells was added to DNA in a sterile 
tube. Ligation mixes were used without further treatment.
The DNA/cell mixture was incubated on ice (15 min) then 
placed in a 37° water bath. After 3 min, 2 ml LB (pre­
warmed to 37°) was added and incubation continued for h, 
before plating.
2.18 Preparation of crude extracts of E.coli
E.coli crude extracts were prepared from 100 ml cultures, 
grown in 2 x 50 ml batches (for aeration- in 230 ml flasks). 
Minimal medium, minimal medium supplemented with aromatics, 
or LB was used. 30 p.1 of -20° glycerol stock cells was 
inoculated into 10 ml LB (+ antibiotic for plasmid selection, 
if present) and shaken overnight at 37°• A 1 ml sample 
was taken for confirmation of plasmid, if present. Each 
30 ml batch of medium was inoculated with 0.1 - 1.0 ml of
overnight culture, depending on the strain and/or amount
The cells were washed with sonication buffer and 
resuspended in 5 ml of the same buffer. The two buffers 
used were:
sonication buffer !A ’ = 200mM-KCl, ^OOmM-KH^PO^, 2mM-MgCl2>
lmM-t3-mercaptoethanol (pH 7*0) 
sonication buffer 1 B ‘ = 200mM-tris, 200mM-KCl, ImM-EDTA,
ImM-dithiothreitol (pH 7•5)•
The cells were then disrupted by 3 x 30s bursts of 
sonication, with a 30s cooling period between (Dawe soniprobe 
Type 7532A; output 2, 80W).
The extracts were then centrifuged (MSE Prepspin 50>
200 000 x g, 2 h) to remove debris and membrane bound enzymes
2.19 Enzyme assays
The instrument used for all spectrophotometric assays 
was a Gilford-Unicam model 252 spectrophotometer (chart 
full scale 0.1A or 0.05A). Assays (total volume 1 ml in 
1 cm path length cells) were all conducted at 25°• One 
unit of enzyme activity is defined as the amount of enzyme 
that catalyses the conversion of 1 iimol substrate/min.
2.19«l(a) 3-dehydroquinase
3-dehydroquinase was assayed in 0.1 M-potassium phosphat 
buffer, pH 7*0. Extract was added to the cuvette and a
of growth required and the culture shaken at 37°• Cultures 
were harvested during late-log phase (A^q = 0.8 - 0.9) or 
stationary phase (A^q = 1 . 3 - 1  • 5) •
baseline A2 3 obtained. The reaction was initiated by the 
addition of 3-dehydroquinate to a final concentration of 
0.2 mM. The ammonium salt of 3-dehydroquinate was a gift 
from Dr S. Chaudhuri.
2.19»2(b) 3-dehydroquinate synthase
3-Dehydroquinate synthase was assayed by coupling to 
the 3-dehydroquinase reaction and measuring the rate of 
change of The final concentrations of the components
in the assay mix were:
glycine/KOH pH 8.k
‘ CoC12 
NAD+
DAHP
partially purified E.coli 
3-dehydroquinase 0.02 U
The measured change in reaction rate was initiated with
DAHP and the baseline rate at 23^ nm was subtracted to
give the true rate. DAHP and partially purified E.coli
3-dehydroquinase were gifts from Ms A. Coia.
2 . 1 9 » 3 ( c )  . EPSP synthase
EPSP synthase activity was measured in the reverse 
direction by coupling the formation of PEP to the pyruvate 
kinase and lactate dehydrogenase reactions. The assay 
mix contained (final concentration):
100 mM 
200 pM 
50 viM 
400 p,M
potassium phosphate pH 7*0 100 mM
ADP 2.3 mM
MgCl2 2.3 mM
NADH 0.1 mM
EPSP 30 p-M
PK/LDH 2.3 P-l (Boehringer)
The rate of change of was measured and a blank rate
(due to NADH oxidase) obtained. EPSP was added to the 
cuvette to initiate the reaction and the change in the 
rate of decrease in A3^0 measured. EPSP was a gift from 
Ms A. Lewendon.
2.19*Md) PSAT
The assay for PSAT activity is based on that described 
in Hirsch-Kolb & Greenberg (1971)> and modified by Ann 
Lewendon. Assay mixes (l ml) contained:
tris (pH 8.2) 50 mM
NH^ acetate 32 mM
glutamate 2 mM
NADH 0.2 mM
l^-hydroxypyruvate 2.3 mM (or phosphohydroxy-
pyruvate)
Glutamate dehydrogenase 0.02 mg
The reaction was initiated by the addition of P- 
hydroxypyruvate and the change in the rate of absorbance 
change at 3^0 nm measured.
2.20 Determination of protein concentration
Protein concentrations were determined by the method 
of* Bradford (1976). A standard curve was set up with 
varying concentrations of bovine serum albumin in the same 
buffer in which the protein determinations were to be 
carried out.
2.21 Polyacrylamide gel electrophoresis in the presence of SDS 
Polyacrylamide gel electrophoresis in the presence of 
SDS was performed by the method of Laemmli (1970). The 
percentage acrylamide used is described in the text; a 
3% stacking gel was used. Samples were boiled for 3 min 
in 3% SDS, 50 mM-tris (pH 6.8), 10% glycerol, 2% bromophenol 
blue before loading. Gels were stained for protein in 50% 
methanol, 10% acetic acid, 0.1% Coomassie blue (Serva G-250) 
for 45 min at 40° and destained overnight in 10% methanol,
10% acetic acid (40°).
Molecular weight markers were:
Bovine serum albumin (68 000)
Catalase (60 000)
Glutamate dehydrogenase (53 000)
Aldolase (40 000)
Glyceraldehyde phosphate dehydro genas e(3 8 000)
Carbonic anhydrase (29 000)
Approximately 2 pg of each was loaded.
2.22 DNA sequencing
All DNA sequencing was carried out using the M13/ 
dideoxy method (Sanger, 1981; Messing, 1983)* Initially, 
the components for M13 cloning and DNA sequencing were 
purchased in the form of kits; latterly, individual 
components were purchased and substituted. All the protocols 
for cloning and sequencing were supplied with the kits in 
the form of the "Ml 3 cloning and sequencing handbook" 
(Amersham International pic), and these were strictly adhered 
to. In the following sections, page numbers in the format 
(handbook p.l) refer to the Amersham handbook.
2.23 M13 vector DNA
The paired vectors M13mp8 and M13 mp9 (Messing &
Vieira, 1982) were used. The double stranded replicative 
form (RF) of the DNA was supplied'with the-cloning kit, or 
was a gift from Mr G. Millar.
2.24 Digestion of RF DNA and storage (handbook p.22)
2 p,g of RF DNA was digested with the appropriate
enzyme(s) and the extent of digestion determined by gel 
electrophoresis. Completely digested vector was purified 
by phenol extraction and ethanol precipitation. It was 
resuspended in TE buffer to give a final concentration of 
10 Tig/p.1 and stored at -20°. Each preparation was checked 
by transformation of competent E. coli JM101 with 10 tig 
cut vector and with 10 ng cut and religated vector.
2.25 Ligation of RF DNA to insert DNA (handbook p.24)
Ligation mixes for ligation of RF DNA to insert DNA
were as follows:
RF DNA (20 ng) 2 pi
insert DNA (100 ng) 5 P-l
10 x ligase reaction buffer 1 pi
ATP 10 mM 1 pi
Dithiothreitol 1 pi
T4 DNA ligase 1 pi
T4 DNA ligase: for sticky ends 0.1 unit/pl
for blunt ends 0.4 units/pl 
Incubation was for 4-6 h at 14° (sticky ends) or 0° for 
24 h (blunt ends).
Final volume was varied from 10-20 pi, depending on 
the volume of buffer the insert DNA was resuspended in.
2.26 Transformation of E.coli JM101 (handbook p.25)
E. coli JM101 was streaked out on MM and after overnight 
growth the plate was stored at 4° (for approximately 1 month 
before re-streaking). A single colony was inoculated into 
10 ml 2TY and shaken overnight at 37° • 40 ml 2TY was
inoculated with 2 ml fresh overnight culture and shaken 
(37°) for 3 h. 10 ml 2TY was also inoculated with a drop 
of overnight culture to provide fresh cells. Cells from 
the 40 ml 2TY culture were harvested (5 000 x g, 5 min), 
resuspended in 20 ml 50mM-CaCl2 and left on ice for 20 min. 
Cells were then harvested (5 000 x g, 5 min) and resuspended
in 4 ml 50mM-CaCl2* 0.3 ml o-f competent cells was added 
to 5 pi of DNA ligation mix and kept on ice 40 min. Cells 
were then heat shocked (42°, 3 min) and returned to ice.
The following were added to each tube:
lOOmM-IPTG (lsopropyl-|3-D-thio-galactopyranoside) 40 pi
2% X-gal (5-hromo-4-chloro-3-indolyl-P-galactoside) 40 pi
(in dimethylformamide)
fresh cells 200 pi
molten H top agar (kept at 42°) 3 ml
and the tube poured onto a pre-warmed (37°) H plate.
2.27 Preparation of single-stranded template DNA (handbook p.27) 
A single plaque was inoculated using a sterile Eppendorf 
pipette tip into 1*5 ml 2TY containing 1 ml/100 ml medium of 
an overnight E.coli JM101' culture. This culture was shaken 
(37°) for 5- h then centrifuged 5 min (microfuge). At this 
stage, supernatants were sometimes stored at -20° for later 
analysis. The pellet of cells produced at this stage was 
also broken open and RF DNA extracted using the mini-prep 
technique. The RF DNA produced could then be investigated 
with restriction enzymes.
The supernatant was transferred to another tube and 
reeentrifuged (5 min). The supernatant was added to 200 pi 
PEG/NaCl (20% polyethylene glycol 6 000/2.5M-NaCl), shaken 
and left for 15 min. This was then centrifuged 5 min and 
the supernatant discarded. Following a further 2 min spin, 
all remaining traces of PEG were removed using a drawn out 
pasteur pipette. 100 pi TE and 50 pi phenol were added to
the viral pellet and mixed by vortexing (15 s). After 
standing the tubes for 15 min, the contents were re-mixed 
(vortex, 15 s) and centrifuged 3 min. The upper layer was 
transferred to a fresh centrifuge tube and 1 ml chloroform 
added. The chloroform was mixed (vortex, 15 s) and separated 
(microfuge, Is). 10 pi 3M-Na acetate (pH 6) and 250 pi 
ethanol were added and the DNA precipitated by placing the 
tube at -70° (dry ice/methanol) for 15 min. The DNA was 
recovered by centrifugation (10 min) and washed with 1 ml 
(-20°) ethanol. The ethanol was poured off and the tube 
left to dry. The DNA pellet was redissolved in 50 pi TE 
and stored at -20°.
2.28 Annealing of primer and template (handbook p.33)
For each clone, the following were placed in a 1*5 ml
microfuge tube:
single stranded template DNA 5 P-l
primer 1 pi
*10 x Klenow reaction buffer 1.5 pi
distilled water 2.5 |il
(*100mM-Tris pH 8.5; lOOmM-MgCl^)
The primer used is a 17mer with the sequence:
5 1-GTAAAACGACGGCCAGT-31
The mixture was incubated in an oven at 53° For 2 h.
2.29 The sequencing reactions (handbook p.34)
To the annealed primer/template mix was added 1.5 pi 
(15 pCi) of (a - “^ S)dATP a S at >600 Ci/mmol (Amersham
SJ304) and 1 pi (l U/pl) of Klenow fragment of E.coll DNA 
polymerase I. 2.5 pi of the mixture was placed on the rim 
of each of four tubes, marked A, C, G or T in a microfuge 
rotor. 2 pi of the relevant dNTP/ddNTP mix (see below) 
was placed inside the rim of each tube and a brief spin 
mixed the contents. After 20 min, 2 pi of chase mixture 
(an 0.5 mM uniform mixture of dATP, dCTP, dGTP and dTTP) 
was placed on the rim of the tube and mixed in with a 
brief spin. After a further 15 min chase reaction, 4 pi 
formamide dye mix was added. Formamide dye mix was prepared 
as follows: 100 ml of formamide was deionised by stirring
with 5 g Amberlite (BDH) for 30 min, then filtered to remove 
the resin; to this was added 0.03 g xylene cyanol FF,
0.03 g bromophenol blue and 4 ml O.5M-EDTA.
2.30 Reaction mixes (handbook p.32)
The final concentration of each reagent in a sequencing 
reaction mix is listed in Table 2.6. Three sets of reaction 
mixtures were used:
A* - or * normal* reaction mixes-; for use with labelled 
dATP used in most experiments 
A*/low dideoxy - in these mixtures the dideoxy
concentration was 0.75 times that in the A* mixes; 
for long runs on linear gels, allowing reading of 
up to 400 bp 
C* - for labelling with radioactive dCTP.
(a) A*
A reaction 
mix
C reaction 
mix
G reaction 
mix
T reaction 
mix
dATP 16.6 16.6 16.6 16.6
dCTP 28 0.3 28 28
dGTP 28 28 0.3 28
dTTP 28 28 28 0.3
ddATP 22.2 (16.6) - - -
ddCTP - 22.2 (16.6) - -
ddGTP - - 66.6 (49.8) -
ddTTP - - - Ill (83)
(b) C*
A reaction 
mix
C reaction 
mix
G reaction 
mix
T reaction 
mix
dATP 0.3 28 •28 28
dCTP 16.6 16.6 16.6 16.6
dGTP 28 28 0.3 28
dTTP 28 28 28 0.3
ddATP 22.2 - - -
ddCTP 22.2 - -
ddGTP - - 66.6 -
ddTTP - - - Ill
Table 2.6: Final concentration of reagents in sequencing reaction mixes. 
All concentrations are
Numbers in brackets refer to the final concentrations of 
dideoxy nucleotide in the *1o u j dideoxy1 mixes.
2.31 Polyacrylamide gel electrophoresis (handbook pp.36 and 45)
The DNA fragments in the sequencing reaction mixes were
separated by electrophoresis on polyacrylamide gels (20 x 
40 x 0.4 cm). The notched plate was siliconised before use 
with Repelcote (BDH).
Two types of gel were employed, linear and buffer 
gradient. The quantities of reagents necessary to pour a 
6fo acrylamide, 8M-urea tris-borate gel are shown in Table 2«7« 
Before loading, the wells were flushed out with running 
buffer (l x tris-borate) to remove unpolymerised acrylamide 
and urea, which leaches into the gel slots, preventing the 
samples from forming a precise layer.
The samples were heated to 95° for 3 min then loaded 
immediately onto the gel. Gels were run at 28 mA for 
varying lengths of time (see Chapters 4, 5 and 6).
Gels were fixed after removing the notched plate by 
soaking in a 2:1 bath of 10$> acetic acid, 10^ methanol for 
30 min to remove the urea. The gel was removed from the 
bath and a sheet of Whatman 3MM paper laid on top. The 
gel was peeled off with the paper backing, placed on a 
Bio-rad Model 1125 gel drier and covered by Saranwrap.
Thirty minutes under vacuum was sufficient to dry the gel 
completely.
2.32 Autoradiography
The dried gel was placed in a light-proof cassette 
and covered by a sheet of Fuji RX film. The film was
linear buffer gradient
top bottom
urea (g) 21 19.2 3.8
acrylamide stock (ml) 7.5 6 1.125
10 x tris-borate (ml) 5.0 2 1.875
sucrose (9) - - 0.75
bromophenol blue 
(0.01 g/ml) (ml) . - - 0.075
water, to (ml) 50 40 7.5
TEMED (p-l) 50 80 15
AMPS (%aqe) (lil) 300 (10) 80 (25) 15 (25)
Table 2.7: Quantities of reagents necessary to pour a single 
polyacrylamide gel for DNA sequence analysis.
Abbreviations: TEMED - NNN*Nf-tetramethylethylenediamine
AMPS - ammonium persulphate
Acrylamide stock - 40%; 38:2 acrylamide: NNf methylenebisacrylamide, 
deionised by stirring with 5 g Amberlite MB1 and filtered through 
a sintered glass funnel then passed through a Millipore filter 
(0.45vi-m).
Urea - ultrapure (BRL).
exposed overnight at room temperature before developing.
2.33 T-track analysis (handbook p.39)
This technique was used to classify clones into groups 
containing the same insert (see Chapter 5)» For ten clones 
the following mix was made up:
k pi primer, 6 pi 10 x Klenow reaction buffer,
12 pi water. 2 pi priming mix was added to 2 pi template 
DNA and the tube incubated at 55° fk>r 2 h.
A sequencing mix was made up:
16 pi dTTP/ddTTP, 3 pi (a - ^S)dATP aS , 2 pi (2U> 
Klenow fragment.2 pi sequencing mix was added to the 
annealed primer/template and the reaction started by a 
brief spin (microfuge). After 20 min, 1 pi chase solution 
was added and the reaction stopped after a further 15 min 
by the addition of 1 pi formamide dye mix.
2.3^ - Preparation of RF DNA in vitro (handbook p. 29)
Primer and single stranded template DNA were annealed 
as for a sequencing reaction. 1 U of Klenow fragment and 
1 pi chase solution were added and the mixture incubated at 
room temperature for 30 min. The reaction was stopped by 
heating at 70° for 10 min.
2.35 Clone turn-around
Clone turn-around was used to obtain the opposite 
strand of a small fragment, or to sequence the other end 
of a long fragment.
RF DNA was prepared in vitro, then the following were 
added: 2 pi 10 x restriction enzyme buffer, 5 U EcoRI,
5 TJ Hindlll. The sample was incubated for 1 h at 37° 
and the fragments separated by electrophoresis on a LMT 
agarose gel. Insert DNA was recovered from the gel and... 
ligated to the complementary vector, prepared by cleavage 
with EcoRI and Hindlll.
2.36 Computer programs for manipulation of DNA sequences
The following programs were utilised in the compilation, 
manipulation and analysis of the DNA sequences. Programs
(a) - (d) were run on a Digital PDP 11-3^ computer, with 
a multi-user facility, in the Biochemistry Department, 
University of Glasgow.
2.36.1(a) BATIN: This program is used to store new gel
readings onto a disk. Any number of separate gel readings 
may be entered and stored in individual files.
2.36.2(b) TTEM: A version of DBCOMP (Staden, 1980),
modified by Dr R. Eason (Department of Biochemistry, 
University of Glasgow) so that it runs more efficiently.
This program searches for. overlaps between sequences, 
comparing each sequence in a set of sequences with each 
other sequence and other complementary sequence.
2.36.3(c) DBUTIL: Described in detail in Staden (1980).
This program enables the user to establish and change the 
relationship between gel reading data, and build up a 
consensus sequence.
2.36.4(d) TRNTRP: This program translates DNA sequences
into peptide sequences (Staden, 1978).
2.36.5(e) WISGEN; A number of the programs of the WISGEN 
(University of Wisconsin Genetics Computer Group) package 
(Devereux e_t al. , 1984) were run on the ERCC (Edinburgh 
Regional Computing Centre) VAX 11/750 computer. This 
package contains programs for the analysis and investigation 
of DNA sequences and for comparison of sequences with those 
in the EMBL database (European Molecular Biology Laboratory, 
Heidelberg, West Germany) and the NIH-Genbank database 
(Bolt, Baranek'& Newman, Inc., Cambridge MA, USA).
322.37 Determination of P in DNA samples
Precipitation with trichloroacetic acid (TCA)
A known volume of the sample to be assayed was spotted 
onto a Whatman GF/C glass fibre disk (2.4 cm diameter). An 
equal volume was added to a tube containing 100 pi of salmon 
sperm DNA (500 pg/ml in 20 mM-EDTA) • 5 nil of ice-cold 10%
TCA was added and the tube kept on ice 15 min. The 
precipitate was collected by filtering through another 
GF/C disc and washing the disk six times with 5 ml of 
ice-cold 10% TCA, followed by 5 ml of* 95% ethanol. Both
filters were dried under a heat lamp then placed into 
scintillation vials. 8 ml of scintillation fluid was added 
and the samples counted in an Intertechnique SL4 000 
scintillation counter. The scintillation fluid used was 
4g/l PPO (2,3-diphenyloxazole) in 2:1 toluene; triton X-100. 
The first filter measures total radioactivity; the second 
measures the radioactivity incorporated into nucleic acids.
2.38 5 1- etid labelling of DNA fragments
23 pmol of 3 1-termini, purified free of salts and 
proteins by phenol/chloroform extraction and ethanol 
precipitation were resuspended in 80 p,l 50mM-tris (pH 8.2) 
and O.3U calf-intestinal phosphatase (Boehringer) was added. 
After incubation at 37° for 30 min, the reaction was stopped 
by the addition of 20 p.1 30 mM—EDTA and further incubation 
at 63° for 13 min. The DNA was purified by phenol/chloroform 
extraction and ethanol precipitation. It was then resuspended 
in 20 \l1 30 mM-tris (pH 8.2), 10 mM-MgCl2, 1 mM-EDTA,
30 mM-dithiothreitol, 1 mM-spermidine. To this was added:
10 y.1 (}f32P )ATP (3 000 Ci/mmol, Amersham PB10218) and a 
1 p,l sample taken to determine total radioactivity. 8U 
T4 polynucleotide kinase (Boehringer) was added and incubated 
for 3 0 at 37°• A 1 p,l sample was taken for determination 
of TCA insoluble radioactivity. The DNA was then purified 
by phenol/chloroform extraction and ethanol precipitation.
2.39 Preparation of RNA from E.coli
RNA was prepared from E.coli AB2829/pKD501, as follows: 
100 ml LB/tet, inoculated with E.coli AB2829/pKD501 was 
grown to = 0.3» The cells were harvested and re­
suspended in 6 ml buffer R (0.02M-Na acetate (pH 5*5)>
0.5$ SDS, ImM-EDTA). 12 ml phenol (equilibrated in buffer R)
was added and the tube incubated at 60° for 10 min with 
gentle shaking. The sample was centrifuged to separate 
the phases and the aqueous phase removed to a fresh tube.
This was re-extracted with phenol at room temperature.
The aqueous phase was again separated and removed to a 
fresh tube. 2.5 volumes of ethanol were added and the tube 
chilled to -70° for 30 min. The precipitate was collected 
by centrifugation (12 000 x g, 30 min) and resuspended in 
3 ml buffer R. Ethanol precipitation was repeated twice 
more and the final precipitate dissolved in 500 ]il TE 
buffer.
2.40 Nuclease SI mapping
Nuclease SI was purchased from BRL. SI buffer was:
80$ formamide (deionised before use); 20mM-PIPES (Sigma) 
0.4M-NaCl.
2.41 Blotting of DNA and RNA to nitrocellulose
Both DNA and RNA agarose gels were blotted onto nitro­
cellulose (Schleicher & Schuell BA85) by the method of 
Southern (1975)> as described in detail in Maniatis e_t al.
(1982).
2.42 Hybridisation solution for Northern blot
Both pre-hybridisation and hybridisation of nitro­
cellulose filters for Northern blot analysis was carried 
out with the same buffer, except that during hybridisation, 
the radioactive probe was added:
6 x SSC 
5 x Denharts
100 p,g/ml salmon sperm DNA (sheared) (Sigma).
0.5$ SDS
SSC: 0.15M-NaCl, 0.015M-sodium citrate
50 x Denharts: 1$ Ficoll, 1$ polyvinylpyrrolidone (Sigma), 
1$ BSA.
CHAPTER 3 STUDIES ON THE aroB GENE of E.coli
3.1 Introduction
3.1.1 The aroB gene
A purification scheme for 3-dehydroquinate synthase, 
the product of the E.coli. aroB gene has been reported 
(Maitra & Sprinson, 1978). 5^0 p.g of homogeneous enzyme
was obtained from 380 g of E.coli in 6$ overall yield after 
a 5-step purification. The purification factor was nearly 
3 000 fold. The apparent molecular weight estimated both 
by gel filtration under native conditions and by SDS-PAGE 
was 57 000, suggesting that the enzyme is monomeric.
Since the enzyme is present in such low concentrations 
in wild type E.coli cells and the purification is difficult, 
mechanistic work on this enzyme has been hindered. The 
enzyme purification would be greatly simplified if an 
overproducing strain could be constructed. This requires 
the cloning of the aroB gene and its insertion into a 
multicopy plasmid vector. Reasonable quantities of the 
pure enzyme should then be available for detailed structural 
and mechanistic studies.
The aroB gene has been identified on pLC29-47> a member 
of the Ciarke-Carbon E.coli genomic library (Clarke &
Carbon, 1976; Takeda e_t al• , 198l). pLC29-47 was the source
of the aroB gene for the sub-cloning described in this study.
3.1.2 Previous work on pLC29-47
Takeda _et al. (1981) searched the Clarke-Carbon plasmid
collection for markers closely linked to penicillin-binding
protein genes. One such marker is aroB; it is closely
(mtcA)
linked to the ponA^gene, at minute 74 on the E. coli genetic 
map (Bachmann, 1983; Figure 1.4).
The vector used to construct the Clarke-Carbon library 
was ColEl. This vector has two disadvantages for over­
expression of enzyme genes - it exists in low copy number 
within the cell and it has no readily selectable phenotype. 
We therefore wanted to subclone the genomic portion of 
pLC29-47 onto a more readily manipulated vector. pAT153 
(Twigg & Sherratt, 1980) was used throughout.
Comparison of the limited restriction enzyme analysis 
of pLC29-47 carried out by Takeda ei; al. (1981) with the 
restriction map of ColEl (Dougan e_fc al. , 1978) showed that 
a 7«2 kb PstI fragment of pLC29-47 carried most of the 
genomic material (Figure 3*la). The first objective was 
to sub-clone this fragment and confirm that it carried 
the aroB gene.
3.2 Sub-cloning and analysis of the aroB gene
3.2.1 Construction of pKDlOl and pKD102
pLC29-47 was digested with PstI and the digestion 
products separated by electrophoresis on 1 °fo LMT agarose.
A band at approximately 7*2 kb was excised and the DNA 
purified. The fragment was ligated into the PstI site, 
of phosphatase-treated pAT153 (Sections 2.15 and 2.16).
Figure 3»1: Restriction mapping of* various aroB 
subclones•
(a) pLC29 -^7; data From Takeda et al. 
(1981).
(b) pKD10l/pKD102; mapping and orient- 
ation with, respect to pAT153»
(c) pKD106; detailed restriction map.
(d) pJBl4; region in common with pKD106, 
and orientation of* the aroB gene.
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The ligation mix was used to transform E. coli AB2826 and
plated on LA/tet (Section 2.17)« After overnight growth
at 37°> colonies were transferred by replica plating to
minimal medium and grown a further 2b h at 37°• 100 of
the colonies which grew on minimal medium were picked off
and gridded onto LA/tet, LA/amp and MM to check their
growth properties. Colonies containing plasmids carrying
the aroB gene at the PstI site within the ampicillin
R S +resistance gene of pATl53 should be tet , amp , aroB •
10 such colonies were picked and grown in 10 ml LA/tet.
Plasmid DNA was extracted and analysed after digestion
with various restriction enzymes. The asymmetric location
of a pair of Sail sites within the PstI fragment was used
to determine the orientation of the PstI fragment relative
to the vector. Two clones were retained for further analysis.
Each had the 7»2 kb PstI insertion, but in opposite
orientations; they were designated pKDlOl and pKD102
(Figures 3«lb and 3*2).
Two controls were performed in this experiment, and
indeed in all experiments involving identification of clones
by relief of auxotrophy. A crude preparation of recombinant
plasmid was used to retransform the auxotrophic mutant
employed to identify the clone (in this case E.coli AB2826)
R S +and all resulting transformants were tet , amp , aroB .
The same crude preparation was used to transform a second
auxotrophic aro mutant (E.coli AB2829> aroA). In this
R Scase, all transformants were tet , amp but remained 
unable to grow on unsupplemented medium.
3.2.2 Restriction mapping of* pKD10l/pKD102
To design a strategy for further subcloning of the 
aroB gene, a more detailed restriction map of pKDlOl than 
that published by Takeda at al. (1981) was required. A 
series of single and double enzyme digests were carried 
out on crude preparations of pKDlOl and pKD102 using 
enzymes that would be useful in further cloning. The 
resulting map is shown in Figure 3»lb. The two Bglll 
sites and the single EcoRI site are the most useful for 
further subcloning.
3.2.3 Construction of pKD103/pKD104-
pKDlOl and pKD102 were each cleaved with Bglll and 
the resulting DNA fragments separated by electrophoresis 
on 1 °fo LMT agarose. The slowly migrating fragment (9*3 kb) 
was excised and the DNA purified. This DNA was then self- 
religated and transformed into’ E. coli AB2826. After 
overnight growth on LA/tet, colonies were checked for the 
presence of recircularised plasmid of the correct size and 
for growth on minimal medium. Two plasmids, designated 
pKD103 and pKD104- were constructed by recircularisation 
of pKDlOl and pKD102 respectively. Both are capable of 
complementing the aroB mutation in E.coli AB2826.
3.2.4 Construction of pKD105
From the same Bglll digest of pKDlOl described in the 
previous section, the smaller fragment (1.4-3 kb) was excised
and the DNA purified. This whs then ligated to BamHI 
cleaved pAT153 and transformed into E.coli AB2826. After 
overnight growth on LA/amp, colonies were screened for 
inserts into the tetracycline resistance gene and 6 
representatives were checked for an insert at the BamHI 
site by isolating samples of DNA and checking their size. 
These clones were found not to grow on minimal medium.
One clone was retained and designated pKD105»
The finding that removal of the 1.4-5 kb Bglll fragment 
from pKDlOl does not affect the ability of the plasmid to 
complement aroB implies that aroB does not lie between 
the two Bglll sites and does not span either of them.
3»2.5 Construction of pKD106
In a similar way, one final construction was made. The 
3.5 kb Bglll-EcoRI fragment of pKDlOl was inserted into 
BamHI and EcoRI cleaved pAT153« Several colonies were 
grown up and plasmid DNA extracted. In each case digests 
showed the presence of the 3*5 kb insert expected and the 
loss of the BamHI site (the BamHl/Bglll hybrid site is 
cut by neither enzyme). This plasmid is able to complement 
an aroB mutant.
The sub-cloning constructions described in this section 
are summarised in Figure 3»2.
More detailed restriction enzyme analysis of pKD106 
was carried out with a view to identifying restriction 
sites which might be used to clone fragments for DNA sequence 
analysis. A combination of single and double digests was
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was used and the digestion products analysed on 1*5$ or 
2°fo agarose gels. The data obtained is shown in Figure 
3.1c.
3.2.6 Activity of 3-dehydroquinate synthase in crude extracts
The specific activity of 3-dehydroquinate synthase was 
determined in crude extracts of E.coli K12, E.coli AB2826 
and E.coli AB2826 harbouring each of the plasmids described 
in the preceding sections.
Crude extracts were prepared from stationary phase 
cultures as described in Section 2.18. Cells were grown 
in 100 ml minimal medium, except in the case of E.coli 
AB2826 and E.coli AB2826/pKD105 which were grown in minimal 
medium containing the aromatics supplement. Sonication 
buffer !A' was used.
DHQ synthase was measured by using 3-dehydroquinase 
as a coupling enzyme; this enzyme converts 3-dehydroquinate 
to 3-dehydroshikimate which absorbs strongly at 23 -^ tim 
(see Section 2.19). The results are shown in Table 3*1*
Extracts of E.coli K12 contain a very low concentration 
of DHQ synthase. In the crude extract there is a high 
background A A ^ ^  in the absence of added DAHP and this 
rate may contribute to the measured DHQ synthase rate.
It is therefore difficult to quantitate the DHQ synthase 
level in wild type cells and so the estimates of the over­
expression factor in the table can vary according to the 
value taken for the basal level in E.coli K12. We can 
be sure that the increase in the rate of absorbance change
following DAHP addition is the authentic DHQ synthase 
activity for three reasons:
(i) The reaction is inhibited by NADH, a known inhibitor 
of the enzyme. This was checked in two ways. Firstly 
addition of NADH to a final concentration of 50 p-M 
during an assay causes the rate to drop. Secondly, 
addition of MAPI* to 50 p.M before initiation with
DAHP gives a diminished DHQ synthase rate.
/ \ 2+(ii) The DHQ synthase reaction is dependent on Co •
2+Crude extracts are partially active without added Co
This Co^+ can be chelated by the addition of EDTA/
NaOH pH 7.0 to 10 mM and incubation at 25° for 3 min.
Following the standard assay procedure, but omitting 
2+Co there is no response to the addition of DAHP.
Cobalt can then be added back to the reaction mix
and DHQ synthase activity is seen when [co2+] is 
. in excess of CeDTa I •
(iii) The reaction is dependent on the presence of 3-
dehydroquinase. A time lag in the increase in the 
rate of change of absorbance following DAHP initiation 
is observed and this decreases as more coupling 
enzyme is added. When no purified 3-dehydroquinase
is added to the mix and the reaction is dependent on 
endogenous 3-dehydroquinase, the lag is greater but 
the same steady state rate is reached.
The results shown in Table 3»1 indicate that in all 
the crude extracts of cells carrying recombinant plasmids, 
except E.coli AB2826/pKD105, there is an increase in the
Extract Specific activity of 
3-dehydroquinate synthase
Relative
activity
K12 0.07 1
AB2826 no activity -
AB2826/pLC29-47 0.072 10
AB2826/pKDlOl 0.168 24
AB2826/pKD102 0.154 22
AB2826/pKD103 0.136 19
AB2826/pKD104 0.140 20
AB2826/pKDl05 no activity -
AB2826/pKD106 0.136 19
Table 3.1 Specific activity of 3-dehydroquinate synthase in E.coli 
crude extracts.
specific activity of DHQ synthase. This correlates with 
the ability of the plasmids to complement the aroB mutation 
in E.coli AB2826.
E. coli AB2826/pLC29-47 produces approximately 10 fold 
more DHQ synthase than does E.coli K12. This strain, 
however, grows poorly on the minimal medium required to 
maintain the plasmid.
All the other aroB complementing plasmids overexpress 
DHQ synthase approximately 20-25 fold. This indicates 
that in each case, the entire aroB gene and any flanking 
sequences involved in its expression have been cloned.
These derivatives of pLC29-47> cloned in pAT153 can now 
be maintained and grown in hosts which are not aroB; 
the plasmids may be maintained by antibiotic selection.
It is important to maintain the integrity of these plasmids 
by growing them in recA host strains. E.coli AB2826 is 
recA+ and there is a danger that the aroB gene on the plasmid 
might recombine with the defective chromosomal aroB marker. 
For this reason, all plasmids have been maintained in 
E.coli HB101 which is recA , aroB .
3»3 Relationship to other work on aroB
Frost ejt al. (1984) have independently sub-cloned the 
aroB gene from pLC29-47 by a different route. Their 
strategy was to clone fragments of pLC29-47> produced by 
limited digestion with tetranucleotide recognising enzymes 
into the vector pKK223-3 (J« Brosius, unpublished results),
prior to selection for the aroB gene by relief of auxotrophy 
of a suitable E.coli mutant.
pKK223-3 is a pBR322 derivative, designed for very 
high level overexpression of foreign genes in E.coli. Its 
structure is shown in Figure 3*3* Fragments of DNA from 
any source may be cloned into the 1 polylinker' site. .The 
* polylinker' is flanked by a 1tac1 promoter and a terminator 
sequence. The 'tac' promoter is a hybrid of the E.coli 
trp operon promoter -35 region and the E.coli lac operon 
-10 region, with the lac TJV5 mutation which renders the 
promoter insensitive to catabolite repression. This structure 
gives very high level initiation of transcription from the 
trp -35 region but control from the lac -10 region. Growth 
of the plasmid in a lacl^ strain switches off expression 
of any gene downstream of the'promoter, but this repression 
can be overcome by the addition of IPTG to log phase 
cultures. The terminator sequence of the E.coli rrnB 
operon is also necessary for the efficient expression of 
a gene located in the 1 polylinker' site.
The plasmid pJBl4, which carries aroB cloned into 
pKK223-3 "was derived by the following routes pKf£223-3 
was prepared by digestion by EcoRI, filling in the ends 
produced and ligation of Clal linker molecules. Digestion 
with Clal then provided free Clal ends. pLC29-47 was 
digested with TaqI under conditions that would give incomplete 
cleavage of the plasmid. The fragments were separated by 
electrophoresis on an agarose gel and those corresponding 
to the size range 2 - 2 . 5  kb were excised and cloned into
BamHI
/  /Sm alEcoR
polylinker
Hind III Ps\
terminator tac promoter
Bam HI
.Sal
pKK223-3 
(4585 bp)m
Pvu II
Figure 3»3: Structure of pKK223-3*
pKK223-3« The aroB carrying recombinant (pJBl4) was 
identified by relief of auxotrophy of E» coli AB2826.
Frost _et al. claim that cells harbouring this plasmid 
contain 1 000 times more DHQ synthase activity when fully 
induced than do E.coli K12.
Comparison of the detailed restriction map of the 
insert in pJBl4 (G. Millar, unpublished results) with that 
of pKD106 shows a region which they have in common (Figure 
3 .Id). This allows the direction of transcription of the 
aroB gene to be determined since the gene is transcribed 
from the tac promoter of pKK223-3 »
3>^ ~ Further studies on aroB
The long term aim of studies on DHQ synthase is to 
determine the mechanism of action of this unusual reaction. 
Ultimately this will require the determination of the 
three-dimensional structure of the enzyme. Gene cloning 
can assist structural studies in two ways. Firstly, the 
crystallisation of an enzyme, prior to X-ray crystallography 
requires large quantities of pure enzyme which can now be 
obtained from overexpressing strains. Secondly the amino 
acid sequence of the enzyme can most easily be derived by 
determining the DNA sequence of the gene. An accurate 
knowledge of the amino acid sequence is a prerequisite to 
the model building associated with three-dimensional 
structure determination.
In furtherance of this aim, a simple two column 
purification of homogeneous DHQ synthase has been developed
(Frost _et al. , 1984). The starting material for this is 
a cell lysate of E.coli harbouring the plasmid pJBl4 in 
which aroB expression was induced by IPTG during the log 
phase of growth. It is now possible by this method to 
purify'approximately 100 mg of enzyme from 50 g of E.coli.
The complete amino acid sequence of DHQ synthase 
has recently been determined by DNA sequencing of the aroB 
gene (G. Millar, unpublished), but is not discussed in 
this thesis.
CHAPTER 4 STUDIES ON THE aroD GENE OF E.coli
4.1 Introduction
4.1.1 The aroD gene
The E.coli aroD gene encodes the enzyme 3-dehydroquinas 
A 5*6 kb PstI fragment of the E.coli genomic DNA has been 
cloned into pBR322 and shown to carry aroD (Kinghorn ejfc al., 
1981). This recombinant (pJKK12) encodes a 3-dehydroquinase 
activity which is indistinguishable from that isolated 
from wild type E.coli on the basis of heat stability, 
ammonium sulphate fractionation and sucrose density gradient 
Evidence from the sucrose density gradients, and from 
minicell labelling of plasmid encoded proteins suggested 
that the native enzyme is a dimer composed of two 31 500 
dalton subunits. Recently, this quarternary structure 
has been confirmed by studies on the purified E.coli enzyme 
(Chaudhuri & Coggins, 1984b).
4.1.2 Analysis of pJKK12: (i) Kinghorn et al. (1981)
The 5*6 kb insert in pJKK12 is sufficiently large to
encode several E.coli genes. Restriction mapping and sub­
cloning were carried out in order to identify the location 
of aroD on the clone.
The insert contains two Bglll sites and single sites 
for Hpal, Sail and Xhol. No EcoRI, BamHI or Hindlll sites 
were detected (Figure 4.l).
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pJKK12 was digested with Bglll and the smaller
fragment produced was subcloned into the BamHI site of
pBB322 (recombinant pJKK26). After deleting the Bglll
fragment, the plasmid was recircularised (pJKK20). Neither
pJKK26 nor pJKK20 complement aroD mutants of E.coldL. This,
35together with evidence from S labelling of proteins m  
mini cells suggests that Bglll cleaves within the aroD 
gene or within a region essential for aroD expression.
4.1.3 Analysis of pJKK12: (ii) This study
Previous workers (Kinghorn e_t al. , I98I 5 see above) 
had suggested that the aroD gene spanned one of the two 
Bglll sites located in the insert of pJKK12 which encoded 
only aroD and would have been of suitable size for DNA 
sequence analysis.
Restriction enzyme digests of pJKK12 were carried out 
with three enzymes: Aval, Clal and PvuII. A series of
double digests were used to locate the sites at which these 
enzymes cut the 5*6 kb insert. The results are illustrated 
in Figure 4.1.
It was shown that Clal cuts the insert four times 
and has a site midway between the two Bglll sites. Therefore 
it is possible to identify Clal fragments of 1.8 kb and
2.2 kb which each carry a different portion of pJKK12, 
surrounding a Bglll site.
Figure 4.2a? Clal sub-clones of pJKK12
Track 1 pKD202/ClaI
2 p JKK12/ Cl al
3 pKD201/Clal
1 3
Tag fragments
115
T1
T2
T3
Ti
Hpall fragments
■HI 620
•H2 5^0
,H3 275
h 4 185
■H5 135
h 6 80
Figure h .2b: TaqI and Hpall digests of the Clal insert of 
pKD201 (sizes are in bp)
Tract 1 TaqI digest of the 1.8 kb Clal insert 
of pKD201
2 pBR322/HinfI
3 Hpall digest of the 1.8 kb Clal insert 
of pKD201
4.2 Sub-cloning and analysis of the aroD gene
4.2.1 Construction of pKD201 and pKD202
2 p-g °f pJKK12 was digested with Clal and separated
by electrophoresis on 1% LMT agarose. The 1.8 kb and 2.2 kb
bands were excised and the DNA extracted. Each DNA sample
was then ligated into the Clal site of phosphatase-treated
pAT153* Ligation mixes were used to transform E.coli AB2848
(aroD) and plated on LA/amp. 100 transformants from each
ligation/transformation were gridded onto LA/amp, LA/tet
and MM. All those colonies arising from ligation of the
R S1.8 kb Clal fragment which were amp , tet were also able
to grow on MM. By contrast, all those transformants arising
Rfrom ligation of the 2.2 kb Clal fragment which were amp ,
S
tet were found to be incapable of growth on MM. Plasmid
R SDNA was extracted from five amp , tet colonies of each 
type and in each case a Clal insert was found which was 
of the expected size. pAT153 recombinants carrying the
1.8 kb and 2.2 kb inserts were named pKD201 and pKD202 
respectively. An ethidium bromide stained agarose gel of 
a Clal digest of these plasmids is shown in Figure 4.2a.
4.2.2 3-Dehydroquinase activity in crude extracts 
Crude extracts of E.coli K12, E.coli AB2848/pKD201
and E.coli AB2848 were prepared as described in Section 
2.18. 100 ml cultures were grown in minimal medium or
’aromatics1 medium (E.coli AB2848 only). Sonication buffer 
' B ’ was used. The results obtained are shown in Table 
4.1.
Extract Specific activity 
of 3-dehydroquinase 
(U/mg)
E.coli
E.coli AB2848 
E.coli AB2848/pKD201
0.032 
no activity 
2.955
Table 4.1 Specific activity of 3-dehydroquinase 
in crude extracts.
These results confirm the pattern of* aroD complementation. 
The 3-dehydroquinase specific activity in cells harbouring 
pKD201 is approximately 3 U/mg, a 90-100 fold increase 
over that found in wild type E.coli. From the estimated 
of 3-dehydroquinase, the aroD gene would be expected to 
be approximately 1 kb in length. Since aroD is being over­
expressed at the copy number level of pAT153> this implies 
that the entire aroD coding region and any sequences 
necessary for its expression are located on the 1.8 kb 
Clal fragment.
4.3 Determination of the DNA sequence of the aroD gene
4.3»1 Sequencing strategy for aroD
A strategy was required for sequencing the aroD gene 
which would give the entire sequence of the 1.8 kb Clal 
fragment on both strands and then allow identification of 
the aroD gene within this sequence. The logic behind the 
development of this strategy is set out below:
(i) Since pKD201 was constructed by insertion of a Clal 
fragment into pAT153> the insert is flanked by an 
EcoRI and a Hindlll site. Recovery of the insert 
from EcoRI + Hindlll cleaved pKD201 and cloning into 
M13mp8 and M13mp9 followed by DNA sequence analysis 
will give the sequence at either end of the insert.
(ii) Cleavage of pKD201 at the unique Bglll site within 
the insert and at the unique BamHI site within the 
vector yields two fragments. Each of these may be 
cloned into BamHI cleaved M13mp8 and the sequence
either side of the Bglll site derived.
(iii) These sequences will provide a framework onto which 
the remainder of the sequence can be built. The 
majority of the sequence information can now be 
obtained by cloning smaller fragments of the insert 
DNA and sequencing these.
(iv) The insert DNA can be fragmented by the use of 
restriction enzymes which recognise tetranucleotide 
sequences. For the Clal clone, the most useful enzymes 
for this purpose are TaqI and Hpall. These enzymes 
produce the same ’sticky ends' as Clal, and may be 
cloned into the AccI site of M13mp8 or M13mp9 (Figure 
^•3).
The successful outcome of this approach to sequencing 
the aroD gene relies on two factors. Firstly, the enzyme 
used must have sites distributed in such a way as to give 
fragments with lengths up to 400 bp. The entire sequence 
on both strands of the DNA can then be determined for each 
of these fragments. Secondly, the distribution of the sites 
must be such that the sequences obtained from one set of 
cleavages will overlap the restriction sites for the second 
set of cleavages.
It is important that the entire DNA sequence is derived 
on both strands of the DNA as a confirmation of the sequence 
on the complementary strand. This is especially true in 
regions of DNA which encode proteins where an omission or 
insertion of a single base pair can lead to mis-interpretation 
of an open reading frame, with disastrous consequences.
AT*CGAT Cla I
T*CGA Tag I
C+CGG Upa fl
GT+CM jac Acc I
Figure 4.3: Restriction enzyme sites used in cloning of 
TaqI and Hpall fragments for DNA sequence 
analysis into the Accl site of M13mp8 and 
M13mp9« The AccI site in these vectors has 
the sequence GTCGAC.
Mistakes leading to an alteration in the sequence of the 
C-terminal region of a protein might go unnoticed because 
a polypeptide of similar molecular weight and composition 
might be predicted.
All restriction sites must also be overlapped in 
order that no small fragments are missed during the cloning 
procedures.
4.3«2 Size distribution of TaqI and Hpall fragments
8 p,g of pKD201 was digested with Clal and the resulting 
DNA fragments separated by electrophoresis on a preparative 
1 °fo LMT gel. The 1.8 kb Clal insert was excised and prepared 
for digestion with a second enzyme as described in Section 
2.14. The second enzyme digestion was with Hpall (10 U,
37°, 2 h) or TaqI (20 U, 54° oven, 2 h); this was followed 
by electrophoresis on 2% agarose (Figure 4.2b).
Hpall cleaves the fragment at least five times yielding 
six fragments, ranging in size from 80 bp to 620 bp. These 
were designated HI to H6 as shown on the diagram. There 
are at least four TaqI sites on the insert, yielding five 
fragments designated T1 to T3» Only three of these 
fragments are below 400 bp in length. Altogether four 
out of the eleven TaqI and Hpall fragments are greater 
than 400 bp in length and if the restriction sites are 
such that any of the large fragments are substantially 
overlapped then it may not be possible to obtain the 
entire sequence of the Clal fragment on both strands of 
the DNA from these two sets of fragments. For this reason,
it was necessary to locate the TaqI and Hpall sites on 
the insert DNA.
4.3*3 Distribution of TaqI and Hpall sites on pKD201
The TaqI and Hpall sites on the insert DNA were detected
by mapping using the partial restriction enzyme digestion
technique of Smith & Bernstiel (1976). The principle of
this technique is as follows: The DNA in question is
32enzymatically labelled with P at one end. It is then 
digested with the chosen enzyme(s) so as to produce a 
partial digest. A large spectrum of partial digestion 
products may be produced, but the labelled fragments form 
a simple overlapping series, all with a common labelled 
terminus. These are fractionated according to molecular 
weight by gel electrophoresis and detected by autoradiography. 
The relative mobility of each labelled fragment allows 
determination of its molecular weight by comparison with 
a set of DNA standards and this in turn locates the distance 
of the respective restriction sites from the labelled 
terminus. The order of the fragments and their lengths 
thus correspond directly to the order of the restriction 
sites along the DNA molecule.
5 ]ig of pKD201 (approximately 2.5 pmol) was digested 
with EcoRI and the DNA purified free of restriction enzyme 
by phenol/chloroform extraction and ethanol precipitation.
The 5 phosphoryl groups were removed by treatment with 
phosphatase (Section 2.15)* The termini were then labelled 
using ATP and T4 polynucleotide kinase (Section 2.38).
After completion of the labelling reaction the number of 
TCA precipitable counts showed that approximately 1 hfo- 
of the label had been incorporated into DNA.
The labelled material was again purified by phenol/ 
chloroform extraction and ethanol precipitation. The DNA 
was resuspended in 50 ]il 1 x high salt restriction enzyme 
buffer containing BSA (100 p-g/ml). 10 U Hindlll was added 
and digestion carried out for 1- h at 37°• The DNA fragments 
in the digest were then separated by electrophoresis on 1 fo 
LMT agarose. The 1.8 kb insert band was excised and 
prepared for further enzyme digestion (Section 2.14).
This fragment is now labelled uniquely at the EcoRI end.
A series of secondary restriction enzyme digests was 
set up as detailed in Table 4.2. The digests were stopped 
after the appropriate time by the addition of EDTA to 
10 mM and by placing the reaction tube on ice, causing 
the agarose to solidify. 5 P<1 of gel loading dye was 
added to each tube and the tube heated to 65° for 5 min 
before loading onto a 2$> agarose gel. The standards 
used on the same gel were:
Track 1 : pBR322 Hinfl fragments 5 ’ ond labelled (*^P
Track 12: A. EcoRl/Hindlll fragments 5 1 end labelled ("^P 
Following electrophoresis, the gel was blotted onto 
nitrocellulose (Section 2.4l). The nitrocellulose blot 
was autoradiographed at -70° with an intensifying screen. 
Several exposures of the blot were' made with the exposure 
time varied from 2 h to 2 days, in order to clearly visualise 
as many bands as possible. Figures 4.4a and 4.4b show
Track Approximate quantity 
of labelled DIMA
Enzyme and number 
of units
Time of 
incubation
1 (pBR322, Hinfl fragments)
2 0.5 ]ig 0.4 U Hpall 20 min
3 0.5 p.g 0.3 U Hpall 20 min
4 0.5 ^g 0.2 U Hpall 20 min
5 0.5 p,g 0.1 U Hpall 20 min
6 0.5 p,g 5 U Bglll 1 h
7 0.5 y.q 5 U PvuII 1 h
8 0.1 ]i g 0.25 U TaqI 20 min
9 0.2 p.g 0.5 U TaqI 20 min
10 0.5 p.g 1.0 U TaqI 20 min
11
12
0.5 p.g
( A,, EcoRI + Hindlll 
fragments)
1.25 U TaqI 20 min
Table 4.2 Enzymes used in partial digestion of labelled pKD201
fragment. Track refers to the gel track on Figure 4.4.
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2 h and 7 h exposures respectively.
Ideally, it is hoped that by varying the amount of* 
restriction enzyme and/or DNA in the partial digest one 
will hit upon conditions under which each of the possible 
partial digestion products are equally well represented.
The autoradiographs shown in Figures 4.4a and 4.4b show 
that this was not achieved - some of the bands are very 
strong an'd others are very weak, (hence the need to show 
two different exposures). However, it is possible to 
locate all of the restriction sites on the DNA using the 
information obtained from the autoradiographs.
The distance from the labelled EcoRI site to each 
restriction site was calculated from the relative mobilities 
of the fragments, compared to the standard A, EcoRl/Hindlll 
fragments. The data obtained was used to construct the, 
restriction map shown in Figure 4.5*
Analysis of the restriction map showed that it was 
possible to cover the entire sequence on both strands of 
the DNA. This is despite the fact that the two longest 
fragments, T1 and HI overlap. The unique Bglll site cuts 
both fragments approximately in the centre of each and so 
sequencing out from this site on either side will complete 
the sequences built up from each set of TaqI and Hpall 
clones. The autoradiographs also show that it is very 
unlikely that there are any very small TaqI or Hpall 
fragments which would not have been seen on an ethidium 
bromide gel such as that in Figure 4.4. Any such fragments 
would have been seen on the autoradiograph as an intense, 
wide band.
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Q.
k,3» ^  Preparation of* M13 clones for sequence analysis
(a) The EcoRI - Hindlll fragment
1 ]ig of pKD201 was digested with EcoRI and Hindlll, 
purified by electrophoresis through 1 fo LMT agarose and 
the 1.8 kb insert fragment identified. The band was excised 
and the DNA extracted and purified by phenol/chloroform 
extraction and ethanol precipitation, and then resuspended 
in 20 p,l 1 x ligase reaction buffer. 10 y.1 was placed in 
each of two tubes and ligation mixes set up in a final 
volume of 20 p.1 (see Section 2.25) and containing 20 ng 
M13mp8 (EcoRI + Hindlll cleaved) or 20 ng M13mp9 (EcoRI + 
Hindlll cleaved). 0/1 U of T4 ligase was added and 
incubation was continued at lb° for h h.
Ligation mixes were used to transform E.coli JM101. 
After overnight growth, two clear plaques were picked 
from each plate and inoculated into 1.5 ml 2TY (containing 
0.1 ml/lO ml broth of fresh JMlOl). After 5 h growth at 
37°> single strand template DNA was purified (Section 
2.27)« The template DNA was checked by electrophoresis 
on 1 fo agarose. The same check was performed on all the 
templates purified for DNA sequencing, and this is 
discussed in Section •
(b) The Bglll - BamHI fragments
1 p,g of pKD201 was digested with Bglll and BamHI.
The two resulting DNA fragments were purified by electro­
phoresis on 1 fo LMT agarose. Both bands were excised and 
the DNA extracted. Then both DNA fragments were cloned
into BamHI cleaved M13mp8 and two templates purified for 
each ligation/transformation.
(c) The TaqI and Hpall fragments
8 p.g pKD201 was digested with Clal and electrophoresed 
on a preparative 1 °fo LMT agarose gel. The 1.8 kb Clal 
•fragment was excised and prepared for further digestion. 
Secondary digests were performed with TaqI and Hpall and 
these were electrophoresed on a 2 LMT agarose gel. A 
pattern similar to that in Figure 4.2b was observed. Each 
TaqI and each Hpall band was cut out of the gel and the 
DNA purified. Separate ligation mixes were set up for each 
fragment; in each case 20 ng of AccI cleaved M13mp8 was 
used. Each ligation mix was transformed into E.coli JM101 
.and after overnight growth, four clear plaques were picked 
and grown.
After the 5 h growth period, all of the 1.5 ml cultures 
were centrifuged (5 min, microfuge). One of each set of 
four templates was further manipulated to produce single 
strand template DNA. Each of the other three supernatants 
was stored at -20°.
3*5 Checks on single-stranded template DNA
Each single stranded template purified for DNA sequencing 
was checked by electrophoresis on.a 1 °fo agarose gel. This 
was performed prior to sequencing for two reasons:
(i) to confirm that the template preparation contained
DNA, and that the yield of DNA was 'normal1. Initially,
templates were run alongside a control amount of* DNA, 
but latterly experience enabled those template 
preparations containing reduced amounts of DNA to be 
identified. If the DNA concentration in a preparation 
is low, then steps can be /taken to increase the DNA 
content of the subsequent annealing reaction. Visualisation 
of the DNA also reveals very approximately the insert 
size, in a recombinant. Recombinants with insert sizes 
less than about 300 bp are difficult to distinguish 
from control M13 template. However, it is occasionally 
possible to distinguish between different cloned 
fragments by the mobility of the templates on agarose 
gels.
(ii) to check for contamination of the preparation. If two 
bands are seen in one track then it is likely that the 
DNA from two different phages has been co-purified.
This may arise from picking two plaques from a crowded 
region of a plate. This is especially a problem when 
very few clear plaques have been produced. The two 
phages can be separated by retransformat!on and re­
purification.
During template preparation, the final ethanol 
precipitated DNA is resuspended in a volume of 50 A.
4 p.1 sample of this is taken for gel electrophoresis and 
is added to 4 p,l gel loading buffer before loading. An 
example of the type of gel produced is shown in Figure 4.6;
Figure 4» 6: Agarose gel electrophoresis of 
template DNA
Track 1 
2
3
4
5
6
M13mp8/Bglll-BamHI 
M13mp8/BglII-BamHI 
M13mp8/EcoRI-HindIII 
M13mp9/EcoRI-HindIII
9  M 1 3 m p 9
single-stranded
large fragment 
small fragment 
fragment
fragment
it clearly demonstrates the points made above.
Figure 4.6 is a gel of the templates described in 
Sections 4.3*4(a) and 4«3»4(b). The following points 
should be noted:
(i) The quantity of DNA in each track is similar, with 
the exception of track 6.
(ii) Comparison with track 9 clearly shows those templates 
which are recombinants, and the mobility on the gel 
is related to the known size of the inserts.
(iii) Tracks 5 and 6 are different. Track 5 has, as expected 
the same size of insert as do the templates in tracks
7 and 8. Track 6 has the same mobility as track 9, 
indicating that a blue plaque was picked rather than 
a clear plaque.
(iv) Tracks 1 and 2 show that two different DNA’s have 
been co-purified. This has probably resulted from 
accidentally picking a blue plaque near to a clear 
plaque.
4.3« 6 Sequencing reactions
Recombinant templates which were known to have inserts 
of less than 230 bp in length (t 4, T5, H4, H5, H6) were 
sequenced using the standard recipe sequencing mixes 
(Section 2*30) followed by electrophoresis on a buffer 
gradient polyacrylamide gel (Section 2«3l)*
For all the other clones, sequencing reactions were 
performed using the 'low dideoxy' mixes (Section 2*30) 
and separated by electrophoresis on two gels. A buffer
gradient gel gave the first 200-230 nucleotides of sequence 
and this was extended to 330-400 nucleotides by a second 
gel - a non-gradient 6$ polyacrylamide gel (Section 2.3l)> 
run for approximately 6 h.
After electrophoresis, the gels were dried and auto­
radiographed overnight (Section 2.32).
4.3*7 'First round1 of DNA sequencing
DNA sequence data was obtained from each of the EcoRI- 
Hindlll clones and from the Bglll-BamHI clones, ensuring 
that the sequence was not that of pAT133* Each of the TaqI 
and Hpall clone templates was sequenced. Each sequence 
was entered into a separate file on a Digital PDP11-34 
computer using the BATIN program (Section 2.36). Each file 
was then compared, in turn, with each other file in two 
ways: firstly by aligning the sequences to be compared
and looking for matches along the sequence and secondly 
by aligning the complementary.sequence to that which is 
being compared. This analysis was carried out by the 
TTEM program (Section 2.36)*
4.3*8 'Second round' of DNA sequencing
The data derived from running TTEM allowed a preliminary 
map of overlaps and complementary sequences to be built up. 
The preliminary map for the aroD clone showed those regions 
which could be completed by sequencing the complementary 
strand/other end of the TaqI or Hpall clones. In those 
cases, the supernatants which had been stored at -20° were
thawed and template DNA purified in the usual manner.
These were then sequenced until the entire sequence was 
complete, on both strands of the DNA, and all the restriction 
sites used in cloning had been overlapped.
4.3*9 The complete sequence of the 1.8 kb Clal fragment 
Each nucleotide in the sequence was checked against 
the complementary nucleotide by reference to the original 
autoradiographs, until all ambiguities were resolved. The 
complete sequence of the 1.8 kb Clal fragment was built up 
using the program DBUTIL (see Section 2.36). The entire 
sequence is illustrated in Figure 4.7> and the sequencing 
strategy summarised in Figure 4.10.
4.4 Analysis of the DNA sequence
4.4.1 Identification of open reading frames on the sequence
(a) Translation of both strands of the DNA sequence
Both strands of the DNA sequence were translated in 
all three reading frames using the TRN TRP program (see 
Section 2.36). The positions of stop codons were plotted 
and the open reading frames identified. It was expected 
that the aroD gene would be located near the unique Bglll 
site in the sequence (Kinghorn ejb al •, 1981).
Only one open reading frame was found which was 
sufficiently long to encode an enzyme of the correct 
molecular weight. This open reading frame spans the Bglll 
site. All the other reading frames are blocked many times.
10 30 50
ATCGATGCCGAACAAACAACTGGCGTGVGAATATGTTGATGAATTAACACCAGCTGCCAA
1  +  +  +  +  + -------- — :-+ 60
TAGCTACGGCTTGTTTGTTGACCGCACACTTATACAACTACTTAATTGTGGTCGACGGTT
70 90 110
ACTGGTGGGGGCCATCAACACCATCGTTAATGATGATGGCTATCTGCGTGGCTATAACAC.
61  + -  +   + - •  + -r  + 121
TGACCACCCCCGGTAGTTGTGGTAGCAATTACTACTACCGATAGACGCACCGATATTGTG
130 150 170
CGACGGCACGGGCCATATTCGCGCCATTAAAGAGAGCGGTTTTGATATCAAAGGCAAAAC 
121 “ + + *■ + + ~ — + IB 1
GCTGCCGTGCCCGGTATAAGCGCGGTAATTTCTCTCGCCAAAACTATAGTTTCCGTTTTG
190 210 230
GATGGTGCTGTTAGGGGCCGGTGGTGCCTCAACGGCAATTGGCGCGCAGGGGGCAATTGA
131 — + — — - —  - — —  +   + —  —  + —----- ■“"■■“+ 24t
CTACCACGACAATCCCCGGCCACCACGGAGTTGCCGTTAACCGCGCGTCCCCCGT7AACT
250 270 290
AGGTTTAAAAGAAATTAAACTCTTTAACCGTCGGGATGAGTTCTTCGATAAAGCCCTCGC
141  +----------+----  +----  +----------+---------- + 30'
TCCAAATTTTCTTTAATTTGAGAAATTGGCAGCCCTACTCAAGAAGCTATTTCGGGAGCG
310 330 350
c t t c g c g c a g g c g t t a a t g a a a a c a c c g a t t g t g t c g t c a c g g t c a c c g a t c t c g c c g a t
301 --------- +----------+----------+--- +----------+---------- + 361
GAAGCGCGTCCGCAAT7ACTTTTGTGGCTAACACAGCAGTGCCAGTGGCTAGAGCGGCTA
370 390 410
CAGCAAGCCTTTGCTGAAGCCCTGGCTTCCGCCGACATTTTTAACCAATGGCACAAAAGT
361     + - - -~ + ~+ — - —  - +  +------  + 42!
GTCGTTCGGAAACGACTTCGGGACCGAA('»GCGGCTGTAAAAATTGGTTACCGTGTTTTCA
430 450 470
GGGTATGAAACCCTTGAGAATGAATCAT7GGTTAATGATATCGATCTGTTACATCCOGGA
421  -----— + +---~  + ~ —  — - - —  - + —  ~ —  - ■ +---—------+ *+3'
CCCATACTTTGGGAACTCTTACTTAGTAACCAATTACTATAGCTAGACAATGTAGGCCCT
490 510 530
CTTCTGGTCACTGAAACTGGCGTGTATAACCCGCATATGACGAAGTTATTGCAGCAGGCG
431 ~ ~ - ~ + + — +   — + — -------- +---~ — — — — — 4. 54<
GAAGACCAGTGACTTTGACCGCACATATTGGGCGTATACTGCTTCAATAACGTCGTCCGC
Figure 4,7: The complete DNA Fequence of the 1 ♦ Skb Clal fragment- 
inserted in pKD201,and the predicted AroD coding 
region.
601
661
721
781
841
901
GTTGTTCGACCAACGTTTTGCTAACTACCTATGCCGTACCACAACACCGTTCCCCGACTT
CIO 630 650
CAGTTCACATTATGGACTGGCAAAGATTTCCCTCTGGAATATGTTAAACAGGTCATGGGG
 - + + +   + '   + + 660
GTCAAGTGTAATACCTGACCGTTTCTAAAGGGAGACCTTATACAATTTGTCCAGTACCCC
AroD coding sequence ->
670 690 710
TTCGGTGCCTGACAGGCTGACCGCGTGCAGAAAGGGTAAAAAATGAAAACCGTAACTGTA
--------- +----------+----------+ + -  +----------+ 720
AAGCCACGGACTGTCCGACTGGCGCACGTCTTTCCCATTTTTTACTTTTGGCATTGACAT
MetLysThrVa1ThrVa1 
M K T V T V 
[13
Bglll
750 770
AAAGATCTCGTCATTGGTACGGGCGCACCTAAAATCATCGTCTCGCTGATGGCGAAAGAT
y 80
TTTCTAGAGCAGTAACCATGCCCGCGTGGATTTTAGTAGCAGAGCGACTACCGCTTTCTA 
LysAspLeuVa1 11eGlyThrG1yAlaProLys!1e 1 1eVa1SerLeuMetAlaLysAsp 
K D L V I G T G A P K I  I V S L M A K D  
171
790 810 830
ATCGCCAGCGTGAAATCCGAAGCTCTCGCCTATCGTGAAGCGGACTTTGATATTCTGCAA
--------- +----------+----------+----------+---------- + + 840
TAGCGGTCGCACTTTAGGCTTCGAGAGCGGATAGCACTTCGCCTGAAACTATAAGACCTT 
I leAl aSerVa 1 LysSerGl uAl aL.eu.Al aTyrArgG 1 l.A1 aAspPheAspI leLeuGlu 
I A S V K S E A L A Y R E A D  F D  I L E  
[273
850 870 ,890
TGGCGTGTGGACCACTATGCCGACCTCTCCAATGTGGAGTCTGTCATGGCGGCAGCAAAA
--------- +----------+----------+---------- +----------+---------- + 900
ACCGCACACCTGGTGATACGGCTGGAGAGGTTACACCTCAGAC-AGTACCGCCGTCGTTTT 
TrpAraVa1AspHisT yrA1aAspLeuSerAsnVa1G 1uSerVa1 Me tA1 aA1aA1aLys 
W R V D H Y A D L S N  V E S V M A A A  K 
[473
910 930 950
ATTCTCCGTGAGACCATGCCAGAAAAACCGCTGCTGTTTACCTTCCGCAGTGCCAAACAA
----------+ --------- +---------- +----------+---------- +---------- + 960
TAAGAGGCACTCTGGTACGGTCTTTTTGGCGACGACAAATGGAAGGCGTCACGGTTTCTT 
I 1eLeuArgGluThrMetProGluLysProLeuLeuFheThrPheAraSerAlaLysGlu
I l r e t m p e k p l l f t f r 's a k e
[673
Figure 4«7:(cont)
1C21
1081
1141
1201
1261
1321'
i-UU'JCGCTCGTCCGCTAAAGGTGGCTCCGAATAATAACGTGAGTAGCACGTCGGTAGCTG 
G 1yG1yG1u G 1n A 1 a I)eSerThrG1uAlaTyrTyrCysThrHisArgA1aAla I 1eAsp 
G G E Q A I S T E A Y Y C T H R A A I D  
C873
1030 1050 1070
AGCGGCCTGGTTGATATGATCGATCTGGAGTTATTTACCGGTGATGATCAGGTTAAAGAA -
—  - — - —  - 108< 
TCGCCGGACCAACTATACTAGCTAGACCTCAATAAATGGCCACTACTAGTCCAATTTCTT 
SerG1yLeuVa1AspMe 111eAspLeuG1uLeuPheThrG1vAspAspG1nVa )LysG1u 
S G L V D M  I D L E L F T  G D D Q V K E  
C1073
1090 1110 1130
ACCGTCGCCTACGCCCACGCGCATGATGTGAAAGTAGTCATGTCCAACCATGACTTCCAT
--------- +----------+----------+----------+----------+---------- + 114(
TGGCAGCGGATGCGGGTGCGCGTACTACACTTTCATCAGTACAGGTTGGTACTGAAGGTA 
ThrVa1A1aTyrA)aHisA1aHisAspVa1LysVa1V a 1MetSerAsnHisAspPheHis 
T V A Y A H A H D V K V V M S N H D  F H  
[1273
1150 1170 1190
AAAACGCCGGAAGCCGAAGAAATCATTGCCCGTCTGCGCAAAATGCAATCCTTCGACGCC
120 C
TTTTGCGGCCTTCGGCTTCTTTAGTAACGGGCAGACGCGTTTTACGTTAGGAAGCTGCGG 
LysThrProGluAIaGluGlul1el 1eAlaArgLeuAraLysMetGlnSerPheAspAla 
K T P E A E E  I I A R L R ' K M Q S F D A  
[1473
1210 1230 1250
CATATTCCTAAGATTGCGCTGATGCCGCAAAGTACCAGCGATGTGCTGACGTTGCTTGCC
 +  +   " + +  + 126 0
CTATAAGGATTCTAACGCGACTACGGCGTTTCATGGTCGCTACACGACTGCAACGAACGG 
AspI1eProLysI1e A 1aLeuMetProGInSerThrSerAspVa1LeuThrLeuLeuA1 a 
D I P K  I A L M P Q S T S D V L T L L A  
[1673
1270 1290 1310
GCGACCCTGGAGATGCAGGAGCAGTATGCCGATCGTCCAATTATCACGATGTCGATGGCA
   —  —  + 1320
CGCTGGGACCTCTACGTCCTCGTCATACGGCTAGCAGGTTAATAGTGCTACAGCTACCGT 
A \ aThrLeuGl uMe tG 1n G 1uG1nTyrAI aAspArqProI \ e 11 eThr Me tSer-Me tA 1 a 
A T L E M Q E Q Y A D R ' P I  I T M S M A  
[1873
I
1330 1350 1370
AAAACTGGCGAAATTTCTCGTCTGGCTGGTGAAGTATTTGGCTCTGGCGGCAACTTTTGG
-  —  —  —  -  - 4 . —  _  _  _  _  +  _  —  4 - ~  ~  4 . 1380
TTTTGACCGCTTTAAAGAGCAGACCGAGCACT7CATAAACCGAGACCGCCGTTGAAAACC 
LysThrG1yGlulleSerAr gLeuA1aG1vG1uVa1PneG1ySerG1yG1yAsnPheTrp 
K T G E I S R L A G  E V F ' G  S G G  N F W  
[2073
Figure 4*7:(cont)
1381
1441
1501
1561
1621
1681
1741
1390 1410 1430* _^_
TGCCCTAAAAAAAGCGTCTGCGCCAGGGCAAATCTCGGTAAATGATTTGCGCACGCTATT
--------- +----------+----------+-------  + -7----- +---------- + 144(
ACGCCATTTTTTTCGCAGACGCGGTCCCGTTTAGAGCCATTTACTAAACGCGTGCCATAA 
CysGlyLysLysSerVa\CysAlaArgAlaAsnLeuGlvLysEnd 
C G K  K S V C A R A N L G  K *
C2273 [2403
1450 1470 471490
AACTATTTTACACCAGGCATAAGCAATAATATTTCGGCGGGAACACCCTCCC£GCCG„AAC
--------- +.....  +  + --- + 150<
TTGATAAAATGTGGTCCGTATTCGTTATTATAAAGCCGCCCTTGTGGGAGGGGCGGCTTG
1510 1530 1550
TAAAAAATATATTCAATCGTATTTAATAAAAATATTTCGTGAGTCTCTGTGCGCTAATTC
 -------- +----------+----------+----------+---------- +  + 156<
ATTTTTTATATAAGTTAGCATAAATTATTTTTATAAAGCACTCAGAGACACGCGATTAAG
.1570 1590 1610
TCCATTTGGCGTAGGGAAAATCACATCTGAATCAGGAATTAACAATGAAACCTGTAAAAC
AGGTAAACCGCATCCCTTTTAGTGTAGACTTAGTCCTTAATTGTTACTTTGGACATTTTG
1630 1650 1670
CACCTCGTATTAATGGACGAGTGCCGGTCCTGTCGGCACAGGAAGCGGTGAATTATATTC
-  —  —  4- -  —  —  —  —  —  —  —  —  4 . —  -  - -  - -  - -  -  4 . - - - - -  —  -  -  —  4 . —  -  —  —  -  —  -  - -  - 4 . 168C
GTGGAGCATAATTACCTGCTCACGGCCAGGACAGCCGTGTCCTTCGCCACTTA4TATAAG
1690 1710 1730
CCGACGAAGCAACACTTTGTGTGTTAGGCGCTGGCGGCGGTATTCTGGAAGCCACCACGT
--------- +----------+----------+---------- f---------- +---------- + 174C
GGCTGCTTCGTTGTGAAACACACAATCCGCGACCGCCGCCATAAGACCTTCGGTGGTCCA
Clal
1750 1770 1'790
TAATTACTGCTCTTGCTGATAAATATAAACAGACTCAAACACCACGTAATTTATCGAT
- - - -  -  - - - - 4 - - - - - - - - - - 4 . - - - - - - - - - 4 - *  -  - -  - -  -  - -  4 . - - - - - - - - - 4 _ - - - - - - - -  1798
ATTAATGACGAGAACGACTATTTATATTTGTCTGAGTTTGTGGTGCATTAAATAGCTA
Figure 4.7:(cont)
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(b) Application of Fickett*s "Testcode*
The program TESTCODE in the Wisgen package (Section 2.36) 
was applied to both strands of* the DNA sequence. TESTCODE 
searches for genes by plotting the running value of Fickett’s 
’’Testcode*' statistic (Fickett, 1982) along the length of 
the sequence. The testcode statistic is a measure of the 
1 period three constraint* of each region of a DNA molecule; 
it is independent of the reading frame and is based on 
measurements of the period three constraints in an entire 
database for regions thought to be coding and non-coding.
The resulting plots (Figures 4.8a and 4.8b) are divided 
into three regions for which the statistic makes a prediction. 
The top is the region within which 95$ of coding regions 
fall and within which 959° of4 the non-coding regions do 
not fall. The bottom region is the opposite. The middle 
ground is the 1window of vulnerability* where the statistic 
does not have a significant ability to predict coding 
and non-coding regions.
Figure 4.8a shows that the open reading frame falls 
into the regipn where 95$ of coding regions fall, confirming 
that this probably represents the aroD gene sequence. It 
is interesting to note that a second open reading frame 
(data not shown) which begins at the Clal site and runs 
to position 516 (Figure 4.7) is also likely to be protein 
coding i.e. the 3* end of a gene. The identity of this 
gene is unknown.
Figure 4.8b shows that there are no significant protein 
coding regions on the other strand.
Figure 4.8: Application of Fickett's Testcode to
the sequence of the 1.8 kb Clal fragment
(a) The DNA strand shown as 0r-l800 in 
Figure 4.7> including the predicted 
aroD coding region.
(b) The strand; no sijm'Jitanfr- open
reading frames were observed in 
this sequence.
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4.4.2 Does the open reading frame encode 3-dehydroquinase?
(a) Size and composition of the polypeptide encoded in the 
open reading frame
Taking the ATGr/Met codon at position 703 in the sequence 
as the start of the open reading frame, then the gene encodes 
a polypeptide of 240 amino acids, ending with a UGA/stop 
codon at position 1423*
The amino acid sequence of the putative aroD gene is 
shown in Figure 4*7* From this sequence, the amino acid 
composition of 3-dehydroquinase has been predicted, and is 
shown in Table 4»3» From this data a molecular weight of 
28117 can be calculated for the protein. This compares 
favourably with the estimated of 29000 obtained for the 
purified E.coli enzyme by SDS-PAGE (Chaudhuri & Coggins, 
1984b).
(b) Codon utilisation in the open reading frame
Recent comparisons of a number of E.coli structural 
genes have shown that there is a non-random utilisation of 
codons in protein coding sequences. The bias in genetic 
code usage has two main components. Firstly there is a 
correlation with tRNA availability in the cell and secondly 
the choice of 1 codewords1 generally favours codon-anticodon 
interactions of intermediate strength over those involving 
very strong or very weak interactions (Grosjean & Fiers,
1982; Gouy & Gautier, 1982). This bias in codon usage can 
be used to predict whether or not an open reading frame in 
the DNA sequence is likely to be a protein coding sequence. 
The codon utilisation for the open reading frame/putative
Amino
acid
Number predicted by 
DNA sequence
Asp 17
Thr 15
Ser 16
Glu 18
Pro 7
Gly 13
Ala 29
Cys 3
l/al 17
Met 11
H e 16
Leu 19
Tyr 6
Phe 8
His 6
Lys 17
Arg 10
Trp 2
Asn 4
Gin 6
Table 4.3 Amino acid composition of 3-dehydroquinase 
predicted from the DNA sequence.
aroD sequence (Figure 4.7) is listed in Table 4.4. The 
analogous data for four enzymes of the tryptophan bio­
synthetic pathway, namely trpE. trpD, trpC and trpB has 
been pooled and is listed in Table 4»5> for comparison 
(data taken from Table 2 of Gouy & Gautier, 1982). The 
two tables show a very similar pattern of codon utilisation, 
which suggests very strongly that the putative aroD sequence 
actually encodes a protein. One might expect the utilisation 
patterns to be similar since all the above mentioned genes 
encode proteins which fulfil a similar biosynthetic role 
within the cell and will be expressed at approximately the 
same level during the synthesis of tryptophan.
Examples of bias include; avoidance of the ATA codon 
for isoleucine; preference for CGT/C over CGA/G or AGA/G 
for arginine; preference for GGT/c over GGA/G for glycine 
(see Table 4.4).
Further aspects of the codon utilisation of aroD will
be discussed in Chapter 6.
4.4.3 Other features associated with a monocistronic E.coli 
gene
(a) Ribosome binding site
The initiation of protein synthesis in bacteria involves 
the specific binding of the small ribosome subunit to a 
region of the mRNA containing the initiation codon. The 
initiating subunit selects only the AUG or GUG codon at 
the beginning of a cistron, ignoring the many internal AUG
or GUG codons. Recognition involves the untranslated
T C A G
PHE 5 SER 3 TYR 5 CYS 0 T
PHE 3 SER 5 TYR 1 CYS 3 C
T
LEU 1 SER 0 Term - Term . - A
LEU 1 SER 2 Term - TRP 2 G
LEU 1 PRO 2 HIS 4 ARG 7 T
C
LEU 5 PRO 0 HIS *2 ARG 2 C
LEU 0 PRO 2 GLIM 2 ARG 0 A
LEU 11 PRO 3 GLIM 4 ARG 2 G
ILE 9 THR 3 ASIM 2 SER 2 T
ILE 7 THR 8 ASIM 2 SER 4 C
A
ILE 0 THR 0 LYS 16 ARG 0 A
MET 11 ' THR 4 LYS 1 ARG 1 G
UAL 2 ALA 3 ASP 11 GLY 5 T
UAL 6 ALA 13 ASP 6 GLY 8 C
G
UAL 4 ALA 6 GLU 11 GLY 0 A
UAL 5 ALA 7 GLU 7 GLY 0 G
Table 4.4 Codon utilisation in the E.coli aroD gene.
T C A G
PHE 68 SER 30 TYR 76 CYS -27 T
PHE 67 SER 39 TYR 40 CYS 34 C
T
LEU 57 SER 21 Term - Term - A
LEU 52 SER 42 Term - TRP 12 G
LEU 43 PRO 20 HIS 62 ARG 77 T
LEU 43 PRO 25 HIS 62 ARG 122 C
C
LEU 21 PRO 28 GLN 70 ARG 9 G
LEU 244 PRO 115 GLIM 121 ARG 7 G
ILE 113 THR 22 ASN 59 SER 33 T
ILE 83 THR 99 ASIM 91 SER 68 C
A
ILE 2 THR 27 LYS 115 ARG 7 A
WET 91 THR 40 LYS 26 ARG 2 G
UAL 62 ALA 71 ASP 133 GLY 116 T
UAL 51 ALA 154 ASP 81 GLY 127 C
G
UAL 31 ALA 70 GLU 187 GLY 27 A
UAL. 113 ALA 162 GLU 62 GLY 47 G
Table 4.5 Codon utilisation for a number of the trp biosynthetic 
enzyme structural genes from E.coli, namely trpE, trpD, 
: trpC and trpB.
sequence of the mRNA to the 5* side of the initiator codon. 
Shine & Dalgarno (1975) showed that there is a purine-rich 
tract in the ribosome binding site of different bacterial 
mRNAs which shows complementarity to the 3 1 end of l6S 
ribosomal RNA, and that it is the specific pairing of mRNA 
to 16s rRNA which allows the initiation of translation 
to take place.
> v'' Q r' AC f'
It has been proposed that the sequence 5 1-ACCUCCU-3* 
in l6S rRNA is the site at which pairing takes place. A 
consensus sequence for the recognition region has been 
derived from a knowledge of a number of E.coli mRNAs; the 
sequence 5 ,-*AGGAG-3' (Shine-Dalgarno or S-D sequence) 
precedes structural genes at a distance of 4-6 bp from the 
initiation AUG or GUG codon. The control of initiation of 
translation may be mediated by the degree of complementarity 
of the mRNA and rRNA and by the accessibility of the purine- 
rich segment of the message to the terminus as determined 
by the secondary structure of the initiation region.
The DNA sequence upstream of the proposed aroD coding 
region is illustrated.in Figure 4.9* The region to the 
3 '-side of the putative AUG/Met initiation codon is very 
purine rich. A possible S-D sequence is located 8 nucleotides 
before the start of the gene and is indicated on Figure 4*9* 
This provides further evidence that the open reading frame 
encodes a gene and that the AUG/Met codon is the correct 
initiation point. The next Met codon is located at position 
769 and is not preceded by a purine rich tract.
361
421
481
541
601
661
380 400 " 420
CAGCAAGCCTTTGCTGAAGCCCTGGCTTCCGCCGACATTTTTAACCAATGGCACAAAAGT 
--------- +----------+----------+ +  + + 41
440 460 480
GGGTATGAAACCCTTGAGAATGAATCATTGGTTAATGATATCGATCTGTTACATCCGGGA 
--------- +--------- +----------+----------+---------- + + 41
500 520 540
CTTCTGGTCACTGAAACTGGCGTGTATAACCCGCATATGACGAAGTTATTGCAGCAGGCG 
--------- +----------+----------+----  +---------- + ---------- + 5-*
560 580 600
CAACAAGCTGGTTGCAAAACGATTGATGGATACGGCATGGTGTTGTGGCAAGGGGCTCAA 
  + +  +  +  + +
-35 4—  17bp — > -10
4 s /
GGCAAAGATffcC^CTGGAATATGT’
+--------- ■-+---------- +--------- *---------- +---------- + 6E
     ,  .. 660
CAGTTCACATTATGGACf cCCTCTGGA TAAACAGGTCATGGGG
S-D
680 _ 700 ♦ -----> aroD
t t c g g t g c c t g a c a g g c t g a c c g c g t g c a g a a a g g c -t a a a a a a t g a a a a Cc CTa a c t g t a
 + + + +  +  +
MetLysThrVaIThrVa1
Figure 4*9: The DNA sequence upstream of the aroD coding
region showing the location of a possible promoter 
sequence*
(b ) Promoter
Gene expression in E.coli is controlled, in part, at 
the level of RNA transcription. Transcriptional regulation 
can be achieved by modulating the efficiency with which 
RNA polymerase can recognise and interact with initiation 
sites (promoters) on the DNA.
Promoters are expected to share common structural 
features, reflecting a similar interaction with RNA polymeras 
Comparison of a large number of E.coli promoters has shown 
that they contain two regions of conserved DNA sequence, 
located about 10 and 35 base pairs upstream of the trans­
cription startpoint (Rosenberg & Court, 1979; Hawley & 
McClure, 1983)* However there is also considerable sequence 
diversity which is related both to the wide range of 
initiation frequencies and to the partial overlap of binding 
sites for transcriptional control proteins.
The first conserved region is located about 10 bp 
upstream of the mRNA start point and is known as the *-10 
region1 or 'Pribnow box1 (Pribnow, 1975)* The consensus 
Pribnow box sequence is TATAAT. Within this sequence, 
however, some residues are more highly conserved than others. 
The final T is very well conserved. Four, and five bp 
upstream, two other strongly conserved bases (T and A 
respectively) are found. The three residues between these 
sites, TAA, are also conserved, though less stringently.
.The second conserved region is located about 35 
upstream of the mRNA start point (the '-35 region’ or 
recognition region). In order to align -35 regions with
+-10 regions, it is necessary to allow a -2 residue 
flexibility in the spacer region between them. The 
homology between promoters consists of a highly conserved 
TTG trinucleotide upstream and adjacent to a less conserved 
ACA sequence.
Comparison of many mRNA startpoints indicates that 
initiation of transcription takes place predominantly from 
a single position some 6 to 9 bp beyond the final T of the 
-10 region. The starting nucleotide is usually an A, 
sometimes a G, but only very rarely a C or a T.
The region upstream of the putative aroD coding sequence 
(Figure 4.9) was scanned by eye for promoter like sequences. 
Initially, a search was made for the highly conserved 
hexanucleotide TA— -T, as expected for the -10 region. In 
the 300 bp preceding the coding region, only one such 
sequence was found, at position 640. This sequence TATGTT 
is similar to the consensus TATAAT. 17 bp further upstream 
the sequence CTGGCA occurs; this is homologous to the 
consensus -35 region, TTGACA. The mRNA startpoint could 
then be either of the G residues at positions 651 and 652, 
both of which are within the allowed 6 to 9 bp from the 
final T of the -10 region. Some startpoints outwith this 
spacing are known, and so the actual transcription start 
could be the A residue at position 650, or the A residue 
at position 655* The latter A residue is in fact at the 
centre of the weakly conserved triplet CAT, often found 
around the A initiation point.
This search for the aroD promoter is by no means 
exhaustive. More rigorous methods of searching for a 
promoter have been developed, making use of a weighted 
analysis of each residue in a sequence (e.g. Staden, 1984), 
but the computer programs were not available to us.
There is as yet no evidence, either in vitro or in vivo 
to support the prediction outlined above for the location 
of the aroD promoter. Further experiments such as SI 
nuclease mapping of the plasmid encoded transcripts would 
provide hard evidence for the proposals.
(c) Terminator
Comparisons of the site of termination of transcription 
have been made for a number of E.coli genes (Rosenberg &
Court, 1979)* Three common features are' found at termination 
sites:
(i) an inverted repeat sequence
(ii) U residues are found at the 3* terminus of the transcript
(iii) G/C rich sequences are found preceding the stopsite.
The sequence to the 3*-side the putative aroD
coding region was scanned, again by eye, for the presence 
of an inverted repeat. One inverted repeat was located 
centred at position i486. This has a stem of 9 bp and a 
9-base loop. If this forms part of the terminator of aroD 
transcription, then this sequence fulfils bvo of the 
features of a terminator detailed above. The repeat is
; .... :1 not followed 
by a run of T residues. Again, experimental evidence is
required to reveal the true point of termination of the 
aroD transcript.
4.5 Future prospects
It is now possible to compare the sequence of 3- 
dehydroquinase from E.coli with the sequence of the catabolic 
dehydroquinase of Neurospora, the product of the qa-2 gene 
(Alton ejb al• , 1982; Dr M. Case, unpublished results), and 
with the peptide sequence around the active site lysine 
of the Neurospora arom complex (Dr S. Choudhuri, unpublished 
results). This will be discussed in Chapter 7»
The availability of 3-dehydroquinase in large amounts 
from an overproducing strain of E.coli (Dr S. Choudhuri, 
unpublished results) will allow the protein chemistry of 
the active site of the enzyme to be investigated. A knowledge 
of the’ amino acid sequence of the enzyme will assist this 
investigation.
4.6 Note added in proof
Since the time of writing, the amino-terminal sequence 
and the amino acid composition of 3-dehydroquinase have 
been determined (Murray Campbell, unpublished results).
The N-terminal sequence confirms that the aroD coding region 
begins with the Met at position 703> and the amino acid 
composition is in good agreement with that predicted by 
the DNA sequence (data not shown).
CHAPTER 5 SUB-CLONING AND ANALYSIS OF THE E.coli aroA GENE
5»1 Introduction
5»1«1 The source of the aroA gene for this study
The E.coli ribosomal protein SI is encoded by the 
gene rpsA, which is located at minute 20.5 on the E.coli 
genetic map, close to both aroA and serC (Bachmann, 1983; 
Figures 1.3 & 1.4). As part of a study of the structure 
and function of this protein, the rpsA gene has been isolated
and its entire DNA sequence has been determined (Kitakawa
\
et al., 1980; Schnier & Isono, 1982).
The rpsA gene has no readily selectable phenotype and 
so its proximity to the gene serC was utilised to obtain a 
collection of phage which carried the region of the E.coli 
chromosome around min 20. Plaque-forming A. phage were 
isolated after induction of an E. coli K12 A. lysogen. Those 
phage which, because of abherrant excision, had picked up 
a region of the E.coli chromosome were identified by their 
ability to complement the serC mutation, following infection 
of E.coli KL282. SerC is a selectable marker; mutants 
require serine and pyridoxine for growth and so relief of 
auxotrophy was used to isolate a series of transducing 
phage carrying serC.
In vitro transcription of non-A genes and two dimensional 
gel electrophoresis of the products was used to show that 
one of the phage, hereafter named A pserC also synthesised 
a 65kdal protein with identical properties to ribosomal 
protein SI. Further proof that the phage carried the
serC-rpsA region of the E.coli chromosome was provided by 
infection of an E.coli aroA mutant - E.coli AB2829* Again, 
relief of auxotrophy was used to show that aroA was present 
on the phage, as expected, since aroA is located between 
serC and rpsA (Kitakawa et al.. 1980).
5.1»2 The genomic DNA insert in ApserC
The genomic DNA inserted in ApserC has been extensively
0
mapped with a number of restriction enzymes (Schnier &
Isono, 1982; Figure 5«l)* ApserC DNA was digested with a 
number of enzymes in turn, which were known to cleave the 
genomic DNA insert, and the DNA was transcribed and translated 
in vitro. Translation products were subjected to gel electro­
phoresis and enzymes identified which abolished a band 
corresponding to protein SI. In this way, the rpsA gene 
was located. It was then sub-cloned and the entire DNA 
sequence of the gene determined.
Figure 5*1 shows the restriction map of the serC-aroA 
region and the location of the rpsA gene. This diagram also 
illustrates the conventional view of the map adopted 
throughout this work i.e. ’left* or * right1 is with respect 
to this map. Attention is also drawn to the regions 
designated A-C.
E.coli strain KL282, lysogenic for ApserC was obtained 
from* Dr K. Isono, Max-Planck-Institut fur Molekulare 
Genetik, Berlin, FRG. In this lysogen, the A phage is 
present at one copy per chromosome, and hence is providing 
only one extra copy of the aroA gene. To increase the
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copy number of aroA and hence to overexpress EPSP synthase, 
the gene must be sub-cloned onto multi-copy plasmid 
vectors; pAT153 and pBR322 have been used for this purpose.
5.2 Sub-cloning and analysis of aroA
5.2.1 Construction of pKD501 and pKD502
Examination of the restriction map in Figure 5»1 reveals 
that there is a PstI fragment of approximately 4.5 "to 5*0 kb 
in size which carries most of the genomic material of ApserC 
but which does not encode rpsA. Sub-cloning this fragment 
gave the best chance of transferring aroA onto a plasmid, 
without disrupting the gene in any way.
ApserC was purified after heat induction of the E.coli 
KL282 lysogen, as described in Section 2.9* DNA extracted 
from the phage was digested with PstI and the fragments 
separated by electrophoresis on a 0*7*/° LMT agarose gel 
(Figure 5*2). Three bands were observed in positions 
corresponding to the size range 4*5 - 5*0 kb. The individual 
bands were not completely resolved and so all three were 
excised as a group. DNA was extracted and ligated to PstI 
cleaved and phosphatase treated pAT153« The ligation mix 
was used to transform E.coli AB2829 and the plasmid trans­
formed cells selected by growth overnight on LA/tet. Colonies 
obtained in this way were replica plated onto minimal medium 
and incubated a further 24 h at 37°• Because of the 
auxotrophic mutation in E.coli AB2829> only colonies trans­
formed with recombinant plasmids carrying aroA would grow 
under these conditions. From the many colonies which grew
Figure 5*2: Restriction enzyme digestion of ApserC
Track DNA Enzyme
1 Aps erC undigested
2 A Hindlll (wild type)
3 ApserC BamHI
k ApserC Hindlll
3 ApserC EcoRI
6 ApserC PstI
7 A EcoRI (wild type)
on minimal medium, 100 were picked and checked for
ampicillin sensitivity; all were found to be sensitive,
indicating an insertion at the PstI site. Plasmid DNA
R Swas extracted from 10 tet , amp colonies by the mini-prep 
technique and digestion with various restriction enzymes 
established that all the clones carried the anticipated
4.6 kb PstI fragment. Two clones (pKD501 and pKD502) 
were retained for further examination; each carried the 
same fragment, but in opposite orientations (Figure 5*3)•
Large scale plasmid DNA preparations of pKD501 and 
pKD502 were made (Section 2.7) and the DNA digested with 
various mixtures of restriction enzymes in order to confirm 
the restriction map shown in Figure and to establish
that the PstI insert originated from A-pserC. Figure 5*^ 
shows one of the gels obtained. The pattern obtained for 
each enzyme confirmed that expected from the restriction 
map and from the map of pAT153> except in the case of 
PvuII. Figure 5*1 locates two PvuII sites within the 
PstI fragment, but the digests clearly showed that three 
fragments were produced. There are no PvuII sites in 
pAT153‘. Further mapping has shown that there is a PvuII 
site to the right of the leftward PstI site; it is possible 
that the Pvul site on Figure 5«1 at this location should 
be a PvuII site.
5.2.2 Overexpression of EPSP synthase in cells carrying 
PKD501
The expression of EPSP synthase from cells carrying
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Figure 5*^: Restriction enzyme digestion of pKD^Ol and pKD502
Track DNA Enzyme
1 pKD502 Hindlll
2 pKD502 PvuII
3 pKD502 Clal
k pKD502 PstI
5 pKD502 Hindlll + Bglll
6 ApserC PstI
7 A Hindlll
8 pKD501 Hindlll + Bglll
9 pKD^Ol PstI
10 pKD501 Clal
11 pKD501 PvuII
12 pKD501 Hindlll
various aroA recombinant plasmids will be discussed in 
greater detail in Section 5*2*7* In order to establish 
that E. coli AB2829/pKDf>01 can be used to overproduce the 
enzyme, EPSP synthase activity was measured in crude 
extracts of E.coli K12 and E.coli AB2829/pKD501* Cells 
were grown in liquid minimal medium to saturation ( A ^ q= 
1.3-1*5) and sonicated in sonication buffer 'B*. The 
specific activity of EPSP synthase in crude extracts of 
E. coli AB2829/pKI>501 was 0.42 U/mg, which is over 100-fold 
higher than that found in E. coli K12 strain ATCC 14-948 
(0.004 U/mg)•
The high specific activity of EPSP synthase in E. coli 
AB2829/pKD501 has led to the use -of this strain for the 
preparation of EPSP synthase. On a large scale, cells are 
grown in 500 ml batches in 2.5 1 conical flasks on an 
orbital shaker. Minimal medium is always used; cells 
are grown to saturation before harvesting.
A loopful of -20° glycerol stock E.coli AB2829/pKD501 
is inoculated into 10 ml LA/tet and shaken overnight. 1 ml 
is transferred into 100 ml minimal medium and shaken a 
further 24 h. 5 ml is then used to inoculate the 500 ml 
flasks.
5.2.3 Is plasmid encoded EPSP synthase identical to the 
*wild type1 enzyme?
Since the overproduced enzyme was required for protein 
chemistry and enzymology it was essential to demonstrate 
that it was identical to that purified from the wild type 
E.coli K12 strain.
EPSP synthase has been purified to homogeneity from 
both E.coli K12 (Lewendon & Coggins, 1983) and from E.coli 
AB2829/pKE501 (Duncan, Lewendon & Coggins, 1984a). The 
enzyme purified from E.coli AB2829/pKD501 is indistinguish­
able from that isolated from untransformed E.coli on the 
basis of:
(i) P.A.G.E. under native conditions and in the presence 
of SDS.
(ii) one-dimensional peptide mapping after partial S.aureus . 
V8 protease digestion.
(iii) fractionation on a TSK G2000 SW gel permeation column.
(iv) kinetic parameters.
(data obtained by Ann Lewendon, and described in detail in 
Duncan, Lewendon & Coggins, 1984a).
It is now possible to produce milligram quantities 
of homogeneous EPSP synthase. The availability of large 
quantities of pure, active protein has facilitated further 
mechanistic and structural studies of this enzyme (Ann 
Lewendon, Ph.D. Thesis, University of Glasgow, 1984).
5.2.4 Growth of E.coli in the presence of Glyphosate
It has previously been shown that the growth of E. coli 
is inhibited in the presence of the herbicide glyphosate 
and that the enzymatic step involved is that catalysed by 
EPSP synthase (Section 1.4.6). This suggests that glyphosate 
tolerant cells might be obtained as follows:
(i) by the production of a structurally altered form 
of the enzyme, so that the herbicide has a lowered 
affinity for the enzyme, binding less efficiently 
than substrate;
(ii) by overproduction of the EPSP synthase from an amplified 
aroA gene, requiring more herbicide to inhibit growth. 
The aroA gene is expressed constitutively in E.coli
(Tribe ejfc al•, 1976) and so the gene will be overexpressed 
in cells carrying a multi-copy plasmid by a factor similar 
to the copy number of the plasmid. This has already been 
shown to be the case with aroA cloned into pAT153 (pKD50l) 
where a 100 fold higher level of EPSP synthase is found.
In order to test the hypothesis that amplification of 
aroA will make E.coli cells glyphosate tolerant, E.coli K12 
was tested for growth on minimal agar containing a range 
of concentrations of glyphosate, with and without the aroA 
recombinant plasmid.
E.coli K12 and E.coli K12/pKD501 were grown in LB and 
LB/tet respectively to an = 0.5 (mid log phase).
Cultures were harvested, washed in M9 salts and resuspended 
in the original volume of M9 salts. 100 ]il aliquots
g
(cell density approximately 10 cells/ml) were spread onto 
MM, MM containing glyphosate and MM + aromatics + glyphosate 
plates (analytical grade glyphosate was sterilised by 
filtration before adding the appropriate amount to medium 
at 55°• Glyphosate was a gift from Dr S. Ridley, I.C.I. 
Jealott's Hill).
The concentrations of glyphosate used and the results 
obtained are shown in Table 5*1* These results show that 
on MM, growth of E.coli K12 is substantially inhibited by 
3 mM-glyphosate and is completely stopped by 5 mM-glyphosate 
Transformation of E. coli with pKDfJOl increases tolerance 
so that near normal growth is obtained even on 50 mM- 
glyphosate.
Minimal medium + aromatics contains the end products 
of aromatic biosynthesis and so growth of E.coli K12 and 
E. coli AB2829 on this medium should be unaffected by the 
presence of glyphosate. Clearly this is not so. Growth 
is affected in both cases, though to a greater extent for 
E.coli AB2829* This may be due to secondary effects of 
glyphosate on the metabolism of E.coli and unconnected with 
the effect on EPSP synthase.
The results presented here are qualitative, but they 
clearly illustrate that amplification of the aroA gene 
confers resistance to glyphosate. In this respect, the 
aroA gene can be used as a selectable marker on plasmids 
in the same way as ampicillin or tetracycline resistance. 
This might have its uses in larger scale growth of plasmid 
carrying cells where a selection must be maintained. It 
is both difficult and costly to remove antibiotics from 
growth media before disposal. Glyphosate poses no such 
problems. It has no effects on mammalian systems and is 
bio-degradable.
In order to quantify the effects of glyphosate on the 
growth of E.coli it is necessary to measure growth rates
(glyphosate)
(mM)
Minimal Plates Minimal + aromatics Plates
E.coli
K12
E.coli
K12/pKD501
E.coli
K12
E.coli
AB2829
0 +++ +++ +++ +++
• 1 +++ +++ +++ +++
2 +++ +++ +++ +++
3. ++ +++ +++ +++
4 + +++ +++ ++
5 +++ +++ ++
20 - +++ ++ +/-
30 - +++
40 - +++
50 - ++
Table 5.1: Growth of E.coli in the presence of glyphosate
Key: +++ confluent growth overnight
•H* slight growth overnight
+ growth after 2 day incubation
+/- slight growth after 2 day incubation
- no growth
in liquid medium under constant conditions and varying 
glyphosate concentrations. Some experiments of* this kind 
have been carried out by workers at Monsanto Co., St. Louis, 
USA (Rogers ejfc al•, 1983)* They have Shown that E.coli cells 
harbouring a recombinant aroA carrying plasmid, pM0N4, are 
able to grow in the presence of 40 mM-glyphosate. This is 
eight times the concentration required to give a very much 
reduced growth rate for E.coli cells carrying a plasmid 
lacking the aroA gene.
5»2.5 Construction of pKD503. pKD'504 and pKD505
The PstI fragment inserted in pKD501 is 4.6 kb in 
length. This is considerably larger than the size required 
to encode the aroA gene (calculated to be 1.2 - 1.4 kb, 
from the of 49 000 estimated for EPSP synthase by SDS- 
PAGE (Lewendon & Coggins, 1983))*
If the aroA gene could be more precisely located within 
the 4.6 kb DNA fragment then the amount of DNA sequencing 
required to obtain the gene sequence would be considerably 
reduced.
The 'shotgun* cloning approach was used to produce a 
series of derivatives of ApserC carrying the aroA gene.
ApserC DNA was cleaved with a pair of different enzymes 
and the DNA fragments randomly cloned into pAT153 which 
had been cut with the same enzymes, or enzymes producing 
the same complementary ends (N.B. since the recognition 
sequence of Aval is G^PyCGPuG, the internal redundancy 
means that there is only a one in four chance of an Aval 
end cloning into the Aval site of pAT153)«
For each enzyme combination: l]ig of ApserC DNA
was digested with a pair of enzymes and mixed with 100 ng 
of pAT153, digested with enzymes producing the same 
complementary ends. The mixture was immediately phenol/ 
chloroform extracted and ethanol precipitated. Ligation 
mixes were set up and incubated overnight at 14° before 
being used to transform E.coli AB2829* Transformed cells 
were selected by growth on LA/amp, replica plated onto MM 
and incubated a further 2k h. Six colonies from the MM 
plate were each inoculated into 10 ml LB/amp and after 
overnight growth, plasmid DNA was prepared by the mini- 
prep technique.
The enzyme combinations used and the resulting 
recombinants obtained are detailed in Table 5«2.
For each combination of enzymes, the six mini-preps 
were found to contain the same recombinant plasmid. A 
series of single- and double-enzyme digests were carried 
out on each plasmid in order to locate the region of the 
phage carried on the plasmid. The information obtained 
from this, and the deduced location of each cloned fragment 
is shown in Figure 5«3»
Combining the sub-cloning results so far, the boundaries 
of the aroA complementing region of the phage are the Clal 
site used in the*construction of pKD505 and the PstI site 
used in constructing pKD501.
A pserC diqested by: pAT153 digested by: Resultant
recombinant:
Bglll + Hindlll BamHI + Hindlll pKD503
Bglll + Aval BamHI + Aval pKD504
Clal + Aval Clal + Aval pKD505
Table 5.2 Restriction enzyme combinations used in 'shotgun* 
cloning of aroA from ApserC.
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5*2.6 Construction of pKD506
The cloning of a Clal-PstI fragment into pAT153 
results in the disruption of both the ampicillin and the 
tetracycline resistance genes. For this reason, it was 
decided to clone a fragment extending from the Clal site
to a PvuII site approximately 200 bp to the left of the
/
PstI site. 'When this 1*9 kb fragment was cloned into 
pBR322, the ampicillin resistance gene remained intact, 
and it was hoped that the recombinant plasmid would still 
be aroA complementing.
The 1.9 kb Clal-PvuII fragment was isolated after 
electrophoresis of a Clal/PvuII digest of pKD501 on 1 °fo 
LMT agarose. It was ligated (overnight, 0°) to Clal/
PvuII cleaved pBR322 and used to transform E.coli AB2829* 
Six colonies were obtained after overnight growth on LA/ 
amp and colonies were picked and transferred onto LA/tet 
and MM. All were capable of growth on MM. Plasmid DNA 
was extracted from one colony; restriction enzyme digests 
confirmed that this recombinant plasmid contained the 
correct 1*9 kb Clal-PvuII fragment, and it was designated 
pKD506.
The sub-cloning results are summarised in Figure 5«3« 
Each plasmid is phenotypically aroA+ on the basis that it 
can relieve the auxotrophic mutation in E.coli AB2829*
All the plasmids are equally capable of complementing aroA 
None of the transformed cells show a slow growing phenotyp 
which might be indicative of either weak complementation 
from an altered EPSP synthase, or intra-molecular
complementation between plasmid encoded enzyme and mutant 
chromosomally encoded enzyme. These results suggest that 
the whole aroA gene lies on pKD506 between the Clal and 
PvuII sites. However, confirmation that the gene is intact 
and that any sequences necessary for its expression are 
also present can only be gained through determination of 
the specific activity of EPSP synthase in crude extracts 
of cells harbouring each of the plasmids. As stated earlier 
the aroA gene is expressed constitutively and so one can 
predict that EPSP synthase will be overexpressed at the 
level of the copy number of the vector. This would suggest 
that each clone will overexpress approximately 100-fold, 
as the copy number of pAT153 is approximately 100. This 
level of expression has already been shown to occur with 
pKD501 (see Section 5*2.2). One of the plasmids, pKD506, 
since it was obtained from pBR322, would be expected to 
have a lower copy number.
5*2.7 Specific activity of EPSP synthase in crude extracts 
of cells carrying the recombinant aroA plasmids 
It has already been shown that E.coli AB2829 cells 
harbouring pKD501 are an excellent source of EPSP synthase. 
The high copy number of the plasmid results in a 100-fold 
increase in the specific activity of EPSP synthase in these 
cells as compared with the activity found in wild type cells 
In this section the levels of EPSP synthase in cells 
harbouring other recombinant plasmids carrying the aroA 
gene are compared.
Crude extracts were prepared as detailed in Section 
2.18 from 100 ml minimal medium cultures grown to saturation 
(A65O ” 1*5)* Sonication buffer lB ! was used throughout.
In each case, the values given for specific activities 
are an average of at least two independent duplicate 
experiments. All the assays were performed in the reverse 
direction, following the formation of PEP by coupling to 
the pyruvate kinase and lactate dehydrogenase reactions 
(Figure 5*6). The results obtained are shown in Table 5*3»
In the crude extracts there is a steady absorbance 
change at 3^0 nm in the absence of added EPSP, which is 
due to an NADH oxidase activity. This blank rate makes 
the accurate determination of the specific activity of 
EPSP synthase in extracts of wild type cells difficult.
The blank rate poses no problems in cells where the aroA 
gene is overexpressed from a plasmid because the observed 
rates are so high. Despite the difficulties in measuring 
low levels of EPSP synthase activity, we can be confident 
that the relative expression values quoted in Table 5*3 
are accurate for the following reason: during full scale
preparation of the enzyme from E.coli K12 or from E.coli 
AB2829/pKD501, the specific activity of EPSP synthase can 
be determined very accurately after ammonium sulphate 
fractionation of the crude extract (the first step in the 
purification procedure), and the overexpression factor 
obtained is 100, in good agreement with the value obtained 
in Table 3•3•
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Extract Specific activity 
of EPSP synthase (U/mg)
Relative
activity
K12 0.004 1
AB2829 no activity ... -
AB2829/pKD501 0.420 105
AB2829/pKD502 0.425 106
AB2829/pKD503 0.425 106
AB2829/pKD504 0.356 89
AB2829/pKD5D5 0.0044 1.1
AB2829/pKD506 .0.0048 1.2
Table 5.3: Specific activity of EPSP synthase in E.coli crude 
extracts.
All the plasmids derived from pAT133 should have 
similar high copy numbers and therefore give similar high 
levels of EPSP synthase. For cells harbouring pKD301, 
pKD302, pKD303 and pKD304, the specific activity of EPSP 
synthase in the crude extract is indeed similar, and is 
approximately 100 fold higher than in E.coli K12. In 
contrast, the crude extracts of cells harbouring pKD303 
and pKD306 have EPSP synthase specific activities which 
are very much less than expected. The values obtained are 
approximately the same as the level found in wild type 
cells. This amount of enzyme will be sufficient to allow 
mutant cells to grow in unsupplemented medium. Thus all 
the plasmids are capable of relieving the auxotrophic 
requirement of E.coli AB2829> and are indistinguishable 
phenotypically. However, an explanation is required for 
the occurrence of two classes of aroA containing plasmid, 
one of which gives 'high* levels of EPSP synthase activity 
and one of which gives unexpectedly 'low' levels of activity.
3*2.8 Expression of aroA on pKD505 and pKD506
Both pKD303 and pKD306 were constructed by insertion 
of fragments obtained by cleavage at a common Clal site. 
pKD306 extends 1«9 kb to a PvuII site, but pKD303 extends 
beyond this site, and beyond the PstI site used in the 
construction of pKD301. It is possible, therefore, that 
cloning from the Clal site is responsible for a reduction 
in the level of expression of the aroA gene. Two simple
models which would explain the low levels of enzyme activity 
are shown in Figure 5*7*
Figure 5*7a shows the removal of the 3 1 end of the 
aroA coding region during the cloning procedure. This would 
result in the production of large quantities of a truncated 
polypeptide which might have very little enzyme activity.
Figure 5»7h illustrates a second possibility, the 
removal or alteration of the promoter of the aroA gene.
The low level of expression observed might then be due 
either to an altered, ineffective aroA promoter, or, if the 
aroA promoter has been completely removed, expression might 
be due to a minor plasmid promoter.
5*2.9 SDS-P.A.G.E. of crude extracts
In an attempt to distinguish between tlie two possibilities 
outlined in the previous section, crude extracts were 
analysed by SDS-P.A.G.E. In extracts where the enzyme is 
overexpressed, it ought to be possible to see a Coomassie 
Blue stained band corresponding to EPSP synthase providing 
there are no highly abundant E.coli proteins migrating to 
the same position in the gel. If the reduction in specific 
activity is due to production of a truncated polypeptide 
then a shift in the position of this band should be 
observed. However, if the problem is the disruption of 
the promoter, then a heavily staining band should be absent 
from the low activity extracts.
Crude extracts were prepared and analysed by electro­
phoresis on a 12% polyacrylamide gel in the presence of 
SDS, as described in Section 2.21. The gel was stained
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with Coomassie Blue, destained overnight and photographed 
(Figure 5*8).
A heavily staining band of the same mobility as EPSP 
synthase can be seen in tracks a - d which correspond to 
the ’high activity’ extracts. However, the same band is 
observed in the 'low activity* extracts (tracks f and g) 
and also in E.coli K12 (track h) and E.coli AB2829 (track i) 
Thus, no conclusions can be drawn from this gel regarding 
the expression of aroA in 'low activity* and 'high activity* 
extracts. A highly abundant E.coli protein is masking EPSP 
synthase throughout the gel: the likeliest candidate for
this is Elongation Factor Tu, which is expressed at a very 
high level (89 000 molecules/cell, data from Gouy & Gautier, 
1982) and has an of 46 000.
This negative result is presented here, however, becaus 
the gel shown in Figure 5*8 shows that in four of the crude 
extracts, tracks a-d, there is a very prominent band 
(M^ .40 000) which is not present in the other extracts.
This protein is presumably also plasmid encoded since it 
is not present in extracts of E.coli K12 but is only present 
in the 'high activity* extracts. This would imply that it 
is encoded by sequences to the left of the Clal site used 
in the construction of pKD505 and pKD506. The significance 
of the prominent band will be discussed in detail in 
Chapter 6.
5.2.10 The 0.5 kb Clal fragment
One way of restoring 'high activity' to the 'low 
activity' plasmids might be to reclone and include the
a b c d e f g h i  j
60k
40k
Figure 5*8: SDS-P, 
Track
) of E.coli crude extracts
a E.coli AB2829/pKD501
b E. coli AB2829/pKD502
c E.coli AB2829/pKD503
d E.coli AB2829/pKD504
e EPSP synthase
f E.coli AB2829/pKD505
S E.coli AB2829/pKD506
h E.coli AB2829
i E.coli K12
j Molecular weight markers
sequences to the left of* the Clal site in the plasmids*
This is feasible as there is a unique Clal site in pKD306 
and the 0*5 kb Clal fragment (’B' on Figure 3«l) to the 
left of the Clal site can be readily isolated from pKD301.
Fragment B can be inserted into pKD306 in either 
orientation, but it will be expected to restore ’high 
activity1 only when it is in the correct orientation relative 
to Fragment A. Glyphosate tolerance would be expected to 
select any recombinants with ’high activity’ phenotype.
E* coli AB2829/pKD506 shows the same pattern of sensitivity 
to glyphosate as does E* coli K12, but restoration of ’high 
activity’ will change the pattern to that of E.coli 
AB2829/pKD501.
Fragment B was recovered after digestion of pKD301 
with Clal and electrophoresis through LMT agarose. This 
was then ligated to Clal cleaved and phosphatase treated 
pKD506. Extra care was taken in this case to ensure that 
the phosphatase reaction had removed all 5'-phosphate 
groups. A control ligation after phosphatase treatment 
showed that essentially no recircularisation of pKD306 
was possible and hence that any transformants obtained 
after ligation of fragment B would be recombinants. It 
was then predicted that approximately 30°fo of recombinants 
would be glyphosate tolerant.
The ligation mix was used to transform E.coli AB2829
and transformants were selected by overnight growth on
LA/amp. As a selection for the restoration of 'high
Ractivity', 100 amp colonies were transferred and gridded 
onto an MM plate and an MM + glyphosate (20 mM) plate.
Under these conditions, only colonies carrying recombinant 
clones with inserts in the correct orientation would be 
expected to grow.
None of the colonies screened were able to grow on 
the plate containing glyphosate (AB2829/pKD501 did grow 
on this plate). The experiment was repeated and 800 colonies 
were screened by replica plating onto MM + glyphosate 
(20 mM). Again, none were able to grow on glyphosate.
Plasmid DNA was prepared from 20 transformants and digested 
with Clal. All were found to have an.insert at the Clal 
site of the correct size. It was not possible, however, 
to show conclusively that any of these had fragment B 
in the correct orientation relative to fragment A of 
pKD506, as the only known restriction site on fragment B 
(Kpnl; Figure 5»l) is very close to the centre.
Crude extracts were prepared from cells carrying six 
of the recombinant clones and the specific activity of 
EPSP synthase was determined. In each case, the activity 
was close to wild type, i.e. the clones were of the 'low 
activity' type.
It is exceedingly unlikely that all of the transformants 
screened had the 0.5 kb Clal fragment introduced into 
pKD506 in ike 'wrong' orientation. This leads to the 
conclusion that insertion of this DNA and restoration of 
the correct fragment B - fragment A interface has no effect 
on expression of the aroA gene. 0.5 kb of DNA is enough 
to encode more than a third of the aroA gene. Addition 
of this much DNA to the inserts in pKD505 and pKD506
should improve the levels of EPSP synthase activity if 
these had been reduced by truncation of the gene. Since 
there is no improvement, an alternative explanation for 
the 'low activity' plasmids is required. One possibility 
is that aroA is not a 'normal' monocistronic E.coli gene, 
but is co-ordinately expressed with the 40 000 M gene 
product. To obtain evidence for this hypothesis, the 
entire DNA sequence of the aroA region has been determined.
5.3 Determination of the DNA sequence of the aroA gene
5.3.1 DNA sequencing strategy for aroA
DNA sequencing studies on the aroA gene were concentrated 
initially on fragment A of A.pserC - the 1*9 kb Clal-PvuII 
fragment subcloned in pKD506. The M13/dideoxy sequencing 
method was used throughout. Full details of the techniques 
employed to construct clones and produce templates, and 
the dideoxy sequencing reactions are given in Sections 
2*22 to 2.30.
The strategy which was followed for providing clones 
and templates for .sequencing is outlined below. It was 
hoped that this would give the entire DNA sequence on both 
strands and overlaps at all the restriction sites used 
in cloning.
(a) left end of the sequence: use a Clal fragment from
pKD502 to define the left end of the sequence.
(b) Right end of the sequence: there is a unique HincII 
site within fragment A which is located approximately 
1.1 kb to the right of the Clal site; cloning of a
0.8 kb HincII-PvuII fragment defines the right end 
of the sequence and also gives some internal sequence,
(c) Internal sequence: use a set of fragments produced by- 
digestion of fragment A with the restriction enzymes 
TaqI and Hpall (the rationale for this has been 
outlined in Section 4.4.1). The sequence of these 
fragments will give most of the internal sequence.
5.3*2 The Clal site
pKD502 was digested with Clal and the DNA fragments 
separated by electrophoresis on 1 °fo LMT agarose. A 2*5 kb 
fragment spanning the Clal-PvuII region and extending to 
the Clal site in the vector was excised and cloned into 
the AccI site of M13mp8. Four recombinant templates were 
purified and the sequence to the right of the Clal site 
was determined. The sequence was entered into a file on 
a PDP11-34 computer using the BATIN program (Section 2.36).
5»3»3 The PvuII site
In a similar way, a 0.8 kb HincII-PvuII fragment of 
pKD506 was isolated and ligated to Smal cleaved M13mp8.
Six templates were purified and sequenced in turn till the 
sequence at both ends had been obtained. Again, the data 
was entered into the computer. The sequence at the PvuII 
end showed that the nearest Hpall and TaqI sites were 
located 12 and 1 bp respectively away from the PvuII site - 
this indicated that in cloning Hpall and TaqI fragments 
very little information would be lost through the inability 
to clone the Taql-PvuII and Hpall-PvuII fragments.
3*3*4 Number and size of Hpall and TaqI fragments in region A 
The Clal—PvuII fragment of pKD306 was isolated by- 
digestion of 8 pg of pKD306 with Clal and PvuII, followed 
by electrophoresis on a preparative 1 °fo LMT agarose gel.
This fragment was then digested (without further purification) 
by the enzymes Hpall and TaqI.
The digestion products were separated by electrophoresis 
on .a 3% polyacrylamide gel (Section 2.12) and the gel stained 
with ethidium bromide (Figure 3*9)* Unfortunately, the 
quantity of DNA used was too little to allow the bands to 
be seen under the normal exposure conditions. The photograph 
is overexposed to compensate for this. Examination of the 
original negative gives more information than the photograph. 
Clearly, at least nine bands are present in the Hpall digest 
and six bands are seen in the TaqI digest.
5.3*5 Preparation of Hpall and TaqI clones for sequencing 
An aliquot of each digestion mix from the experiment 
detailed in the preceding section and containing approximately 
100 ng of fragments was purified by phenol/chloroform 
extraction and ethanol precipitation. After recovery, the 
fragments were ligated to AccI cleaved M13mp8 and trans­
formed into E.coli JM101. Single strand template DNA was 
produced from sixty clear plaques.
5.3*6 Characterisation of the Hpall and TaqI clones
As these clones have been constructed using a 'shotgun' 
cloning approach, many will contain the same fragment
Hpall fragment sizes 
(estimated) 3^0 HI 
315 H2 
233 H3 
210 H4 
140 H3 
130 H6 
90 H7 
60 H8 
40 H9
Tg.ql fragment sizes 
T1 370 (estimated) 
510 
400 
200 
110 
100
Figure 3»9■ The TaqI and Hpall fragments within the 1.9 kb 
Clal-PvuII region (sizes are in bp)
Track DNA Enzyme
1 1.9 kb Clal-PvuII 
fragment
Hpall
2 pKD306 Hpall
3 pBR322 Hinfl
4 pKD306 TaqI
3 1.9 kb Clal-PvuII 
fragment
TaqI
inserted in the same or in the opposite direction. All 
the clones were subjected to T-track analysis (see Section 
2.33) and those showing the same pattern were grouped.
In some cases it was possible to identify complementary 
strands of the same fragment from the length of the cloned 
segment. ' A number of clones, thought to represent all 
the possible sequences, were selected for'complete 
sequence analysis.
5.3*7 Sequence analysis of Hpall and TaqI clones
Sequencing reactions were performed as described in 
Sections 2.28 - 2.30, using the ’normal' sequencing reaction 
mixes. Electrophoresis was on 6$> polyacrylamide gels and 
the gels were dried before overnight autoradiography 
(Section 2.32). In most cases, sequencing reaction products 
were electrophoresed on two linear gels; one was run for 
4j- h and the other for approximately lj h. Clones which 
T-tracking had shown to have an insert of less than 200 bp 
were electrophoresed on a single buffer gradient gel.
The sequence data showed that many of the clones which 
were sequenced had more than one fragment inserted into 
the vector. This may have been caused by having too high 
a ratio of fragment ends to vector ends in the ligation 
mixes, or by having too high a concentration of ligase, 
causing concatenation of fragments before cloning. This 
problem was avoided in later experiments by phosphatase 
treatment of the fragments, rather than the vector.
¥h.ere a TaqI site was found in the sequence of a 
TaqI clone, the sequence was divided into two parts, A 
and B, referring to before and after that site. In only 
a very few cases were the fragments linked as they would 
be in vivo indicating that most multiple cloning events 
were due to spurious linkage and not partial digestion of 
the original DNA.
Each sequence was entered into a computer file.
5.3*8 Building up the sequence
The complete sequence of the Clal-PvuII region was 
built up using the method outlined in detail in Chapter 4 
for the aroD gene. Briefly, each sequence was compared 
with all the other sequences and a map of overlaps and 
complementary sequences built up. Each nucleotide was 
then checked against its complementary strand partner and 
all doubtful sequences resolved. Corrected sequences were 
then built into a single complete sequence.
The complete sequence obtained in this way contained 
several gaps. Not every TaqI or Hpall fragment was present 
in the collections of clones.
5.3.9 Filling in the gaps
In order to complete the sequence, two further experiments
were needed:
*
(a) Clone turn-around (see Section 2.35)* Hpall fragment 
H2 (Figure 5*9) was turned around in order to complete 
the complementary strand in this region.
(b) The largest TaqI fragment (T1 in Figure 5*9) was
missing from the set of TaqI clones. This fragment 
was isolated after TaqI digestion of pKD506 and 
electrophoresis through 2°fo LMT agarose. After ligation 
to AccI cleaved M13mp8 and transformation of E.coli 
JM101, six recombinant templates were purified as 
described previously. These were sequenced in turn 
till the sequence at both ends of the fragment was 
obtained. Two clones carrying the fragment in opposite 
orientation were re-sequenced using the ’low dideoxy' 
mixes (see Section 2*30) and electrophoresed on a 6fo 
linear polyacrylamide gel for 6 h. This allowed the 
sequence to be read far enough to overlap a Hpall 
site. This in fact showed that there were two Hpall 
sites, separated by 63 bp. The 63 bp Hpall fragment 
was missing from the set of Hpall clones.
5.3*10 Complete sequence of the Clal-PvuII fragment
The sequencing strategy, including the location of the 
sites used for cloning and the extent of sequencing for the 
entire Clal-PvuII fragment is summarised in Figure 5*10.
The complete DNA sequence is shown in Figure 5*11* The 
Clal-PvuII region is 1959 bp in length and the entire 
sequence is covered on both strands of the DNA with all 
the restriction enzyme sites used for cloning overlapped 
by 34 sequences. Note that the numbering system puts the 
Clal site at position 791 in the sequence, not at position
1. The reason for this is that later experiments (see
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ATCG ATGG TATCGC CATCGA CCAAACGC CAOA CTTCG GC GC  AGA TGTGGTGG' i 'CGCCGCT
791.. ....... - - ---------- *----------+---------- + ----------«■-----------+
TAGCTACCATAGC GG T AGCTGCTTTGC G G TC TG A A G C C G C G TCTA C A CC A C CA G C G G CG A
870 890 910
GACTTCTCTTCAACCATTCTTTCCCGTCCGATTGACGTCACCCGTTATGGTGTAATTTAC
851  ♦---------- + -  +----------♦ ---------- ♦-----------+
CTGAAGAGAAGTTGGTAAGAAACGGCAGGCTAACTGCAGTCGGCAATACCACATTAAATG
930 950 970
CCTGGCGCGCACAAAAATATCGGCCCGGCTGGCCTGACAATCGTCATCGTTCGTGAAGAT
911  ♦---------- +----------+---------- +  ♦-----------+
CGACCGCGCGTCTTTTTATAGCCGGGCCGACCGGACTGTTAGCAGTAGCAAGCACTTCTA
990 1010 1030
TTGCTGGGCAAAGCGAATATCGCGTGTCCGTCGATTCTGGATTATTCCATCCTCAACGAT
971  ♦----------♦----------+----------♦---------- ♦-----------+
AACGACCCGTTTCGCTTATAGCGCACAGGCAGCTAAGACCTAATAAGGTAGGAGTTGCTA
1050 1070 1090
AACGGCTCCATGTTTAACACGCCGCCGACATTTGCCTGGTATCTATCTCGTCTGGTCTTT
031
TTCCCGAGGTACAAATTGTGCGGCGGCTGTAAACGCACCATAGATAGACCAGACCAGAAA
1110 1130 1150
AAATGGCTGAAAGCGAACGGCGGTGTAGCTGAAATGGATAAAATCAATCAGCAAAAAGCA
091  +----------+----------♦---------- +---------- +----- +
TTTACCGACTTTCGCTTGCCGCCACATCGACTTTACCTATTTTAGTTAGTCGTTTTTCGT
1170 1190 1210
CAACTGCTATATGGGGTGATTGATAACAGCGATTTCTACCGCAATGACGTGGCGAAACGT
151  +---------- ♦---------  + ---------- ♦---  +-----------♦
CTTGACGATATACCCCACTAACTATTGTCGCTAAAGATGGCGTTACTGCACCGCTTTGCA
1230 1250 1270
AACCGTTCGCCGATGAACGTGCCGTTCCAGTTGGCGGACAGTGCGCTTGACAAATTGTTC 
211 — -  — — — -  — — — — — — + — — — — — — -  + — — -  — — — ~ *  * —  — +
TTGGCAAGCGCCTACTTGCACGGCAAGGTCAACCGCCTGTCACGCGAACTGTTTAACAAG
1290 1310 1330
CTTGAAGAGTCTTTTGCTGCTGGCCTTCATGCACTGAAAGGTCACCGTGTGGTCGGCGGA
271 --------- ♦ 7 +--------- +----------+----------+ -----------+
GAACTTCTCAGAAAACGACGACCGGAAG7ACCTGACTTTCCAGTGGCACACCAGCCGCCT
910
970
103Q
1090
1 150
121CI
127 C
133C
Figure 5.11sComplete DNA sequence of the Clal-PstI region, 
and the coding sequence of the fc.co\ i aroA 
gene.
1410 1430 1450
TGGTTGAGTTCGAACGCCGTCACGGTTAATGCCGAAATTTTGCTTAATCCCCACACCCA
 +  +  + +  +  +
TACCAACTCAAGCTTGCGGCAGTGCCAAT TACCGCTTTAAAACGAATTAGCGGTG7CGGT
aroA coding sequence 
1470 1490 1510
GCCTGTGGGGTTTTTATTTCTGTTGTAGAGAGTTGAGTTCATGGAATCCCTGACGTTACA
451   +---------- +----------  +---------- +
CGGACACCCCAAAAATAAAGACAACATCTCTCAACTCAAGTACCTTAGGGACTGCAATGT
Me tG1uSerLeuThrLeuG1 
M E S L T L Q 
111
1530 1550 1570
ACCCATCGCTCGTGTCGATGGCACTATTAATCTGCCCGGTTCCAAGACCGTTTCTAACCG
511   +----------+---------- +----------+-----------+
TGGGTAGCGAGCACAGCTACCGTGATAATTAGACGGGCCAAGGTTCTGCCAAACATTGGC 
nProI1eAlaArgVa1AspGlyThr11eAsnLeuProGlySerLysThrVa1SerAsnAr 
P I A R V D G T I N L P G S K T V S N R  
[8]
1590 1610 1630
CGCTTTATTCCTGGCGGCATTAGCACACGGCAAAACAGTATTAACCAATCTGCTGGATAG
571  +---------- +----------+---------- *---------- +---------- +
GCGAAATAACGACCGCCGTAATCGTGTGCCGTTT7GTCATAATTGGTTAGACGACCTATC 
gAIaLeuLeuLeuAlaAlaLeuAlaHisGlyLysThrValLeuThrAsnLeuLeuAsoSe 
A L L L A A L A H G K T V L T N L L D S  
£28]
1650 1670 1650
CGATGACGTGCGCCATATGCTGAATGCATTAACAGCGTTAGGGGTAAGCTATACGCTTTC
531  ♦---------- +---------- ♦----------+----------+-----------♦
GCTACTGCACGCGGTATACGACTTACGTAATTGTCGCAATCCCCATTCGATATGCGAAAG 
rAspAspVa1ArgHisMetLeuAsnAlaLeuThrAlaLeuGlyValSerTyrThrLeuSe 
D D  V R H M  L N A L T A L G  V 3- Y T L S 
£481
1710 1730 1750
AGCCGATCGTACGCGTTGCGAAATTATCGGTAACGGCGGTCCATTACACGCAGAAGGTGC
591  +---------- +----------+---------- +---------- +---- +
TCGGCTAGCATGCGCAACGCTTTAATAGCCATTGCCGCCAGGTAATGTGCGTCTTCCACG 
rAlaAspArgThrArgCysG\u l 1eI\eG1yAsnGIvG\vProLeuHi sAlaG1uG\vAI 
A D R T R C E  I I G N G G P L H A E G A 
£68]
1770 1790 1810
CCTGGAGTTGTTCCTCGGTAACGCCGGAACGGCAATGCGTCCGCTGGCGGCAGCTCTTTC 
’51 +
GGACCTCAACAAGGAGCCATTGCGGCCTTGCCGTTACGCACGCGACCGCCGTCGAGAAAC 
aLeuG1uLeuPheLeuG1yAsnA1aGIvThr AIaMe t Ar gProLeuA1aA1aA 1aLeuC y 
L E L F L G N ' A G T  A M R P L A A A L C  
£ 88]
145»
151 C
157C
1630
1690
1750
1810
1811
1871
1931
1991
2051
2111
2171
u u u  i n u ^ n n  t \jn i n l l \_r i V j U  l V j M L L U L j  1 i H  I LfHHRL»ttttULrL»HJLjA 1 1 (jU
--------- +--------- +--------- +--------- +--------- +----------+ 137
AGACCCATCGTTACTATAACACGACTGGCCACTCGGCGCATACTTTCTTGCGGGCTAACC 
sLeuG)ySerAsnAspI 1eVa1LeuThrGIyG1uProAr aMe tLysG)uArgProI)eGI
l g s n d i v l t g i p r ’m k e r f  I G
[1083 -
1890 1910 ~ 1930
TCATCTGGTGGATGCGCTGCGCCTGGGCGGGGCGAAGATCACTTACCTGGAACAAGAAAA
 —  _ _ _ - — - — — — — — — — — — — 193
AGTAGACCACCTACGCGACGCGGACCCGCCCCGCTTCTAGTGAATGGACCTTGTTCTTTT 
yHisLeuVa)AspAIaLeuArgLeuG1yG1yAlaLvsI)eThrTyrLeuGIuG1n G )uAs 
H L V D A L R L G G A  K I T  Y L E Q E N  
C1283
1950 1970 1990
TTATCCGCCGTTGCGTTTACAGGGCGGCTTTACTGGCGGCAACGTTGACGTTGATGGCTC
+ + + + + 1991
AATAGGCGGCAACGCAAATGTCCCGCCGAAATGACCGCCGTTGCAACTGCAACTACCGAG* 
nTyrProProLeuArgLeuGInG)yG)yPheThrG)yG)yAsnVa1AspVa1AspGIySe 
Y P P L R L Q G G F T G G N V D V 3 G S  
C 148]
2010 2030 2050
CGTTTCCAGCCAATTCCTCACCGCAC7GTTAATGACTGCGCCTCTTGCGCCGGAAGATAC
--------- +---------- +----------+----------+----------+ + 205C
GCAAAGGTCGGTTAAGGAGTGGCGTGACAATTACTGACGCGGAGAACGCGGCCTTCTATG 
rVa 1 SerSerG 1 nPheLeuThrAl aLeuLeuMe tTlvr A ) aProLeuA) aProG) uAspTh 
V S S Q F L T A L L M T A P L A P E D T  
C1683
2070 2090 2110
GGTGATTCGTATTAAAGGCGATCTGGTTTCTAAACCTTATATCGACATCACACTCAATCT
211C
CCACTAAGCATAATTTCCGCTAGACCAAAGATTTGGAATATAGCTGTAGTGTGAGTTAGA 
rVa)11eArglleLysG)yAspLeuVa)SerLysProTyrI 1eAsoI1eThrLeuAsnLe 
V I R I K G D L V S K P Y I  D I T L N L  
[1883
2130 2150 2170
GATGAAGACGTTTGGTGTTGAAATTGAAAATCAGCACTATCAACAATTTGTCGTAAAAGG
 -----+----------+---------- +----------+---------- + + 2170
CTACTTCTGCAAACCACAACTTTAACTTTTAGTCGTGATAGTTGTTAAACAGCATTTTCC 
uMe tLysThrPh eGl yVa) G ) u.11 eG) uAsnG 1 nHisTyr G I nG 1 nPheVa )V a 1LvsG1 
M K T F G V E  I E N Q H Y Q Q F V V k ’ g 
C2083
2190 2210 2230
CGGGCAGTCTTATCAGTCTCCGGGTACTTATTTGGTCGAAGGCGATGCATCTTCGGCTTC
--- _ _ _ — —  + - — — —  -   —  - +-----—  —  *■ + —        + 2230
GCCCGTCAGAATAGTCAGAGGCCCATGAATAAACCAGCTTCCGCTACGTAGAAGCCGAAG 
yG) yG 1 nSerTyrG) nSerProG) vThr TyrLeuVa ) G ) u G ) yAspA 1 aSerSer-A 1 aSe 
G Q S Y Q 5 P G T Y L V E G D A S S A S  
C 228]
Fi gure 5.1 1: (con t )
2231
2291
2351
2411
2471
2531
2591
TTACTTTCTGGCAGCAGCAGCAATCAAAGGCGGCACTGTAAAAGTGACCGGTATTGGACC
 +  + + + + +
AATGAAAGACCGTCGTCGTCGTTAGTTTCCGCCGTGACA7TTTCACTGGCCATAACCTGC 
rTyrPheLeuA)aA1aA1aA)a I 1eLysGIyG1vThrVa)LysVa1ThrG1y11e G 1yAr 
Y F L A A A A  I K G G  T V K V T G  I G R  
C248 3
2310 2330 2350
TAACAGTATGCAGGGTGATATTCGCTTTGCTGATGTGCTGGAAAAAATGGGCGCGACCAT
----------+---------- +---------- +---------- +---------- +----------- f
ATTGTCATACGTCCCACTATAAGCGAAACGACTACACGACCTTTTTTACCCGCGCTGGTA 
gAsnSerMe tG) nG i yAsp I ) e ArgPheA) a AspVa ) LeuG1 uLysMe tG) yA ) aThr-1 1 
N S M Q G  D I  R F A D V L E K M G A T  I 
[2883
2370 2390 2410
TTGCTGGGGCGATGATTATATTTCCTGCACGCGTGGTGAACTGAACGCTATTGATATGGA
 + + +  + + +
AACGACCCCGCTACTAATATAAAGGACGTGCGCACCACTTGACTTGCGATAACTATACCT 
eCysTrpGlyAspAspTyrl1eSerCysThrArqG\yG1uLeuAsnAla IJeAspMetAs 
C W G D D Y  I S C T R ’g E L N A  I D M D  
[2883
2430 2450 2470
TATGAACCATATTCCTGATGCGGCGATGACCATTGCCACGGCGGCGTTATTTGCAAAAGG
 + + + ----------- +---------- +  +
ATACTTGGTATAAGGACTACGCCGCTACTGGTAACGGTGCCGCCGCAATAAACGTTTTCC 
pMetAsnHis11eProAspAlaA)aMetThr11e A )aThrA)aA1aLeuPheA)aLysG) 
M N H  I P D A A M  T I A T A A L F A K  G 
[3083
2490 2510 2530
CACCACCAGGCTGCGCAATATCTATAACTGGCGTGTTAAAGAGACCGATCGCCTGTTTGC
 +  +  +  +  +  +
GTGGTGGTCCGACGCGTTATAGATATTGACCGCACAATTTCTCTGGCTAGCGGACAAACG 
yThrThrArgLeuArgAsnI)eT yrAsnTrpArgVa)LysG)uThrAspArgLeuPheA1 
T T R L R N  I Y N W R V K E T D R L F  A 
[3283
2550 2570 2590
GATGGCAACAGAACTGCGTAAAGTCGGCGCGGAAGTGGAAGAGGGGCACGATTACATTCG
 + - + +  +  + +
CTACCGTTGTCTTGACGCATTTCAGCCGCGCCTTCACCTTCTCCCCGTGCTAATGTAAGC 
aMetA) aThrGI uLeuArgLysVa )G) yA) aG)uVa IGluOuG) vHisAspTyrl )eAr 
M A T E L R K V G A E V E E G  H D Y  I R 
!'. 3483
2610__ 2630 2650
TATCACTCCTCCGGAAAAACTGAACTTTGCCGAGATCGCGACATACAATGATCACCGGAT
 + + + ---------- +-----------+ +
ATAGTGAGGAGGCCTTTTTGACTTGAAACGGCTCTAGCGCTGTATGTTACTAGTGGCCTA 
gl ) eThrProProG)uLysLeuAsnPheA1aGlul 1 eA)aThrTvrAsnAspHisArqMe
i t p p e k l n f a e i a t y ' n d h r 'm
[3683
229 (
235C
241C
247C
253C
2590
2650
Flaure 5•11:(cont)
2670 2690 2710
GGCGATGTGTTTCTCGCTGGTGGCGTTGTCAGATACACCAGTGACGATTCTTGATCCCAA
2651  +----------+----------+   - +---------- +---------- +
CCGCTACACAAAGAGCGACCACCGCAACAGTCTATGTGG7CACTGCTAAGAACTAGGGTT 
tAlaMetCysPheSerLeuVaIA1aLeuSerAspThrProVaIThrl1eLeuAspProLy 
A M C F S  L V A L S D T P V T  I L D P K  
C3SS 3
Haelll PvuII
2730 1 2770
ATGCACGGCCAAAACATTTCCGGATTATTTCGAGCAGCTGGCGCGGATTAGCCAGGCAGC 
2711 —  - — — — - — - — - - — — — — — — — _ — — — — — — —
TACGTGCCGGTTTTGTAAAGGCCTAATAAAGCTCGTCGACCGCGCCTAATCGGTCCGTCG 
sC ysThrAlaLysThrPheProAspTvrPheG1jGInLeuAlaArgI1eSerGInAlaA) 
C T A K T  F P  D Y  F P O L A R  I S 0 A A 
[4083 T4273
2790 2810 .2830
c t g a a t g a a c a a c g g g c a a t a a a t a g c c a a a t c t t t c t t t a t c a a a a a c g t c g g c a c At t
2771 ----------4--------- +----------+----------+ ---------- +---------- +
g a c t t a c t t g t t g c c c g t t a t t t a t c g g t t t a g a a a g a a a t a g t t t t t g c a g c c g t g t a a
a***
_______    2850 2870 2890
g t c g g c g t t t t t t t t c g g a c c t t g t g a g t c a t t t t g a t t a a t g g t a g c g t c g c t t g t c a ,a
2831  +----------4----------+----------+---------- +---------- +
c a g c c g c a a a a a a a a g c c t g g a a c a c t c a g t a a a a c t a a t t a c c a t c g c a g c g a a c a g t t
2910 2930 ^  2950
TGTAACGTTGTTGATACATAATATTTATATATGATTAATCAACGGA/TGATTCACAT£AAG
2891   4------------- + -------------4-------------4-------   4--------------4
ACATTGCAACAACTATGTATTATAAATATATACTAATTAGTTGCCTACTAAGTGTACTTC
Pst I
2970
AATACTAAATTACTGCTGGCGATTGCGACCTCTGCAG
2951  4----------4----------4-------- 2987
TTATGATTTAATGACGACCGCTAACGCTGGAGACGTC
271
277
2B3<
289(
295C
Figure 5.11 s (cont)
Chapter 6) provided sequence data to the left of this 
Clal site and the use of these numbers keeps the same 
system throughout this thesis, starting at the leftmost 
sequence obtained.
5.4.1 Identification of the aroA coding region on the sequence
(a) Amino-terminal sequence of EPSP synthase
As part of the overall strategy for obtaining the 
entire EPSP synthase sequence, the amino-terminal sequence 
of the enzyme was established. This was carried out using 
a Beckman Model 890 liquid phase sequencer at the protein 
sequencing facility at Aberdeen University. This sequence 
was determined by Ann Lewendon and is illustrated in 
Figure 5*12. Technical details of the derivation of the 
sequence and an explanation of the anomalies and gaps 
in this sequence can be found in Duncan, Lewendon and 
Coggins (1984b).
(b) Identification of the open reading frame encoding EPSP
synthase
The open reading frame encoding EPSP synthase could 
now be identified by comparison of the amino-terminal protein 
sequence with sequences downstream of methionine codons in 
the DNA sequence. Both strands of the DNA sequence were 
translated in all three possible reading frames using the 
TRNTRP program (Section 2.36).
The start of the open reading frame was found to be 
at position 1491 in the sequence shown in Figure 5»H*
1 10 
Met - Glu - Ser - Leu - Thr - Leu - Gin - Pro - lie - Ala
11
Arg
21
Ser
31
Leu
kl
Leu
Val - X - Gly - Thr - lie 
(Asp)
- Asn - Leu - Pro -
- Lys - Ser - Val - X - Asn - His - Ala - Leu -
20
Gly
30
Leu
Ala - Ala - Leu - Ala - His 
(Val)
kk
X - Asn - Leu -
- Gly - Val -
40
X - Val
Figure 5»12. Amino-terminal sequence of EPSP synthase.
The location of the open reading frame is illustrated on 
Figure 3«10» The solid portion corresponds to that part 
which has been confirmed by protein sequence; the hatched 
portion is the remainder of the sequence. In the amino- 
terminal region there is an exact agreement between the 
experimentally determined amino acid sequence and the 
amino acid sequence deduced from the DNA sequence.
The open reading frame continues to the PvuII site; 
cloning from this site, as in the construction of pKD306 
had, in fact, clipped off the 3* of the gene and removed
an unknown number of residues from the carboxy-terminus 
of the protein.
5.h*2 Isolation of a Haelll fragment to complete the sequence 
In order to complete the sequence of* the aroA gene 
it was necessary to determine the DNA sequence beyond the 
PvuII site. Examination of the sequence derived so far 
(Figure 3*H) revealed that there was a Haelll site at 
position 2717* It was hoped that it would be possible 
to clone a fragment extending from this position to beyond 
the PvuII site in pKD302, and' that the sequence of this 
fragment might complete the aroA sequence.
pKD302 was digested with Clal and a 2.3 hb fragment 
isolated after electrophoresis in LMT agarose. This 
fragment spans the Clal-PvuII region and extends through 
the PstI site used to construct pKD302 to the Clal site 
in the vector. This fragment was digested (without further
purification) with Haelll. Two small aliquots were removed 
One was digested with PvuII and the other with Pstl.
Digests were separated by electrophoresis on a second 
LMT gel and a Haelll fragment, which is cleaved by both 
PvuII and Pstl, was identified. This fragment was isolated 
and the DNA purified. It was cloned into Smal cleaved 
M13mp8 and the sequence of both strands determined.
The sequence extends from position 2717 i*i Figure ^,11 
to position 3757 in the sequence of pBR322 (Sutcliffe,
1979). The sequence of the entire Clal-PstI region is 
now complete and hence the entire sequence of the aroA gene
5.4.3 The predicted amino acid sequences of EPSP synthase 
The DNA sequence of the coding region of the aroA gene
predicts a 427 amino acid polypeptide chain of calculated 
46112 (Figure 5«H)* This is in good agreement with 
the subunit value of 49 000 determined by SDS-PAGE 
(Lewendon & Coggins, 1983) and with the native M of 42 000 
determined by gel permeation chromatography on a TSK G2000 
SW column (Duncan, Lewendon & Coggins, 1984a).
5.4.4 The amino acid composition of EPSP synthase
A comparison of the experimentally determined amino 
acid composition of EPSP synthase (Duncan, Lewendon & 
Coggins, 1984b) with the amino acid composition predicted 
from the nucleotide sequence is shown in Table 5*4. The 
overall agreement is very good.
Amino acid Relative amino acid 
composition based on 
Leu = 48 residues
Theoretical amino acid 
composition predicted 
from the DNA sequence
As*
J 41,9
44
Thr 31.1 34 ,
Ser 19.7 '21
Gl* 38.8 34
Pro 18.1 18
Gly 42.8 37
Ala 44.1 46
Cys 4.9 6
Val 21.7 24
Wet 13.6 14
H e 24.2 26
Leu 48.0 48
Tyr 13.1 13
Phe 13.2 13
His 8.1 8
Lys 17.0 17
Arg 17.2 22
Trp nd 2
Gin nd 12
Asn nd 18
Table 5.4: Amino acid composition of EPSP synthase compared with the
composition predicted by the DNA sequence of the aroA gene.
The protein chemical results quoted here are entirely 
consistent with the predicted amino acid sequence and 
there can be no doubt that the sequenced gene is aroA.
5*4.5 Codon utilisation in the aroA gene
The codon utilisation for the open reading frame 
corresponding to EPSP synthase is shown in Table 5*5* A 
brief comparison with the analogous data for four trp 
biosynthetic genes (Table 4.5) and with the putative aroD 
gene (Table 4.4) shows that they all follow a similar 
pattern of utilisation, providing further evidence that 
this is the EPSP synthase protein coding region. Further 
aspects of the codon utilisation of the aroA gene will be 
discussed in Chapter 6.
5.4.6 Altered expression of the aroA gene
The results presented in Sections 5*2.7 - 5*2.10 of 
this chapter provide evidence that the expression of the 
aroA gene is altered by cloning from the Clal site used 
in the construction of pKD505 and pKD506. The orientation 
of the gene on the clone, is running left to right, ruled 
out the first of the two simple interpretations of the 
’low activity1 clones illustrated in Figure 5*7a.
This suggested that the altered expression must be 
related to either the absence or the disruption of the 
promoter of the gene which was presumed to be near the 
Clal site (Figure 5*7b). The 5' end of the aroA protein 
coding region has been located 700 bp away from the Clal
T C A G
PHE 9 SER 6 TYR 9 CYS 2 T
PHE 4 SER 5 TYR 4 CYS 4 C
T LEU 10 SER 2 Term ■ - Term - A
LEU 5 SER 2 Term - TRP 2 G
LEU 4 PRO 4 HIS 3 ARG 12 T
LEU 3 PRO 3 HIS 5 ARG 7 C
C
LEU 0 PRO 2 GLIM 5 ARG 0 A
LEU 26 PRO 9 GLIM 7 ARG 2 G
ILE 17 THR 7 ASN 9 SER 1 T
ILE 9 THR 10 , ASN 9 SER 5 C
A ILE 0 THR 7 LYS 14 ARG 0 A
MET 14 THR 10 LYS 3 ARG 1 G
VAL 7 ALA 6 ASP 23 GLY 13 T
VAL 4 ALA 7 ASP 3 GLY 18 C
G
VAL 4 ALA 15 GLU 16 GLY 2 A
VAL 9 ALA 18 GLU 6 GLY 4 G
Table 5.5: Codon utilisation in the E.coli aroA gene.
site (Figure 5*10). I** Section 5*2.10 it was shown that
the addition of* fragment B (Figure 5*l) to the insert in 
pKD506 had no effect on aroA expression. This implies that 
expression is controlled by a sequence over 1200 bp upstream 
of the first codon of the aroA gene. The expression of 
aroA will be discussed in Chapter 6.
5.4.7 The aroA gene is truncated in pKD506
The other explanation for the low levels of EPSP 
synthase activity obtained with pKD506 transformed cells 
was that the aroA polypeptide made in these cells was 
prematurely terminated (Figure 5*7a). In Figure 5*13> 
the normal C-terminal sequence of EPSP synthase is shown 
alongside the sequence that would be produced from pKD506 
transformed cells. In this case, the open reading frame 
runs to an ’in phase1 stop codon in the sequence of pBR322.
EPSP synthase from pKD506 would be two residues 
shorter than the wild type enzyme and the last five residues 
would be, except for a single arginine, quite different 
from those found at the normal C-terminus. This difference 
could contribute to the ’low activity' of pKD506, but 
unless there is a crucial catalytic residue in this region 
it is unlikely to be responsible for such a low specific 
activity.
GATTATTTCGAGCAGCTGGCGCGGATTACCCAGGCAGCCTGA
1 ---- :----+---------- +----------+ + -- 42
AspTyrPheGluGinLeuAl a Aral 1 eSerG I nA 1 b A 1 aEnd
Figure 5.13a: C-terminal sequence of EPSP synthase 
synthesised from pKD501«
2740 PvuII
II
GATTATTTCGAGCAGCTGCCTCGCGCGTTTCGGTGA
1   + ----------+----------+---   36
AspTyrPheG1u G 1nLeuProAraA1aPheAr gEnd
Figure 5.13b: C-terminal sequence of EPSP synthase 
synthesised from pKD506«
Figure 5.13: Car-boxy-termina 1 sequence of EPSP synthase.
CHAPTER 6 EXPRESSION OF THE E.COLI aroA GENE
6.1 Introduction
6.1.1 E.coli gene structure
A typical E.coli protein coding gene consists of three 
parts:
(i) the coding region - an open reading frame beginning 
with an ATG/Met or GTG/Val codon and ending with a 
TGA, TAG or TAA codon, specifying the product of the 
gene.
(ii) the 5 1-flanking region - several important features 
are located in the sequence upstream of the coding 
region, most of which are concerned with the control 
of expression of the gene. Immediately before the 
coding region is a ribosome binding site or Shine- 
Dalgarno sequence. Upstream of this is the promoter 
or RNA polymerase binding site, which defines the 
startpoint for transcription of the gene. Related 
modulators of transcription and translation such as 
an operator (Jacob & Monod, 1961) or an attenuator 
(Yanofsky, 1981) may also be found here.
(iii) the 3 ’-flanking region - normally a stop signal for 
transcription (terminator) is found here.
Figure 6.1 shows the structure of such a gene and the 
approximate locations of these features, some of which have 
been described in detail in Chapter 4.
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Most E.coli genes display these features, but a large 
number are organised into operons, in which a number of 
cistrons are co-transcribed from a single promoter into a 
single message which may or may not be processed.
The experiments described in Chapter 5 suggest that 
the aroA gene is not organised in the manner described in 
Figure 6.1. Is there any evidence that aroA forms part of 
a larger transcriptional unit, or operon? This question 
may be addressed initially by a study of the sequences 
flanking the aroA coding region.
6.1.2 Examination of the 5 ’-flanking sequences of the aroA 
protein coding region - the 700 bp Clal - ATG/Met 
sequence.
(a) Shine-Dalgarno sequence
The sequence upstream of the aroA coding region is 
illustrated in Figure 6.2. A possible S-D sequence is 
shown; it is located k bp before the ATG start codon. This 
GAG is likely to be the ribosome binding site for translation 
of aroA.
(b) Promoter
As described in Section 4.4.3> the consensus promoter - 
10 region contains three highly conserved nucleotides out
of six, occurring in the sequence T A  T. The 700 bp was
searched by eye for this sequence and it was found four times. 
In none of these cases is the sequence preceded 17 t>p 
upstream by the consensus sequence TTGACA. It is therefore
137 \
1431
1491
1390 1410 ^ 1430
TTAAAGCGCTGACAGACTTCATGGTTGAGTTCCAACG&CCTfCACGGTTAATGCCCAAATT
 - - - + ♦ + + + + 1 ^
AATTTCGCGACTGTCTGAACTACCAACTCAAGCTTGCGGCAGTGCCAATTACGGCTTTAA 
LysAlaLeuThrAspPheMetVaIGluPheGluArgArgHisGlv*#*
End of open reading frame
Inverted repeat
1450 1470 S-D
— -— }  4----------------
TTGCTTAATCCCCACAGCCAGCCTGTGGGGTTTT7ATTTCTGTTGTAGAGAGTTGAGTTC 
--------- 4------.--- +----------4----------+---------- + + 14
AACGAATTAGGGGTGTCGGTCGGACACCCCAAAAATAAAGACAACATCTCTCAACTCAAG
1510 1530 1550
ATGGAATCCCTGACGTTACAACCCATCGCTCGTGTCGATGGCACTATTAATCTGCCCGGT
--------- 4--------- +--------- +--------- +--------- 4  + 15
TACCTTAGGGACTGCAATCTTGGGTAGCGAGCACAGCTACCGTGATAATTAGACGGGCCA 
MetGluSerLeuThrLeuGlnProlleAlaArgValAspGlyThrl1eAsnLeuProGly
Start of the aroA coding region
Figure £.2: The DNA sequence between the open reading frame 
and the aroA gene*
unlikely that any of these sequences provides the promoter 
for aroA, although it is possible that one or other functions 
as a very weak promoter, allowing low levels of expression 
such as that seen in cells carrying pKD505 and pKD506 
(Section 5*2.7)•
(c) Open reading frames
Translation of the sequence with the TRNTRP program 
shows that there is an open reading frame running from left 
to right, from the Clal site to a stop codon at position 
1418 (Figure 5*H)« This is 'JO nucleotides before the 
start codon of aroA, and may represent the carboxy-terminal 
portion of a protein coding gene - an open reading frame 
of this length would not be found in the DNA by chance.
6.1.3 The 70 bp sequence between the open reading frames
The DNA sequence between the open reading frames is
illustrated in Figure 6.2. Within this region is a sequence 
which resembles that of a rho-independent terminator of 
transcription (Rosenberg & Court, 1979)> an inverted repeat 
followed by a run of T residues. The stem-loop structure 
which can.form from this inverted repeat is illustrated in 
Figure 6*3* Using the rules of Tinoco ejfc al. (l973)> the 
free energy of this RNA structure was calculated to be 
-18.8 kcal/mol.
6.1.4 Examination of the 3 ^ flanking sequences of the aroA 
protein coding region
Approximately 45 bp downstream of the aroA coding region
GC
CG
CG
A T
C G
A
C
0 G
C G
C G
A T
t437
Figure 6.3s The stem-loop structure which may form
downstream of the open reading frame. It 
is typical of the structure of a rho- 
independent transcription terminator.
(centred at position 2828) is a second possible rho-independent 
terminator. It is not as G/C rich, nor is it as long as 
the inverted repeat preceding aroA.
6.1.5 What is the relevance of the features observed in the 
5*-flanking sequence of the aroA coding region?
The features observed in the 5 f-flanking sequence of the 
aroA coding region suggest that there is another E.coli gene 
adjacent to and upstream of aroA. The coding region of this 
gene ends at a position 70 bp upstream of aroA, and is 
followed by a rho-independent transcription terminator. There 
is no space between the terminator of the putative upstream 
gene and the start of the aroA coding sequence for a promoter, 
nor is there any evidence from the sequence that a promoter 
exists. This makes aroA expression dependent on expression 
from the promoter of the upstream gene and read-through by 
RNA polymerase at the terminator. Thus, aroA forms part 
of an E.coli operon.
This explains why cloning from the Clal site destroys 
expression of the aroA gene. The upstream gene is cut and 
aroA is separated from its promoter. The low level of 
expression from pKD505 and pKD506 is probably due to RNA 
polymerase binding to a weak promoter-like sequence or to 
a promoter on the vector.
It was also observed in Chapter 5 that cloning the 
0.5 kb Clal fragment to the left of the Clal site back into 
pKD506 has no effect on aroA expression. From this, one 
can predict that the upstream open reading frame will
originate to the left of or around the second Clal site 
and will run through the Clal fragment continuous with 
that to the left of aroA. The promoter of both genes will 
be located to the left of this Clal site i.e. in region C 
of Figure 5»1» Only by determining the DNA sequence of 
the above mentioned regions can these predictions be 
investigated.
6.2 Further DNA sequence analysis
6.2.1 Determination of the sequence of the 0.5 kb Clal 
fragment (fragment B )
Fragment B was isolated after digestion of pKD501 with 
Clal, followed by electrophoresis through 1 °fo LMT agarose.
An aliquot containing approximately 100 ng of DNA was ligated 
to 20 ng Accl-cleaved M13mp8. After transformation of 
E.coli JM101, six template DNAs were produced. The sequence 
at both ends of the fragment was determined.
Analysis of this sequence revealed three HpaTI sites.
More of the Clal fragment was digested with Hpall and the
/
fragments cloned into the AccI site of M13mp8. Templates 
were produced and sequenced, allowing the complete sequence 
to be built up on both strands of the DNA, with the exception 
of a 12 bp sequence. However, this sequence was very clear 
on the one strand from the sequence at one end of the Clal 
fragment.
6.2.2 DNA sequence of part of region C
pKD501 was digested with Bglll and KpnI. These enzymes 
cleave the DNA at the sites shown in Figure yielding
a 0.8 kb fragment including region C, spanning the second 
Clal site and ending at the KpnI site in the centre of 
region B. The Bglll-Kpnl fragment was isolated after 
electrophoresis on 1 °fo LMT agarose and digested with Hpall.
An aliquot was also digested with Clal. The digestion 
products were separated by electrophoresis on 2$> LMT 
agarose and the Hpall fragment which contains the Clal 
site excised. This fragment was cloned into AccI cleaved 
M13mp8 and the sequence of both strands determined.
The sequence of this fragment allowed the orientation 
of the sequence of the Clal fragment relative to region A 
and region C to be deduced. It also yielded 286 bp of 
sequence to the left of the Clal site. •
6.2.3 The sequences described above
The DNA sequencing strategy described in the preceding 
sections is illustrated as part of Figure 6.16, and the 
sequence given in Figure 6.4. This sequence was linked to 
that of the Clal-PstI region and translated in all three 
reading frames using TRNTRP. An open reading frame was 
found which is continuous with the open reading frame in 
the 700 bp Clal-ATG/Met region (Figure 6.5). The open 
reading frame begins at position 326 and therefore spans 
most of the Clal fragment. This is in line with the prediction 
made in Section 6.1.5 that the protein coding region would
61
121
181
241
301
361
421
481
CCGGAGTCGGCGGACTATGCCTGTATTCGTTGTAGTGAAATCATTCATATGAAAGCGGGG
 + + + + + + 6 0
GGCCTCAGCCGCCTGATACGGACATAAGCAACATCACTTTAGTAAGTATACTTTCGCCCC
70 90 110
GAAAAACAATTATGTCCGCGCTGTGCAAATCCAGAATGGACGAACGCAAGTCGGGCAAAA,
----------+---------- + ---------- +------- +---------- + -----------+ 12
CTTTTTGTTAATACAGGCGCGACACGTTTAGGTCTTACCTGCTTCCGTTCAGCCCGTTTT
130 150 170
CGGGTGACCTGACAGTAAAAACATCGGCTTTTTGCTAATAATCCGAGAGATTCTTTTGTG
----------+---------- +---------- +---------- + ---------- + -----------+ IQ
GCCCACTGGACTGTCATTTTTGTAGCCGAAAAACGATTATTAGGCTCTCTAAGAAAACAC
190 210 230
TGATGCAAGCCACATTTTTGCCCCTCAACGGTTTTACTCATTGCGATGTGTGTCACTGAA
---------+--------- +--------- +--------- +--------- +----------+ 24
ACTACGTTCGGTGTAAAAACGGGGAGTTGCCAAAATGAGTAACGCTACACACAGTGACTT
r ^  Clal
~ ~ — 250 l— ~2f7C {—>
TGATAAAACCGATAGCCACAGGAATAATGTATTACCTGTGGTCGCAATCGATTGACCGCG
ACTATTTTGGCTATCGGTGTCCTTATTACATAATGGACACCAGCGTTAGCTAACTGGCGC
310 330 _  350
GGTTAATAGCAACGCAACGTGGTGAGGGGAAATGGCTCAAATCTTCAATTTTAGTTCTGG
----------+---------- +---------- +---------- f---------- + -----------+ 30
CCAATTATCGTTGCGTTGCACCACTCCCCTTTACCGAGTTTAGAAGTTAAAATCAAGACC
370 390 410
TCCGGCAATGCTACCGGCAGAGGTGCTTAAACAGGCTCAACAGGAACTGCGCGACTGGAA
------------------+ ------------------+   + ■ ~ — - — — — — — — — — — - -f 42
AGGC GCCGTCTCCACGAATTTGTCCGAGTTGTCCTTGACGCGCTGACCTT
(one strand only)
430 450 470
CGGTCTTGGTACGTCGGTGATGGAAGTGAGTCACCGTGGCAAAGAGTTCATTCAGGTTGC
----------+---------- +---------- +---------- + ---------- + -----------+ 4Q
GCCAGAAGCATGCAGCCACTACCTTCACTCAGTGGCACCGTTTCTCAAGTAAGTCCAACG
490 510 530
AGAGGAAGCCGAGAAGGATTTTCGCGATCTTCTTAATGTCCCCTCCAACTACAAGGTATT
----------------- + ------------------ + ------------------ + ------------------ + ------------- ;-----+ -------------------+ 54
T.CTCCTTCGGCTCTTCCTAAAAGCGCTAGAAGAATTACAGGGGAGGTTGATGTTCCATAA
Figure 6.4:DNA sequence of the HpaI I-C1 a I-C1 a I region*
550 570 590
ATTCTGCCATGGCGGTGGTCGCGGTCAGTTTGCTGCGGTACCGCTGAATATTCTCGGTGA
541 -----+-------------- +----------+----------+--------   - +  '*•- +
TAAGACGGTACCGCCACCAGCGCCAGTCAAACGACGCCATGGCGACTTATAAGAGCCACT
610 630 650
TAAAACCACCGCAGATTATGTTGATGCCGGTTACTGGGCGGCAAGTGCCATTAAAGAAGC
601  +  + + + + +
ATTTTGGTGGCGTCTAATACAACTACGGCCAATGACCCGCCGTTCACGGTAATTTCTTCG
670 690 710
GAAAAAATACTGCACGCCTAATGTCTTTGACGCCAAAGTGACTGTTGATGGTCTGCGCGC
661  + + + + + +
c t t t t t t a t g a c g t g c g g a t t a c a g a a a c t g c g c t t t c a c t g a c a a c t a c c a g a c q c g c g
730 750 770
GGTTAAGCCAATGCGTGAATGGCAACTCTCTGATAATGCTGCTTATATGCATTATTGCCC
721 ---------- +--------- +----------+--------- +---------- + -  -+
CCAATTCGGTTACGCACTTACCGTTGAGAGACTATTACGACGAATATACGTAATAACGGG
Clal
790
GAATGAAACCATCGAT
781 ---------- +------- 796
CTTACTTTGGTAGCTA
Figure 6 4 4:(cont)
60C
66C
720
780
\
start at the left of this fragment. There is also not 
enough room for a promoter between the Clal site and the 
first ATG/Me t in the open reading frame, implying, again 
as predicted, that the promoter lies further upstream than 
the second Clal site.
6.2.4 Where is the start of the upstream coding region?
The most likely startpoint for the coding region of
an E.coli gene is an ATG/Met codon. These codons occur at 
positions 332, 368, 440, then at 731 and further positions 
throughout the sequence. Considering the first three, are 
any preceded by an S-D sequence indicative of the startpoint 
of translation?
Figure 6.5 shows the three ATG codons; an S-D sequence 
is likely to be located 4-7 bp upstream of the startpoint. 
Only in the case of the ATG at position 332 is there a 
likely S-D sequence at the correct distance, suggesting 
that this represents the amino-terminus of the protein 
coding region. Only 43 bp separates the Clal site from 
this ATG/Met.
6.2.5 Entire sequence of the protein coding region
The entire sequence of the protein coding region is 
illustrated in Figure 6.6. The startpoint is the ATG/Met 
at position 332 and the open reading frame runs for 362 
amino acids to the TAA/stop codon at position l4l8. The 
molecular weight of the protein encoded in this sequence 
is 39834. This is in agreement with the estimate of 40 000
Start of open reading frame
301
361
421
771
N-terminal Met?
S-D
320   * _____ * 340 360
GGTTAATAGCAACGCAACGTGGTGAGGGGAAATGGCTCAAATCTTCAATTTTAGTTCTGG
--------- +--------- +--------- +--------- +--------- + + 35
V a )AsnSerAsnAlaThrTrpEndG1yGluMetAI aGlnl1ePheAsnPheSerSerG\
*___* 3B0 400 420
TCCGGCAATGCTACCGGCAGAGGTGCTTAAACAGGCTCAACAGGAACTGCGCGACTGGAA
--------- + ----------+----------+---- + ---------;- + + 42
yProAl aMe tLeuProA 1 aG \ uVa 1 LeuLysG \ nA 1 aG inG \ nG 1 uLeuAr aAspTrpAs
*___* 460 480
CGGTCTTGGTACGTCGGTGATGGAAGTGAGTCACCGTGGCAAAGAGTTCATTCAGGTTGC
 ------+----  + + -  +---------- + ---------- + 48
nGIyLeuGlyThrSerValMetGluVaISerHisAroGlyLysGluPhelleGlnVa i
> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > >
C ) a l
790 _  810 830
ATTATTGCCCGAATGAAACCATCGATGGTATCGCCATCGACGAAACGCCAGACTTCGGCG
--------- ♦----------+----------+----------+---------- +---------- + 83
TyrCysProAsnGluThrl leAspGI yl leAl a I leAspGluThrProAspPheGl y
Figure 6.5s Location of the upstream open reading frame 
and possible S-D sequence*
61
121
181
241
301
361
n i \j \j w i wni-in i u i i nn l j l i nu i i i* i \j \j  i 1 lib l MULUULHbMUlJ I I 1 HHh
 + + + + + - - •  + 60
MetAlaGlnilePheAsnPheSerSerG1yPrcAlaMetLeuProA)aCIuVa1LeuLys 
M A Q 1 F N F S S G P A M L P A E V L K  
C13
70 90 110
CAGGCTCAACAGGAACTGCGCGACTGGAACGGTGTTGGTACGTCGGTGATGGAAGTGAGT
+ + +   —  + + + 12(
G 1nAlaG1nGlnGluLeuArgAspTrpAsnGIyLeuG1yThrSerVa1 Me tG1uVa1Ser 
Q A Q Q E L R D W N C L G T . S V M E V S  
C21 ]
130 150 170
CACCGTCGCAAAGAGTTCATTCAGGTTGCAGAGGAAGCCGAGAAGGATTTTCGCGATCTT
----------+---------- +---------- +---------- +---------- +  + IQQ
HisArgGIyLysGluPheIIeG1nVa1A1aGIuG1u A 1aG1uLysAspPheAraAspLeu 
H R G K E F  I Q V  A E E A E K D F R " D L  
C 41 ]
190 210 230
CTTAATGTCCCCTCCAACTACAAGGTATTATTCTGCCATGGCGGTGGTCGCGGTCAGTTT
--------- + + -  +---------- +----------+ + 24C
LeuAsnValProSerAsnTyrLysValLeuPheCysHisGlyGlvGlyAraGlyGlnPhe 
L N V P S N Y K V L  F C H G G G R  ~G Q F 
C613
250 270 290
GCTGCGCTACCGCTGAATATTCTCGGTGATAAAACCACCGCAGATTATGTTGATGCCGGT
" + + + + 30C
A1aAlaVa1ProLeuAsnIleLeuGlyAspLvsThrThrA1aAspTyrVa1AspA1aGly 
A A V P L N I L G D K T T A D Y V  ' D A G
caii
310 330 350
TACTGGGCGGCAAGTGCCATTAAAGAAGCGAAAAAATACTGCACGCCTAATGTCTTTGAC
 +  + + + . + +
TyrTrpAlaAlaSerAlalleLysGluAlaLysLvsTvrCysThrProAsnVa1PheAsD 
Y W A A S  A I K E A K K  Y ’ c T P N V F D  
ClOl]
370 390 410
GCCAAAGTGACTGTTGATGGTCTGCGCGCGGTTAAGCCAATGCGTGAATGGCAACTCTCT
--------- +--------- +--------- +---- +--------- +----------+ 42C
A 1aLysVa1ThrVa1AspG1yLeuArq A 1aVa1LysProMe tAraGIuTrpGlnLeuSer 
A K V T V d ‘ g L R * A  V K P M R * E  W Q L S 
C 121 3
Figure 6.6: Coding sequence of the E.coli ser-C gene.
421
481
541
601
661
721
781
430 450 470
GATAATGCTGCTTATATGCATTATTCCCCGAATCAAACCATCGATGGTATCGCCATCGAC
------- + -  ----------+---------- +   - +----------+---------- f 48
AspAsnAl aAl aTyr-MetHisTyrCysProAsnG1uThr 11 eAspG 1 y I 1 eA 1 a I 1 eAsp 
D N A A Y M H Y  C P N E T  I D G  I A I D 
C 1413
490 ' 510 530
GAAACGCCAGACTTCGGCGCAGATGTGGTGGTCGCCGCTGACTTCTCTTCAACCATTCTT
---------- +----  +---------- +---------- +---------- + -----------+ 54(
G 1uThrProAspPheG1yA1aAspVa1V a 1VaIAIaAlaAspPheSerSerThrI1eLeu 
E T P D F G A D V V V A A D F S S T  I L  
C 161 3
550 570 590
TCCCGTCCGATTGACGTCAGCCGTTATGGTGTAATTTACGCTGGCGCGCAGAAAAATATC 
--------- +---------- +--------------------- +---------- +---------- + goo
SerArgProl1eAspVa1SerArgTyrGlyVa1 11eTvrAlaG1yA1aG1nLysAsnl1e 
S R .  P I D V S R Y G V  I Y A G A Q K N  I 
C 181 3
610 630 650
GGCCCGGCTGGCCTGACAATCGTCATCGTTCGTGAAGATTTGCTGGGGAAAGCGAATATC
 + + + +   + + 660
G 1yProAlaGIyLeuThr11eVa1 I 1eVa1AraG'uAspLeuLeuG1yLysAlaAsnI 1e 
G P A G L T  I V I V R ‘E D L L G K A N  I 
C201 ]
670 690 710
GCGTGTCCGTCGATTCTGGATTATTCCATCCTCAACGATAACGGCTCCATGTTTAACACG
--------- +----------+--------   --+----------4---------- + + 720
A!aCysProSerl1eLeuAspTyrSer11eLeuAsnAspAsnGlySerMetPheAsnThr 
A C P S I L D Y  S I L N D N G S M F N T  
C 221 ]
730 750 • 770
CCGCCGACATTTGCCTGGTATCTATCTGGTCTGGTCTTTAAATGGCTGAAAGCGAACGGC
780
ProProThrPheAlaTrpTyrLeuSerGlvLeuVaIPheLvsTrpLeuLysAlaAsnG1y 
P P T F A W Y L S G L V F K W L K A N G 
C 241 ]
790 810 830
GGTGTAGCTGAAATGGATAAAATCAATCAGCAAAAAGCAGAACTGCTATATGGGGTGATT
--------- +----------+----------+----------+---------- +   + S40
GIyVa1A1aG1uMetAspLysI 1eAsnGlnGlnLysAlaG1uLeuLeuTyrGlyVa1 I 1e 
G V A E M D K  1 N Q Q K A E  L L Y G V  I 
C2613
Figure 6.6 (cont. )
850 870 890
GATAACAGCGATTTCTACCGCAATGACGTGGCGAAACGTAACCGTTCGCGGATGAACGTG
841  +--------- +--------- +--------- +--------- +----------+
AspAsnSerAspPheTyrArgAsnAspVa I Ai aLyEArgAsnArgSer-AraMetAsnVa I 
D N S D F Y R N D V A K R i N l R S R  M N V  
C2S1 ]
910 930 950
CCGTTCCAGTTGGCGGACAGTGCGCTYGACAAATTGTTCCTTGAAGAGTCTTTTGCTGCT
901  +---------- +----------+----------+--- +---------- +
ProPheGlnLeuAIaAspSerAlaLeuAspLysLeuPheLeuGIuGluSerPheAlaAla 
P F Q L A D S A L D K L F L E E S F A A  
[301 ]
970 990 1010
GGCCTTCATGCACTGAAAGGTCACCGTGTGGTCGGCGGAATGCGCGCTTCTATTTATAAC
961 --------- +-----   +------  + “ - +““*■ - —  ~ + ~ ”■+•
G1 yLeuHisAl aLeuLysGI yHisAr gVal ValGl y d  yMetArgAl aSer-I leTyrAsn 
G L H A .  L K G H R V V G G M R A S  I Y N  
C321 ]
1030 1050 1070
GCCATGCCGCTGGAAGGCGTTAAAGCGCTGACAGACTTCATGGTTGAGTTCGAACGCCGT
021  ' +  +  +  +  +  +
A 1aMetProLeuGluG1yVa1LysAlaLeuThrAspPheMetVa1G 1uPheG1uArgArg 
A M F L E G V K A L . T D F M V E F E R R  
C341 3
CACGGTTAA
081    1089
HisGlyEnd 
H G *
[3611
Figure 6*6 (cont)
900
960
1020
1080
for the heavily staining band on tracks a-d of the SDS- 
PAGE gel illustrated in Figure 5*8. It is therefore likely 
that the band on the gel corresponds to the product of this 
gene •
6.2.6 Codon utilisation for the open reading frame
Table 6.1 lists the codon utilisation for the sequence 
described above.
The overall pattern of codon utilisation in the table 
is similar to that for the aroD, aroA and the trp biosynthetic 
genes (Tables 4.4, 4.5 & 5»5)» This suggests two things: 
firstly, the open reading frame is protein coding; secondly, 
the protein encoded is expressed at a similar level to the 
other gene products mentioned here. If the gene had been 
a repressor, expressed at only a few molecules/cell then 
the codon utilisation would have been quite different.
6.2.7 Application of Fickett!s Testcode
The DNA sequence of the open reading frame was analysed 
by running the program TESTCODE of the WISGEN package 
(Sections 2.36 and 4.4.1; Fickett, 1982). The resulting 
plot (Figure 6.7a) was compared to a similar plot for the 
aroA coding region (Figure 6.7b) and this suggests that 
the open reading frame is protein coding.
T C A G
PHE 8 SER 6 TYR 8 CYS 1 T
T PHE 10 SER
4 TYR 5 CYS 3 C
LEU 1 SER 1 Term - Term - A
LEU 3 SER 3 Term - TRP 5 G
LEU 8 PRO 1 HIS 3 ARG 9 T
C LEU 3
PRO 1 HIS 3 ARG .7 C
LEU 3 PRO 2 GLH 4 ARG 0 A
LEU 12 PRO 11 GLH 7 ARG 1 G
ILE 9 THR 1 ASH 10 SER 3 T
A ILE
9 THR 1 ASH 10 SER 3 C
ILE 0 THR 3 LYS 17 ARG 0 A
MET 11 THR 4 LYS 3 ARG 0 G
UAL 7 ALA 13 ASP 15 GLY 14 T
G UAL 7 ALA 8 ASP 10 GLY 12 C
UAL 4 ALA 8 GLU 13 GL’Y 1 A
UAL 10 ALA 12 GLU 6 GLY 1 G
Table 6«1: Codon utilisation for the serC gene.
Figure 6. 7.: Application of Fickett's Testcode to 
.the DNA sequence of the open reading 
frame.
(a) the open reading frame; numbers refer 
to the sequence in Figure 6.6. This 
open readipg frame is clearly protein 
coding, when compared with:
(b) the aroA coding region; numbers refer 
to the sequence in Figure 5»H*

N>-M
-?>
6.2.8 Further aspects of* the codon utilisation, relevant 
to expression of aroA and the other genes sequenced 
in this work
The codon utilisation patterns of4 'highly' expressed 
E.coli genes (e.g. for ribosomal proteins) have been compared 
with those of Weakly1 expressed genes (e.g. for repressors) 
(Grosjean & Fiers, 1982). It has.been proposed that the 
efficiency of translation of an mRNA is affected by two 
parameters. The first is the frequency of use of 'modulating1 
codons i.e. codons recognised by tRNAs which are present in 
relatively low molar amounts. The codon composition of the 
genes sequenced in this study have been analysed and the 
number of modulating codons determined (Table 6.2). For 
comparison, the data for 'strongly* (s) and 'moderately to 
weakly' (w) expressed genes of E.coli has been collated from 
Table III of Grosjean & Fiers (1982). The data suggests 
that the aro genes come into the 'moderately to weakly' 
expressed category (the frequency for aroD is lower than 
0.02, but this is based on a single modulating codon in 59 
possible positions and it is unlikely that this implies 
that aroD is 'strongly' expressed).
The second parameter is the frequency of use of codons 
in a degenerate set that optimises the codon-anticodon 
interaction. The data for 'optimal' and 'suboptimal* codon- 
anticodon interactions is shown in Table 6.3> again along­
side data from Table III of Grosjean & Fiers (1982). In 
this case, the ratio of optimal:suboptimal codons is very 
close for the aro genes, the trp biosynthetic genes and
1Modulating
codons aroD aro A aroE serC trpE,D,C ,B S U
CUA 0 0 1 3 21 3 22
AUA 0 0 3 0 2 2 27
CGA/G 0 2 4 1 16 4 69
AGA/G 1 1 1 0 9 4 45
GGA/G 0 6 5 1 74 18 108
Total 1 9 14 5 122 31 271
Total possible 59 143 81 93 1220 1516 1612
Frequency 0.017 0.06 0.17 0.05 0.1 0.02 0.17
Table 6.2: Frequency of ’modulating* codons in the aro genes.
ft-
Optimal aroD aroA aroE serC trpE»D ,C »B S Ili
UUC 3 4 4 10 67 113 102
AUC 7 9 6 10 83 262 118
ecu 2 4 4 1 • 20 21 29
ACU 3 7 4 1 22 103 48
UAC 1 4 0 5 40 98 65
AAC 2 9 2 10 91 159 98
CGU 7 12 3 9 77 223 99
GGU 5 13 13 14 116 226 124
Total
SuboDtimal
30 62 36 60 516 1205 683
UUU 5 9 10 8 68 39 151
AUU 9 17 9 9 113 . 67 156
CCC 0 3 2 1 25 2 46
ACC 8 10 3 4 99 137 119
UAU 5 9 5 8 76 34 96
CGC 2 7 5 7 122 101 133
GGC 8 18 7 12 127 174 140
Total 37 73 41 49 630 554 841
Ratio 0.81 0.85 0.88 1.22 0.82 2.17 0.81
Table 6.5: Use of optimal and suboptimal codons in the aro genes.
'Ratio* refers to the ratio of optimal to suboptimal codons.
for the 'moderately to weakly' expressed class (w). The 
open reading frame has a higher ratio, probably indicating 
that its product is synthesised in greater quantity within 
the cell than the other gene products mentioned here.
6.3>1 What is the protein encoded by this open reading frame?
The region of the E.coli chromosome around minute 20 is 
illustrated in Figure l.h (from Bachmann, 1983). The map 
shows the marker loci flanking aroA. This cloning work has 
located aroA with respect to rpsA.
In the opposite direction from rpsA. the most closely 
mapped gene is pdxC. According to Bachmann (l983)> pdxC 
is defined as a requirement of pyridoxine. Pyridoxine 
(Vitamin B^) and its coenzyme forms function in a large 
number of different enzymatic reactions in which amino acids 
or amino groups are transformed or transferred. The most 
common type of4 enzymatic reaction requiring pyridoxal 
phosphate as a coenzyme is transamination. Little is known 
about the biosynthesis of pyridoxine in micro-organisms 
and it is assumed that the pdxC mutation is in the structural 
gene for a pyridoxine biosynthetic enzyme.
pdxC was first described in Taylor (1970). This 
mutation represented a third class of non-allelic mutations 
leading to a pyridoxine requirement. Preliminary results 
indicated that it was very closely linked to aro A (95-97$> 
cotransduction frequency with phage Pi), but it was not 
known whether the gene lay clockwise or anticlockwise to 
aroA.
The gene order was established by Cronan €it al. (1972) 
during experiments aimed at mapping the fabA locus 
(unsaturated fatty acid biosynthesis). These indicated that 
-pdxC - aroA - (rpsA) - pyrD - fabA - 
is the correct orientation*
Since the product of the pdxC gene is not known, it 
is not possible to assay the enzyme, either in wild type 
E.coli or in plasmid carrying strains which will be over­
expressing the product.
6.3*2 The serC gene
There is evidence suggesting that the mutation which 
defines pdxC is an allele of the serC gene. The serine 
biosynthetic pathway brings about the conversion of 3- 
phosphoglycerate to serine in three steps (Figure 6.8).
The enzymes catalysing the steps are encoded in the serA, 
serB and serC genes, which have been located on the E.coli 
map (Bachmann, 1983)* The serC genotype, a mutation in 
the gene which encodes 3-pl1osphoserine amino-transferase 
(PSAT), was first described in E.coli B (Dempsey, 1969) 
and subsequently in E.coli K12 (Clarke e_fc al., 1973) where 
it was shown to be closely linked to aroA (PI cotransduction 
frequency 93Y°) • serA and serB mutants require only serine 
for growth, but serC mutants display a double requirement 
for serine and pyridoxine.
While characterising pyridoxine auxotrophs of E.coliB, 
a number of serine and pdxF mutants were studied (Dempsey & 
Itoh, 1970). Five classes of pyridoxineless mutants were
serA
serC
COOH 
H - C - OH
c h 2 - 0 - ®
U-NAD +  
COOH
I
C = 0
c h 2 - o - ®
s-G LULOc KG
COOH
i
H9N - CH 
1 l
serB
c h 2 - 0 - ®  
^ h 2o
COOH
I
HoN - CH
z i
CH2 - OH
3-phosphoglycerate
Phosphoglycerate dehydrogenase
3-phosphohydroxypyruvate
Phosphoserine aminotransferase
3-phosphoserine
Phosphoserine phosphatase
serine
Figure 6.8; The biosynthesis of1 serine From 3-phosphoglycerate.
identified, one of which, pdxF lacked the enzyme PSAT. It 
was shown that pdxF is a special class of serC mutant. Two 
schemes were proposed to explain this finding and are 
illustrated in Figures 6.9a and 6.9b.
E.coli K12 serC mutants also require both serine and 
pyridoxine for growth. Shimizu and Dempsey (1978) showed 
that mutants revert easily to pyridoxine independence 
without regaining PSAT activity. When 3-hydroxypyruvate 
is used as a supplement, both the revertants and the parental 
types synthesise pyridoxine in normal amounts, but neither 
can use this compound to satisfy their serine requirement.
As serine alone is inadequate to provide the nutritional 
requirement of serC mutants, these mutants must be unable 
to synthesise 3-hydroxypyruvate from serine. This suggests 
that in normal E.coli. PSAT serves as a catalyst for trans- 
aminating small amounts of serine to 3-hydroxypyruvate, 
which is then used in pyridoxine biosynthesis (Figure 6.9c),
Transduetional analysis was used to locate the secondary 
mutations in the revertant strains. The results are summarised 
in Figure 6.10. The authors suggest that the secondary 
mutation in KL281B may be either in a gene which lies between 
serC and aroA or it may be a mutation in the serC allele 
itself which allows more efficient conversion of serine 
to 3-hyd:roxypyruvate. The mutation in KL281B20 which 
converts KL281B to wild phenotype must be so closely linked 
to aro A that recombination between it and aroA is extremely 
unlikely.
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Nowhere in the literature are there any reports of4 
transduction analysis using both serC and pdxC mutants.
The observations described above suggest that serC mutants 
and pdxC mutants are different classes of mutants within 
the same gene. . Any mutations in the gene upstream of aroA 
would map extremely close to aroA or would be inseparable 
from it in cotransductional analysis, as was found for the 
revertants described above. The results suggest that the 
product of the open reading frame may be PSAT.
Itoh & Dempsey (1970) have reported the purification 
of PSAT from E.coliB. The enzyme was nearly homogeneous .
(one minor contaminant on SDS-PAGE); the native was 
estimated to be 80 $00 (sucrose density centrifugation).
•They also confirmed that the enzyme used pyridoxal 5*“ 
phosphate as a co-factor, in common with other trans­
aminases.
6,3*3 Transformation of an E.coli serC mutant
The first confirmation that the upstream gene is serC 
was provided by genetic complementation of an E.coli K12 serC 
mutant E.coli KL282. This mutant was obtained from the 
E.coli Genetic Stock Centre as a glycerol stock. The
filter disk carrying the bacteria was dropped into 10 ml 
Nutrient broth (Difco, 13 g/l) and incubated overnight.
This culture was then streaked out onto LA and single 
colonies obtained. A single colony was further purified 
and its growth properties investigated. This .confirmed 
that it required supplementation with both serine (20 pg/ml)
and pyridoxine (75 P-g/l) i-n order to grow on minimal medium.
E.coli KL282 was transformed with a number of plasmids 
and transformants selected by plating on LA, supplemented 
with the appropriate antibiotic. Several colonies from 
each plate were then transferred onto one minimal medium 
and one minimal medium plate supplemented with serine and 
pyridoxine. The plasmids used and the results obtained 
are detailed in Table 6.4. As expected, only those clones 
carrying the entire upstream gene are capable of complementing 
the serC mutation in E.coli KL282.
6.3.4 Specific activity of PSAT in crude extracts
More direct evidence that the upstream gene is serC 
was provided by measuring the specific activity of PSAT 
in crude extracts of E.coli K12 and of plasmid carrying 
strains. Once again, one can predict a 100-fold higher 
level in cells carrying serC on pAT153 than in wild type 
cells, assuming that the gene is expressed constitutively.
PSAT can be assayed by coupling the formation of a- 
ketoglutarate to the glutamate dehydrogenase reaction and 
following the decrease in as -*-s consumed (Figure
6.1l). The assay conditions used were modified from 
Hirsch-Kolb & Greenberg (1971) (Section 2.19)*
Crude extracts were prepared from 100 ml batches of 
E. coli celljs grown in minimal medium to = 1.3*
Sonication buffer * B 1 was used (Section 2.18). Three 
extracts were assayed for PSAT activity - E.coli K12,
E.coli AB2829/pKD501 and E.coli AB2829/pKD506. The specific
Plasmid Growth on: 
minimal medium minimal + serine 
+ pyridoxine
pAT153 0 1
pKD501 1
pKD503 1 1
pKD506 0 1
- 0 1
Table 6.4: Growth of E.coli KL282, transformed with 
a number of different plasmids.
1 - growth 0 - no growth
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activities of PSAT and EPSP synthase are shown in Table 6.5* 
These results show that PSAT is overexpressed 
approximately 100-Fold in cells harbouring pKD501 and that 
a wild type level is seen in cells harbouring pKD506. This 
conFirms the serC complementation results.
6.3*5 PuriFication oF PSAT
It has been suggested that a heavily stained band on 
an SDS-PAGE oF crude extracts oF E.coli carrying certain aroA 
recombinant plasmids (Figure 5*8) represents a plasmid 
encoded enzyme. The experiments described above imply 
that this band corresponds to PSAT. The oF the protein 
in the band is estimated From Figure 5*8 to be 40 000; 
this is approximately halF the native molecular weight 
estimate For PSAT From E.coli B (itoh & Dempsey, 1970).
During the puriFication oF EPSP synthase From E.coli ■ 
AB2829/pKD501 the band corresponding to PSAT can be seen 
to persist through the First two steps, but is seen only 
as a minor component in the pool oF EPSP synthase aFter 
the next step (Figure 1 in Duncan, Lewendon & Coggins,
198^-a) . EPSP .synthase is eTuted From phenyl-Sepharose 
by a decreasing salt gradient. A large protein peak is 
observed beFore the peak corresponding to EPSP synthase.
This peak was assayed For PSAT and it was Found that 
this activity was present. Fractions over the peak were 
pooled and the enzyme was Further puriFied to homogeneity 
by chromatography on an FPLC mono-Q ion-exchange column 
(Ann Lewendon, unpublished results).
Extract Specific activity 
of PSAT (U/mg)
Relative
activity
Specific activity 
of EPSP tynthase 
(U/mg)
E.coli K12 0.011 1 0.004
E.coli AB2829/pKD501 1.06 96 0.42
E.coli AB2829/pKD5D6 0.010 1 0.004
Table 6.5: Specific activity of PSAT in crude extracts of E.coli.
Approximately 8 mg of purified PSAT were obtained
From 20 g oF E.coli• The puriFication Factor From the
crude extract was 6.9 -Fold. It was shown that the enzyme
has a sub-unit M oF 39 000 and a native M oF 68 000,r r 7
similar to the dimeric enzyme isolated From E.coli B 
(itoh & Dempsey, 1970).
6.3.6 The amino acid composition of PSAT
The amino acid composition of purified PSAT has been 
determined (Ann Lewendon, unpublished results). The 
experimentally determined composition and the composition 
derived From the DNA sequence are illustrated in Table 6.6. 
There is a good agreement between both sets of data, 
confirming that the open reading Frame is PSAT. Note that 
there is one Fewer methionine residue in the experimental 
value than in the predicted value.
6.3*7 The amino-terminal sequence of PSAT
The amino-terminal sequence of PSAT was determined oh 
the automated protein sequencer Facility at Aberdeen, by 
Ann Lewendon. The sequence obtained is illustrated in 
Figure 6.12. The sequence agrees with that predicted From 
the DNA, starting with the Ala residue at position 335 in 
the DNA sequence, with the exception of Leu-19* This was 
identified as Phe by HPLC of the PTH-amino acid derivative 
at that cycle. However, there was some doubt as to whether 
this assignment was correct (see A. Lewendon, Ph.D. Thesis, 
University of Glasgow, 1984). The DNA sequence in this
Amino
acid
Relative amino acid composition 
based on Leu = 30 residues
Theoretical amino acid 
composition predicted 
from the DMA sequence
Ask 39.6 45
Thr 12.5 12
Ser 20.2 20
Glx 33.3 30
Pro 15.7 15
Gly . 31.4 28
Ala 43.2 . 4 1
Cys 4.7 4
Val' 28.1 28
Met 10.4 11
H e 18.8 19
Leu 30 30
Tyr 13.1 13
Phe 18.4 18
His 6.2 6
Lys 19.8 20
Arg 16.6 17
Trp nd 5
Gin nd 11
Asn nd 20
Table 6.6: Amino acid composition of PSAT, compared with the
composition predicted by the DNA sequence of the 
serC gene.
1 10
Ala - Gin - lie - Phe - Asn 
11
Ala - Met - Leu - Pro - X 
21
Ala - Gin - Gin - X - Leu
31
Leu - X -  X -  X -  X
Phe - Ser - Ser - Gly -.Pro
20
Glu - Val - Phe - Lys - Gin
30
Arg - Asp - Trp - Asn - Gly
37
Met - Glu
Figure 6«12« Amino-terminal sequence of PSAT.
region is quite clearly correct from both strands of the 
DNA. The codons for Leu and Phe are:
Leu: TTA, TTG, CTT, CTC, CTA* CTG
Phe: TTT, TTC
The Leu codon used at this position is CTT; only a 
change to TTT could alter the DNA sequence to give Phe.
The nucleotide sequence is unambiguously CTT.
The amino-terminal methionine residue predicted from 
the PSAT coding sequence is not found in the native enzyme, 
indicating that it has been removed by post-translational 
modification. This agrees with the finding that the 
experimentally derived amino acid composition has one 
fewer methionine than the DNA sequence predicts.
6.3*8 Is the linked expression of aroA and serC a cloning 
artefact?
It is conceivable that aroA and serC expression is 
not linked in vivo and that the observations which have 
been made during this work are an artefact introduced 
during manipulation of the genomic DNA. For example, 
the deletion of a piece of DNA between the transcription 
terminator located downstream of serC and the start of the 
aroA coding region may have removed the in vivo promoter 
of the aroA gene. It is not possible that this has happened 
in going from the phage DNA (A.pserC) to the. plasmids 
because pKD505 and pKD506 were constructed in a different 
way and yet show the same properties regarding aroA expression.
pKD505 was derived from the phage DNA directly, but pKD506 
was constructed from DNA isolated from a digest of pKD501 
DNA.
This leaves the possibility that a region was deleted 
during the aberrant excision event which led to the 
formation of ApserC, or during propagation of the phage, 
prior to selection. Deletions are not uncommon among 
phage which carry a portion of foreign DNA. Constraints 
on the amount of DNA which can be packaged into a phage 
head mean that deletions which make the DNA a more packagabl 
size will be selected for.
It is very unlikely, however, that any cloning artefact 
are present. The plasmid pMONl (Rogers at al., 1983)* 
which also carries the E.coli aroA gene, was constructed by 
subcloning a Hindlll fragment of a A-recombinant phage 
carrying a segment of the E.coli chromosome around minute 20 
Rogers at al. state that the restriction map of pMONl is 
identical to the independently derived maps of ApserC 
and another phage AaspC (Christiansen & Pederson, 1981), 
both of which carry DNA from the minute 20 region.
Nevertheless, it was decided to confirm these findings 
by isolating the aroA gene from E.coli genomic DNA. High 
molecular weight DNA was prepared from E.coli K12 (ATCC 
1^948) by a modification of the method of Marmur (1961) 
(Section 2.8), followed by centrifugation to equilibrium 
in a CsCl gradient. The DNA was digested with PstI and 
purified by phenol/chloroform extraction and ethanol 
precipitation. The fragments were then ligated to PstI
cleaved and phosphatase treated pAT153 and the ligation
mix used to transform E.coli AB2829* Transformants were
selected by plating on LA/tet then replica plated onto
Rminimal medium. Of approximately 2 000 tet colonies 
screened,. 8 were capable of growth on minimal medium.
Plasmid DNA was isolated from these colonies and restriction 
enzyme digestion revealed an insert at the PstI site in 
only one of them. This plasmid was designated pKD308.
Further digests showed that pKD508 is formally equivalent 
to pKD502 in that it has an insert at the PstI site in the 
same orientation as in pKD502.
6.3*9 Are pKD508 and pKD502 identical?
A series of restriction enzyme digests has shown that
pKD508 and pKD502 are not identical. Figure 6.13,
tracks 10 and 11, shows that the PstI fragment inserted in
pKD508 is larger (4*9 kb) than that inserted in pKD502 
(4.6 kb). Digestion with Clal (tracks 13 and 14) revealed 
an extra site in pKD508 which is not found in pKD502.
A restriction map of pKD508 was built up (Figure 6.14).
The fact that the two clones are not identical may simply 
be due to a different strain of E.coli K12 being used as 
a source of the DNA in the initial cloning/genetic 
manipulation experiments.
More importantly, the fragment sizes in the Clal-PvuII 
region are the same. Tracks 3 and 4 (Figure 6.13) show 
that the same 1.9 kb Clal-PvuII fragment is present in 
both plasmids. In tracks 1 and 2, the lower triplet of
1 3 i5 G 1 8  1 (0 II II 13 14 15 16 U
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Figure 6.13: Restriction enzyme digests of pKD308 and pKD302
Track DNA Enzyme(s)
1 pKD508 BstEII + HincII
2 pKD502 BstEII + HincII
3 pKD508 Clal + PvuII
k pKD502 Clal + PvuII
5 pKD508 Bglll + Clal
6 pKD502 Bglll + Clal
7 Hindlll
8 pKD508 PstI + Clal
9 pKD502 PstI + Clal
10 pKD308 PstI
11 pKD502 PstI
12 pAT153 PstI
13 pKD508 Clal
Ik pKD302 Clal
15
O
n•1—1 kb Clal-PvuII fragment of pKD302, 
digested with Hpall
16 1-9 kb Clal-PvuII fragment of pKD308, 
digested with TaqI
17 1-9 kb Clal-PvuII fragment of pKD302, 
digested with TaqI
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bands is the same; the middle band of this triplet is 
the 0.6 kb BstEII-HincII fragment which spans the serC- 
aroA boundary.
These digests might not reveal minor deletions or 
insertions which could alter the DNA between the genes.
A Clal/PvuII digest of pKD508 and of pKD502 was separated 
by electrophoresis on 1 °fo LMT agarose. In each case, the 
1.9 kb Clal-PvuII band was excised and digested (without 
further purification) with TaqI. Half of the fragment 
DNA from pKD502 was digested with Hpall. Digestion products 
were separated by electrophoresis on 2°fo agarose and the 
ethidium bromide stained gel is shown in Figure 6.13* It 
is difficult to see the TaqI fragments in the digest of 
pKD308 Clal-PvuII fragment, but the negative of this 
photograph clearly shows that the patterns are identical, 
and in particular, no difference in the mobility of the 
124 bp TaqI fragment spanning the serC-aroA interface can 
be observed.
These restriction enzyme digests suggest very strongly 
that the structure of the intergenic region in the DNA 
cloned from ApserC is identical to that cloned from genomic 
DNA, and hence that the expression of serC and aroA are 
linked in vivo. Proof that the two intergenic sequences 
are identical could be obtained by cloning and sequencing 
the 124 bp TaqI fragment from pKD508. To date, this has 
not been carried out.
6.4 The serC-aroA operon
6.4.1 Model of the operon
The most obvious conclusion from the experiments 
described in Chapter 5 and in this Chapter is that the 
serC and aroA genes form an operon. This, conclusion 
suggests a model for the expression of the aroA gene in 
E.coli which is shown in Figure 6.13*
In this model, serC and aroA are both transcribed from 
the same promoter (or promoters) which is located upstream 
of serC. Two messages are synthesised. mRNAl is a poly- 
cistronic message which extends from the promoter to a 
point on the 3* side of aroA. mRNA2 is monocistronic, 
encoding only serC and extending from the promoter to the 
transcription terminator between serC and aroA. mRNA2 is 
likely to be the more abundant message, as the intracellular 
concentration of the serC product is higher than that of 
the aroA product, both when the cloned operon and the 
genomic operon are expressed. The model also predicts 
that transcription terminates in vivo frequently at the 
intercistronic terminator and that aroA expression is 
dependent on read-through at this terminator.
There are several ways in which this hypothesis can 
be tested experimentally. For example:
(a) Northern blot analysis: this involves blotting RNA
prepared from E.coli AB2829/pKD301 to nitrocellulose 
and probing with various parts of the serC-aroA operon. 
Probes from the serC region should identify two mRNA 
species, while those from the aroA region should identify 
a single message.
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(b) SI nuclease mapping: This can be used to identify
transcription start and stop sites.
(c) Hybrid select/translate: by binding a DNA fragment
from the aroA gene to ivctrocellulose, it should be 
possible to select the aroA message. Translation of 
the message in a cell-free system would then be expected 
to give two products, one corresponding to EPSP synthase, 
and one to PSAT.
At the time of writing, the first two experiments have 
been carried out and the preliminary data obtained is 
presented in the sections which follow.
6.4.2 Preparation of RNA from E.coli AB2829/pKD501
RNA was prepared from E.coli AB2829/pKD501 by the hot 
phenol procedure (Section 2.39)• It was then subjected to 
electrophoresis on 1 °fo agarose. A smear was observed with 
bands corresponding to l6S and 23S rRNA.
6.4.3 Northern blot of RNA
The RNA was subjected to electrophoresis on a 1 °fo 
agarose gel containing formaldehyde (2.2M final concentration) 
as described in Maniatis ejfc al. (1982). Approximately 40 p,g 
of RNA was loaded in each of four tracks and electrophoresis 
carried out till the dye front had migrated about 2/3 way 
down the gel. The running buffer was recirculated during 
electrophoresis.
The formaldehyde - denatured RNA was transferred to 
nitrocellulose as follows: the gel was soaked in 20 x SSC
for 10 min. A blot was set up as described in Section 2.41 
and left overnight. The nitrocellulose filter was then 
washed briefly in 3 x SSC, dried in air (l h) and baked 
at 80° under vacuum for 2 h.
6.4.4 Preparation of probes for Northern blot
Radioactively labelled probes for the RNA blots were 
prepared by synthesising the second strand of M13 single­
stranded template DNA corresponding to parts of the serC-
o p
aroA operon. (or P)dCTP was incorporated into the newly 
synthesised strand; templates were chosen so that the 
labelled strand would be complementary to the mRNA.
Four probes were chosen; they are illustrated in 
Figure 6.l6 as PI to P4. The arrows indicate the labelled 
strand. The rationale behind the use of these particular 
portions of the sequence is as follows:
PI - Clal fragment: if two messages are synthesised, then
this probe should locate both.
P2 - TaqI fragment: this fragment overlaps both genes
and includes the terminator sequence. It should again 
hybridise, to both mRNAs.
P3 - Hpall fragment: same reasoning as for P2, but a longer
probe extending beyond the 5 1 and 3* ends of the TaqI 
fragment.
P4 - HincII-PvuII fragment: this probe should detect only
aroA encoding sequences, i.e. only the longer of the 
two predicted mRNAs.
Figure 6.16: Summary of4 the sequencing strategy 
For the entire serC-aroA operon, 
and location of the probes used in 
Northern blot analysis, and SI 
mapping experiments.
Probes: PI 0.5 kb Clal fragment
P2 124 bp TaqI fragment
P3 61k bp Hpall fragment
P4 0.8 kb HincII-PvuII fragment
P5 364 bp Hpall fragment
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Single-stranded templates were annealled to primer 
as described in Section 2.28. To this was added 4 pi C°
(*CTP recipe, Section 2»30), 1.25 1*1 (a^P)dCTP (Amersham 
PB10165; >400 Ci/mmol) and 1 U Klenow fragment of DNA 
polymerase. After incubation at room temperature for 30 min, 
2 nl 0:^  10 x restriction enzyme buffer, 2 pi BSA (l mg/ml) 
and 5 U each of Hindlll and EcoRI were added. Incubation 
was continued a further 1 h at 37° and digestion products 
were separated by electrophoresis on 2°fo LMT agarose. Bands 
corresponding to the labelled inserts were excised and the 
DNA purified by phenol/chloroform extraction and ethanol 
precipitation. The probes were now resuspended in 100 pi
6 x SSC and the radioactivity counted:
PI 1.5 x 10^ cpm/10 pi
P2 0.8 x 10^ cpm/lO pi
P3 1.1 x 10^ cpm/lO pi
p 4 1.4 x 10^ cpm/lO pi
6.4.5 Prehybridisation of nitrocellulose filters
The nitrocellulose was cut into four identical strips,
each having a blot of the E.coli AB2829/pKD501 RNA. The
strips were sealed in polythene along with prehybridisation
2solution (0.2 ml/cm ), taking great care to exclude air 
bubbles (Section 2.42). Prehybridisation was at 68° for 
6 h in a shaking water bath.
6.4.6 Hybridisation of* nitrocellulose filters
The corner of the bag was cut and the prehybridisation
solution was removed. This was replaced by hybridisation
2solution (50 p,l/cm ) and the bag resealed. Hybridisation 
solution was the same as prehybridisation solution, except 
that the remaining 90 p,l of* probe was added before it was 
placed in the bag.
Hybridisation was overnight at 68° in a shaking water
bath.
Filters were then removed and the hybridisation 
solution released to radioactive waste. Before drying, 
the filters were treated as described in Maniatis e^t^ al. 
(1982). Autoradiography was at -70°; an intensifying 
screen was used.
6.4.7 Autoradiography of Northern blot
The autoradiograph resulting from the blot described 
above is shown in Figure 6.17» The four probes used show 
a variation in the pattern of mRNA molecules identified. 
Probes PI, P2 and P3 identify two mRNA molecules whereas 
P4 identifies one (the longer one). This is the result 
which was predicted for this experiment. It suggests that 
two mRNAs are synthesised from a promoter upstream of 
serC.
6.4.8 Nuclease SI mapping of the serC-aroA transcripts 
The enzyme Nuclease SI (from Aspergillus oryzae) will
degrade RNA or.denatured DNA into 5 1-mononucleotides, but
1 3  <.
polycistronic
serC-aroA
message
monocistronic 
serC message
Figure 6.17: Northern blot analysis of the serC-aroA operon 
The probes used in each lane were:
Track 1 P4 (aroA coding sequences only)
2 PI (serC coding sequences only)
3 P2 (aroA and serC coding sequences
and intergenic region)
4 P3 (aroA and serC coding sequences
and intergenic region)
will not degrade duplex DNA or RNA/DNA hybrids under 
appropriate conditions. A fragment of DNA encoding a 
promoter can be hybridised to mRNA and the RNA/DNA hybrid 
digested by nuclease SI. The digestion product, the 
protected DNA sequence, can then be identified by gel 
electrophoresis, and from its length the location of the 
transcription startpoint can be deduced.
The probes used in this work were labelled throughout 
one strand of the DNA (the strand complementary to the mRNA) 
in the-same way as the probes for the Northern blot (Section 
6.4.4). This has the disadvantage that the protected length 
which result could originate from either end of the fragment 
However, it is technically easier to follow this approach 
and the results presented here are preliminary.
Three probes were used (Figure 6.16). The logic 
behind their use is as follows:
P2 - TaqI fragment: this should give full length protection
and/or protection of a shorter length corresponding to 
mRNA2 to the terminator site.
P3 - Hpall fragment: confirmation of the results from P2;
also initiation from a promoter upstream of aroA and 
upstream of P2 would be seen.
P5 - Hpall fragment: this should map the transcription
startpoint.
The probes were prepared exactly as described for the 
Northern blot probes, except that they were finally 
resuspended in 50 P-l hybridisation buffer (Section 2.42).
The radioactivity in each sample was:
P2 0.6 x 10^ cpm/3 V-l
P3 1.4 x 10^ cpm/3 111
P3 0.9 x 10^ cpm/3 P<1
To each probe was added 30 P-g RNA in 30 pi hybridisation 
buffer. The sample was incubated for 3 h at 33°• 300 >il
ice cold 1 x SI buffer (Section 2.4o), containing 2 000 U 
•SI nuclease was added and incubation continued at 43° for 
43 min. Digests were phenol/chloroform extracted and 
ethanol precipitated then resuspended in 10 p.1 TE buffer.
4 p,l of formamide dye mix. was added and the sample boiled 
for 3 min before loading 3 pi onto a DNA sequencing poly­
acrylamide gel, alongside a sequencing ladder* as length 
markers. The gels obtained are shown in Figure 6.18.
6.4.9 Results of SI mapping
The SI mapping results presented here are very 
preliminary. However, they do confirm the predictions 
made for the mRNA startpoint in the model and also can be 
used to define accurately the.transcription startpoint for 
the serC gene. Results are shown in Figure 6.18.
Fragment P3 was protected over its full length from 
SI degradation. This could be due either to protection by 
mRNA spanning the intergene region or to protection by 
the complementary DNA strand. A second protected region 
has a length of approximately 325 nucleotides. If this 
represents protection by the 3 1 ©nd of an mRNA then the 
message terminates at position 1462 in the sequence, at 
the T residues which form part of the terminator structure
Figure 6.18: SI nuclease mapping of the serC-aroA
transcript
A - electrophoresis for 2 h on a
buffer gradient 6fo acrylamide gel.
1 A )
)
2 C ) DNA sequencing reactions
) as size markers
3 G
4 T )
5 mapping of fragment P2
6 mapping of fragment P3
7 mapping of fragment P5
B - electrophoresis for 5 h on a non-gradient 
G°fo acrylamide gel.
8 A )
9 C
10 G ) DNA sequencing reactions
) as size markers
11 T )
12 mapping of fragment P2 nn
13 mapping of fragment P3 *t
14 mapping of fragment P5 ^
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following serC. The alternative explanation that this 
protected region is the 5* end of the aroA message is 
unlikely as the transcription startpoint would be at position 
10239 and no promoter-like sequences are present in this 
region.
Fragment P2 shows a more complex pattern. The M13 
clone from which fragment P2 was obtained carries two TaqI 
fragments, the second of which is not complementary to the 
predicted mRNA and hence will not be protected by mRNA.
The pattern obtained for SI mapping of P2 has three 
protected lengths
275 t>P corresponds to protection of the full tandem 
clone by the opposite strand of the DNA.
. 124 bp corresponds to protection of the TaqI fragment 
containing the intergenic region, by an mRNA which spans 
this region and encodes both serC and aroA.
56 bp corresponds to protection by a transcript which 
either stops or starts within the 124 bp intergene TaqI 
fragment. If protection is by the 3 ’ end of mRNA then the 
transcript stops at position 1458. This correlates well 
with the above finding that P3 is protected from digestion 
by a transcript which ends at position 1462.
The pattern obtained for P2 therefore provides conclusive 
evidence that there are two mRNA transcripts, one of which 
encodes the serC and aroA genes and the other terminates 
at the rho-independent terminator sequence between the 
genes.
Fragment P5 is protected over its full length by its 
complementary strand. There is, however, a ladder of 
protected lengths, the longest of which is 90 nucleotides. 
The ladder effect is probably due to degradation at the 
5 ’ end of the mRNA prior to hybridisation. Working back 
from the Hpall site, the transcription startpoint was 
determined to be at position 274.
6.4.10 Transcription startpoint and promoter of the serC- 
aroA operon
The transcription startpoint determined by SI mapping 
of P5 is shown in Figure 6.19* Upstream of this is a 
sequence which corresponds to the consensus E.coli promoter 
-10 and -35 regions.
6.4.11 Other features in the promoter region
A search for inverted repeats in the sequence of the 
promoter region revealed a 26 bp sequence which can form 
a stem-loop structure similar to that shown in Figure 6.3* 
The -10 region of the promoter is then located at the top 
of the stem-loop. This is a common feature of the operator 
sites of genes which are regulated by a repressor. Examples 
of this in aromatic biosynthesis include the trp operon 
(Platt, 1978), the aroG gene (Davis & Davidson, 1982) 
and the aroH gene (Zurawski et al., I98I). The -10 region 
of the trp operon promoter is located at the top of a stem 
loop to which the trp repressor is known to bind, preventing 
RNA polymerase from binding to the promoter. These
-35 4------ 17 b o  » -10 mRNA
  _    - •-------i
235 ACTGAATGATAAAACCGATAGCCACAGGAATAATGTATTACCTGTGGTCGCAATCGATTG
250 270 ......
-----------  ^ <----    Clal
Inverted repeat
Start of serC gene 
MetAlaGlhlle
295 ACCGCGGGTTAATAGCAACGCAACGTGGTGAGGGGAAATGGCTCAAATC
310 330 345
Figure 6.19: The promoter of the serC-aroA operon.
observations suggest that expression of the serC-aroA 
operon is regulated by a repressor. There is no evidence 
to support this hypothesis as no regulatory mutants of 
either aroA or serC have been described. Further discussion 
of the expression is based on speculation and cannot at 
present be substantiated by experimental evidence.
6.5 Examples of linked gene expression systems in E.coli
Investigations of the expression of several sets of 
linked E.coli genes have shown that the serC-aroA operon 
structure is not uncommon. The U.V. - inducible lexA and 
lexD genes are co-transcribed, but are separated by a 
transcription terminator (Miki _et al. , 1984). The majority 
of constitutive transcription from the lexA promoter is 
terminated at a terminator immediately following the gene. 
However, after induction of lexA, a fraction of the 
transcription passes through the terminator, allowing the 
lexD protein to be synthesised.
A second example is the E.coli pyrE operon. pyrE is 
the structural gene for orotate phosphoribosyl transferase, 
an enzyme which participates in the biosynthesis of UMP. 
Expression of pyrE is regulated by a UTP-modulated relief 
of an attenuator situated in front of the gene (Poulsen 
et al., 1984). The gene in front of pyrE, and which forms 
the other member of this operon, remains to be identified.
In both examples, the operon structure is similar; 
promoter-gene-transcription terminator-gene.
The terminator can be regarded as an attenuator of 
expression of the second gene. However, both examples 
differ from the serC-aroA case in that there is clearly a 
functional reason for the co-ordination of expression and 
attenuation in these systems. In the first case, lexA 
is constitutively expressed at a low level and is auto­
regulated. On U.V.-induction, the lexA product is cleaved 
by recA and transcription is no longer repressed leading 
to the synthesis of large quantities of lexA product, and 
by the attenuation mechanism, to smaller quantities of lexD 
product, both of which are required for the 'SOS response'. 
In the second case,- the function of the gene preceding pyrE 
is not known, but the important point to note is that the 
attenuation mechanism is relieved only in response to a low 
level of UTP within the cell, and hence pyrE expression 
takes place.
In the biosynthetic operons which have been studied in 
detail in E.coli, e.g. the trp and his operons, the enzymes 
encoded in the genes of the operon are related in that they 
catalyse reactions on the same pathway. Induetioh of 
expression of the operon is necessary in order that the 
end product of the pathway may be synthesised, and each 
one of the gene products must be produced, otherwise the 
pathway will not function. For this reason, it is widely 
believed that co-ordination of gene expression in response 
to the needs of the cell is the principal function of the 
operon.
The same cannot be said of the serC-aroA operon.
EPSP synthase and PSAT are enzymes which catalyse reactions
on completely separate biosynthetic pathways. There is 
evidence in the literature that both aroA and serC are 
constitutively expressed (Tribe e t a l . , 1976; McKitrick & 
Pizer, 1980). This begs the question: is there any way
in which co-ordinate control of the expression of these 
genes might be of value to the cell, possibly in a way 
which would be masked in the experiments which showed 
constitutive expression?
There are two biosynthetic points of contact between 
the end products of the serine and shikimate biosynthetic 
pathways. The first is in the synthesis of tryptophan.
At the final step, indolglycerol phosphate and serine are 
converted to tryptophan and glyceraldehyde 3-phosphate by 
tryptophan synthase. Tryptophan is the second least abundant 
of the common amino acids, constituting 1% or less of the 
average protein mass. Serine, however, plays a much more 
central physiological role. Apart from protein synthesis, 
it is also used in cysteine and phospholipid biosynthesis, 
and conversion of serine to glycine provides most of the 
'one-carbon' pool of the cell, which is required for the 
synthesis of many important intermediates. The biosynthesis 
of tryptophan will therefore not be expected to perturb 
significantly the serine pool of the cell, and so co-ordinate 
control of the synthesis of tryptophan precursors is 
extremely unlikely.
The second point of contact is in the biosynthesis of 
enterochelin (enterobactin), which is responsible for 
sequestering iron from the environment. Iron is an essential
requirement for bacterial growth, but under normal environ­
mental conditions it exists as an insoluble ferric hydroxide 
polymer or in the human and animal most is bound to trans­
ferrin in the serum or lactoferrin in secretory fluids.
In response to such iron-limiting conditions, most aerobic 
and facultative anaerobic organisms have evolved a high 
affinity pathway for assimilation of Fe(lll) which consists 
of low-molecular-weight carriers (siderophores) and the 
cognate membrane receptors for binding and uptake. Entero- 
chelin is the siderophore manufactured by E.coli and forms 
the 'high affinity' iron uptake system. A second 'low 
affinity' system is available to E.coli. If citrate is 
present in the growth medium, induction of a system for 
citrate-mediated iron transport occurs (Neilands, 1982).
Enterochelin synthesis begins with chorismate which 
is converted in three steps to 2,3-dihydroxybenzoic acid. 
Enterochelin synthetase, which is composed of four enzymes, 
then converts 2,3-dihydroxybenzoic acid^serine to entero­
chelin, a cyclic trimer of 2,3-dihydroxybenzoylserine.
The enterochelin iron uptake system consists of at least 
seven biosynthetic genes (entA - entG), a transport gene 
(£e£) and a gene (fes) involved in the breakdown of the 
ferric enterochelin complex, all of which map in a cluster 
around minute 13* The expression of the nine genes is 
regulated by the intracellular iron concentration; the 
genes have been cloned and the genetic organisation of 
the cluster investigated (Laird _et al_. , 1980; Laird &
Young, 1980). Recently, it has been shown that five of
the genes form an operon (entA(CGB)E) and that all the 
genes are transcribed from iron-regulated promoters (Fleming 
et al., 1983).
Buck & Griffiths (1981) have shown that in media where 
ferric iron is not freely available, E.coli contains a 
population of specifically undermodified tRNAs. The 
undermodified t R N A ^ e, tRNA^r and tRNA^r^ can function 
as positive regulatory elements of the aromatic amino acid 
transport system. An increased ability to take up aromatic 
amino acids from the medium might give the cell a growth 
advantage. The synthesis of enterochelin is likely to 
impose an imbalance upon the aromatic amino acid bio­
synthetic pathway by depleting the chorismate pool; the 
enhanced ability to acquire rather than synthesise these 
amino acids may be an important feature of cellular economy 
where enterochelin synthesis is necessary for growth. It 
has also been shown that the undermodified tRNAs have 
lowered translation efficiencies and can relieve transcription 
termination at the trp and phe operons (Buck & Griffiths, 
1982). In Salmonella, modification is related to growth 
in aerobic or anaerobic conditions. Iron deficiency is 
usually only a problem during aerobiosis, and it is under 
these conditions that tRNA is undermodified (Buck & Ames, 
1984).
McCray & Herrmann (1976) investigated the ^ repression of 
certain aromatic amino acid biosynthetic enzymes in E.coli 
grown in medium deficient in iron. The results obtained 
suggested that the increased synthesis of enterochelin
during iron starvation could be accounted for by de­
repression of DAHP synthase (tyr) and the branch pathway 
to dihydroxybenzoate. Derepression of DAHP synthase would 
increase the biosynthesis of chorismate in the cell, 
thereby maintaining the chorismate pool for aromatic amino 
acid biosynthesis. The increased expression of aroF is 
thought to be due to relief of attenuation at the tyr operon 
(O’Connell _ejfc al. , 1983, cited in Herrmann, 1983)*
The specific activity of EPSP synthase was not determined 
under the conditions used in McCray & Herrmann (1976). The 
only clue in the literature to the involvement of iron in 
the expression of aroA comes from the work which showed that • 
aroA is constitutively expressed (Tribe e_t al• , 1976).
Close examination of Table 2 of this paper reveals that 
the specific activity of EPSP synthase was consistently lower 
in cells grown in iron citrate, medium than in cells grown 
in either minimal medium or minimal medium supplemented 
with aromatics. The specific activity of the other enzymes 
in the pathway remained constant.
The biosynthesis of enterochelin requires serine and 
chorismate in equimolar amounts. Studies by McKitrick &
Pizer (1980) have indicated that there is a constant, but 
rapidly turning over pool of serine within the cell. Under 
the experimental conditions used, it was shown that the 
transaminase (PSAT) was in large excess. It is likely, 
however, that in the medium used to grow the cells (M9 
salts + glucose), the bacteria would be actively scavenging
iron and so would require a large amount of serine for 
enterochelin biosynthesis. Any reduction in PSAT activity 
due to repression of gene expression would therefore be 
masked.
The observations described in this section provide 
evidence that iron limitation has a large effect on gene 
expression in E.coli. For the systems which have been 
studied in detail, the modulating effect is due to under­
modification of tRNA, which alters the attenuation of 
transcription at a number of biosynthetic operons. The 
repressor which controls expression of the ent, fes and fep 
genes is not known. It is possible that these genes are 
regulated in the same way as the aroF gene; examination 
of the DNA sequences upstream of aroF and the ent genes 
may answer this.
There is no evidence that attenuation plays a role in 
the expression of the serC-aroA operon. The sequences in 
the 5 ’ leader region cannot be folded to form structures 
analogous to these found in the trp operon (Yanofsky, 1981) 
nor is there a ’leader peptide’ located in this region.
The inverted repeat at the -10 region of the promoter may 
be involved in a different type of regulatory mechanism. 
This may be the operator site for an as yet unidentified 
repressor. It is possible that the genes are expressed 
at a low constitutive level under conditions where there is 
sufficient iron and that this amount of each enzyme can 
satisfy the requirements for biosynthesis of both serine 
and chorismate. Only under iron stress are the pools of
serine and chorismate depleted rapidly and so increasing 
the synthesis of the two enzymes might help to replenish 
these intermediates.
Many more straightforward interpretations of the 
linked gene situation are possible. A deletion of the 
promoter of aroA may have made aroA expression dependent 
on expression of serC. Alternatively, a transposition event 
may have moved one of the genes intact to within the other 
gene. Either serC and its terminator was moved to lie 
between aroA and its promoter, or aroA was moved to the 
site downstream of serC.
6.6 Suggestions for further work
Definitive proof that the aroA and serC genes are 
translated from the same mRNA may be obtained by in vitro 
translation of message selected by an aroA sequence probe.
The factors which affect expression of serC and aroA 
in vivo must be studied. In particular, the effects of the 
presence or absence of iron in the growth medium will show 
if iron is a modulator of the expression of this operon.
CHAPTER 7 GENERAL DISCUSSION
7»1 Sequence homology searching
7.1.1 Introduction
One of the aims of the work presented in this thesis 
was to determine the DNA sequence of one or more of the 
E. coli aro genes , deduce the corresponding amino acid 
sequence and then to compare both gene and protein sequences 
with the sequences of the N.crassa (or any other) arom 
cluster gene and the corresponding multifunctional protein 
sequence. As the sequence of an arom gene is not yet 
available, this discussion will necessarily be restricted 
to making comparisons of two E.coli genes that have been 
sequenced with the sequences of related genes. The 
preliminary results of these two searches are presented 
here as examples of the searches which will be instigated 
in the near future.
It is possible to look for homologies between the 
primary structures of proteins and/or their gene sequences 
in a number of ways. The simplest is to scan and compare 
sequences by eye for highly conserved features or to line 
up sequences which are known to be closely related.
However, the comparison and matching of sequences which 
are distantly related, or unrelated, is extremely difficult; 
it requires a computer to compare the sequences and to 
collate information. A number of programs have been written 
for this purpose and also for searching databases for 
homologous or related sequences. For example, the program
COMPARE in the WISGEN package (Section 2.36) is derived 
from the matrix analysis of Maizel & Lenk (1981). The 
review by Doolittle (1981) provides a valuable insight 
into the pitfalls of comparing sequences and deducing 
relatedness.
7.1.2 3-dehydroquinase
The complete sequences of two 3-dehydroquinase enzymes 
are available: the E.coli aroD gene product (Chapter 4) 
and the N. crassa inducible qa-2 gene product (Alton et_ al. , 
1982; Dr M.E. Case, unpublished results). Although these 
enzymes catalyse the same reaction, they play a different 
role in the cell; the E.coli enzyme has a biosynthetic 
function, whereas the inducible N.crassa enzyme has a 
function in catabolism. Are the enzymes derived from a 
common ancestor or are they the result of convergent 
evolution of function? Are either of them related in 
sequence to the 3-dehydroquinase domain of the arom 
polypeptide? These questions can be addressed by comparing 
the sequence around the active site lysine of arom 3- 
dehydroquinase with the sequences around the 17 lysine 
residues in E.coli 3-dehydroquinase and the two lysine 
residues in the catabolic 3-dehydroquinase.
It is known that the mechanism of 3-dehydroquinase 
involves the formation of a Schiff base intermediate
with a lysine residue at the active site of the enzyme.
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This can be- trapped and labelled with H-sodium borohydride 
(Butler ejb al. , 1974). The active site lysine of arom was 
labelled in this way and following proteolysis a labelled
peptide was isolated and its sequence determined by a 
micro-protein sequencing technique (Dr S. Chaudhuri, 
unpublished results). The sequences flanking all of the 
lysine residues are aligned in Table 7*1* The sequence 
most homologous to the arom active site sequence is Lys-138 
of the E.coli enzyme, where 5/15 residues are identical.
In Neurospora the lysine is part of the tetrapeptide VKLV 
and in E.coli the sequence is VKVY, a single conserved change 
One can predict that if both biosynthetic 3-dehydroquinases 
are truly homologous, then lys-138 represents the most 
likely candidate for the active site of the E.coli enzyme. 
Neither of the lysines in the catabolic 3-dehydroquinase 
are homologous to the arom sequence or to the sequence around 
lys-138. Experiments are in progress in our laboratory 
aimed at labelling and identifying the active site lysine 
from both the E.coli and the catabolic enzyme.
This result can be interpreted as implying that the 
catabolic and biosynthetic enzymes have arisen separately, or 
that they have diverged substantially from a common ancester. 
Evidence in support of this comes from consideration of the 
of the enzymes. The catabolic enzyme has an of 20,000 
and exists as a dodecamer whereas the E.coli enzyme has an 
of 28,000 and is a dimer. Following limited proteolysis, 
it is possible to isolate a fragment of the arom complex 
which carries the 3-dehydroquinase and shikimate dehydrogenas 
activities (Smith & Coggins, 1983)* This has an of 
68 000 and is comparable in size to the bifunctional 3- 
dehydroquinase/shikimate dehydrogenase of P .mungo which has 
an Mr of 59 000 (Koshiba, 1979)*
No* of matches
*
arom ALQHGDVVKLVGVAR
AroD
Lys-2   MKTVTVKD 3
- 7  - -M K T V T V K D L V IG T  2
- 1 7  LV IG T G A P K 11V S L M  1
- 2 5  K IIV S L M A K D IA S V K  1
-3 1  M AK P IA S V K S E A LA Y  3
- 6 6  VESVM AAA KILRETM  1
- 7 5  IL R E T M P E K P L L F T F  1
- 8 5  LLFTFRSAKEGGEQA 3
- 1 2 5  LFTGDDQVKETVAYA 3
- 1 3 8  AYAHAHDVKVVMSNH 5
- 1 4 7  VMSNHDFHKTPEAEE 2
- 1 6 0  E E 1 1ARLRKMQ5FDA 1
- 1 7 0  QSFDADIPKAALM PQ 2
- 2 0 7  P11TM S M A K TG E IS R  2
- 2 2 9  SGGNFWCGKKSVCAR 3
- 2 3 0  GGNFWCGKKSVCARA 2
- 2 4 0  VCARANLGK-------------- 1
qa-2
Lys-95 EAGLGPGDKV3AI11 2
-147 RHHSYLSDKAVAVIC 3
Table 7*Is Sequence around the active site 
lysine of arom 3-dehydroquinase* 
and the lysine residues in the 
E.coli and catabolic N*crassa 
enzymes*
7.1.3 Phosphoserine aminotransferase
The primary sequence of a number of transaminases has 
been determined (Barra e_t al., 1980; Doonan et al., 1975?
Huynh erb al. , 1980; Kondo £_t al. , 1984; Shlyapnikov ejfc al. , 
1979> Ur M. Edwards, unpublished results). These sequences 
have been very highly conserved during evolution; comparison 
of bacterial and mammalian sequences show that they are 
approximately 30% conserved. This begs the question: Is
the sequence of the serC gene product also so highly conserved?
The sequences around the lysine to which pyridoxal 
5 ’-phosphate binds in the transaminases described above 
are listed in Table 7»2, along with the sequences flanking 
the lysine residues in the sequence of PSAT. This comparison 
shows that none of the lysines in PSAT is homologous to 
the sequence around the lysine in the other enzymes.
The program COMPARE in the WISGEN package (Section 2.36)•• 
was used to compare the protein sequence of PSAT with that 
of E.coli tyrosine aminotransferase (the tyrB gene product). 
Parameters were set so that each time an identical match 
of two residues was found in a window of three residues, 
a point was plotted. A plot of‘the data obtained (using 
DOTPLOT on a Hewlett-Packard HP 7221 plotter) is shown in 
Figure 7«1« There is no clear pattern to the spread of 
points. A similar comparison between the tyrosine amino­
transferase sequence and the sequence of chicken heart 
cytoplasmic aspartate aminotransferase is shown in Figure 
7«2. In this case the homology is striking; the points 
along the diagonal show that the sequences are highly
Aspartate aminotransferase
QSFSKNFGLYNERVGM 
QSF SKNF GLYNERVGN 
QSYAKNMGLYGERVGA 
QSYAKNMGLYGERVGA 
SSYSKNFGLYNERVGA
Chicken cyto. 
Pig cyto*
Pig mi to.
Rat mito 
E. co1i
Tyrosine aminotranferase 
NSFSKIFSLYGERVGG E.coli
Shlyapnikov et a) (1979 
Doonan et al (1975) 
JBarra et a) (1980) -
Hvunh et al (1980)
Kondo et al (1984)
Dr. M.Edwards (unpub.)
Phosphoserine aminotransferase - lysine residues
Lys-20 AEVLKQAQQELRDWNG 
-44 SHRGKEFIQWAEEAEK 
*-55 EEAEKDFRDLLNVPSN 
-S8 PSNYKVLFEHGGERGN 
“91 ILGDKTTADYVDAGYN 
-108 ASAIKEAKKYCTPNVF 
-111 IKEAKKYCTPNVFDAK 
“112 KEAKKYCTPNVFDAKV 
-122 VFDAKVTVDGCRAVKP 
“132 LRAVKPMREWQLSDNA 
“198 AGAQKNIGPAGLTIVI 
“219 DLLGKAN1AC PSILDY 
-254 GLVFKWLKANGGVAEM 
-257 FKWLKANGGVAEMDKI 
-267 AEMDKINQQKAELLYG 
-272 1NQQKAELLYGV1DNS 
-292 NDVAKRNRSRMNVPFQ 
-311 SALDKLFLEESFAAGL 
-326 LHALK GHRVVGGMRAS 
-348 LEGVKALTDFMVEFER
Table 7*2 The lysine residue to which pyridoxal. 
5-phosphate binds in a number of 
aminotransferases, and the lysine 
residues in PSAT.
\i
Ao
k*
 
n
r
.
n
^
n
k
:
,
 
tf5
2F
i. 
, 
] 
, 
f.o 
. 
dt
ff
l
a  a w u y . A U i A U V  V < l i C U i W 4  9 J l M W U y  A r f j W V A A  J
Figure 7*1i Dotplot of the PSAT amino acid sequence vs* the
amino acid sequence of 5*coli tyrosine aminotransferase. 
A dot was plotted at each position where there were 
two identical amino acids in a group of three*
Ityrosine 
aminotransferase 
(E.coli)
Aspartate aminotransferase (Chicken cytoplasmic)
Figure 7*2: Dotplot of Chicken cytoplasmic aspartate aminotransferase vs
E.ooli tyrosine aminotransferase, A dot was plotted at each 
position where there were two identical amino acids in a group 
of three.
Tyrosine 
aminotransferase 
(E.ooli)
conserved. This is despite the fact that one sequence 
is from a prokaryotic and one from a eukaryotic organism.
These results show that PSAT does not belong to the 
same family of transaminases as the other highly conserved 
members described in Table 7*2. Since the other trans­
aminases are so well conserved and PSAT is so completely 
different it is likely that the two classes of enzyme have 
evolved completely independently of one another - an 
exceptionally good example of convergent evolution of 
function. Only a knowledge of the sequences of the other 
aminotransferases of E.coli will tell if PSAT is unique 
iamong transaminases or if there are others in this second 
class. The nucleotide sequences of the 5 ’-coding regions 
of two other aminotransferase genes from bacteria are 
known. The predicted amino-terminal protein sequences of 
transaminase B from E.coli (the ilvE gene product; Lawther 
et al., 1979) and imidazolyacetolphosphate aminotransferase 
from S.typhimurium (the hisC gene product; Riggs & Artz, 
198^) are not homologous to each other, or to the amino- 
terminal sequences of PSAT, or to the tyrosine and aspartate 
aminotransferases from E.coli. However, without knowing 
the entire sequences it is not possible to say that they 
are not homologous to PSAT.
A final point is that the difference between PSAT 
and the other transaminases may be related to the function 
or evolution of the serC-aroA operon. It is possible that 
the ancestral serC gene had a different function, but one
which was related to the function of the aroA gene. The 
linked expression of the genes might at that time have 
been important to the cell. As the function of the gene 
changed, the linked expression may have become unnecessary, 
but there would be no evolutionary pressure to uncouple 
expression, and in any case, uncoupling would require the 
evolution of a separate promoter for aroA.
7.2 Evolution of the arom gene
The sequences of the aroD and aroA genes, along with 
the sequence of aroE (i. Anton, Ph.D. Thesis, University of 
Glasgow, 198^) and aroB (G. Millar, unpublished results) 
will be used to deduce in detail their evolutionary relation­
ship to the arom gene, when this sequence becomes available.
At present, the sequences and complementary protein chemistry 
data allow us to give hard numbers to the M^'s of the E.coli 
shikimate pathway enzymes. The M ^ ’s are shown in Table 7»3»
With the exception of 3-dehydroquinase, the E.coli 
enzymes corresponding to the arom activities exist as monomers. 
This was unexpected and is unusual for E.coli enzymes, 
particularly for shikimate dehydrogenase, which represents 
the only example of a monomeric dehydrogenase in E.coli.
It is interesting to note that when the subunit M^'s are 
added, the total for one of each type of enzyme is 163 000 
(see Table 7»3)« This is very close to the subunit of 
165 000 for the N .crassa arom polypeptide (Lumsden &
Coggins, 1977)•
Pathway
step
E.coli 
sub-unit M
r
N.crassa 
sub-unit M
r
1 (trp) 39 000 (2) 52 000 (4)
2 40 000 (1)
3 28 000 (2)
4 29 000 (1)
5 20 000 (1) 165 000 (2)
6 46 000 (1)
7 not known 50 000 (?)
Table 7.3. The quarternary structure of the shikimate 
pathway enzymes. The number of subunits 
in the native enzyme is shown in brackets.
Together with the comparative 3-dehydroquinase sequences 
and the comparison with the bifunctional 3-dehydroquinase/ 
shikimate dehydrogenase plant enzyme, this provides more 
evidence that the arom gene evolved by fusion of* ancestral
E.coli-like genes.
7«3 Future prospects for the aroA gene
The identification of EPSP synthase as the primary 
target for the herbicide glyphosate has stimulated interest 
in the use of a cloned aroA gene in gene replacement 
experiments in crop plants. A mutationally altered form of 
EPSP synthase might be resistant to glyphosate and if the 
gene encoding this form of the enzyme was inserted and 
expressed in a plant, then it might confer on the plant 
resistance to the herbicide. This would allow the crop to 
be sown at the same time as the application of the herbicide, 
increasing the length of the growing season.
Towards this end, a strain of S.typhimurium has been 
isolated which has a mutant aroA gene and which synthesises 
EPSP synthase that is resistant to inhibition by glyphosate 
(Comai ejfc al., 1983)* DNA sequence analysis of both the wild 
type Salmonella aroA allele and the glyphosate resistant 
aroA allele has shown two things. Firstly, the sequence of 
the wild type enzyme is very homologous to the E.coli aroA 
sequence. Secondly, a point mutation, resulting in a single 
amino acid substitution is responsible for the glyphosate 
resistant phenotype (D. Stalker, ¥. Hiatt, L. C’omai, 
unpublished results). The change involved is:
Position 101 wild type TCG/Ser 
mutant CCG/Pro
The expression of* an altered aroA gene in plants 
depends on two factors. It is necessary to insert the 
gene into the plant genome in such a way as to ensure that 
it is stably inherited. The gene must then be capable of 
being transcribed and translated^in the plant system. That 
both of these are possible has been shown in a number of 
cases. A chimaeric gene composed of the promoter of the 
Pi sum sativum ribulose 1,3-bdsphosphate carboxylase gene 
along with the coding sequence of a bacterial chloramphenicol 
transacetyiase gene was introduced into the genome of 
Nicotiana tabacum using a Ti plasmid of Agrobacterium 
tumefaciens. It was demonstrated that this gene was 
expressed and that the level of expression was light-inducible 
in chloroplast-containing transformed tissue (Herrera- 
Estrella e_t al. , 1984). A second example is the introduction 
of a chimaeric gene containing the coding sequence of the 
bacterial gene for neomycin phosphotransferase II (the 
Kanamycin resistance enzyme) to plant cells. Ti plasmid 
mediated transformation of Nicotiana plumbaginifolia was used 
to introduce this gene to cells in culture and the cells 
regenerated to morphologically normal plants. These plants 
carry a functional Kanamycin resistance gene which is 
inherited and expressed as a dominant Mendelian trait 
(Horsch ejt al• , 1984).
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